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”It is xenophobia and ignorance that threaten conflict, not alliances and friendships.” – Unknown author,
and unfortunately relevant in 2017.
0.2 Abstract
Transition metal complexes are attractive imaging probes as they offer distinctive photophysical, electro-
chemical and synthetic advantages over organic dyes, quantum dots and fluorescent proteins due to their
high photo-stability, long luminescence lifetimes and large Stokes shifts. Gold nanoparticles have also revolu-
tionised the design, delivery and functionality of imaging probes, being attractive scaffolds to bind lumines-
cent complexes, targeting vectors and therapeutic substances. Previous work in the group has demonstrated
that gold nanoparticles can be efficiently coated with transition metal complexes, with the resulting coated
particles useful in cellular imaging. In this work, a water-soluble luminescent ruthenium complex and pH-low
insertion peptides (pHLIPs) were coupled to gold nanoparticles, and these labelled-nanoparticles exhibited
enhanced uptake into human cervical adenocarcinoma cells. The mechanism of pHLIP-mediated nanoparticle
delivery was investigated, by conducting time and pH resolved experiments, with an interest in contrasting
the benefits of two pHLIP variants as nanoparticle delivery vectors. Subsequent investigations revealed the
concentration of intracellular glutathione imposed an effect on nanoparticle internalization efficiency and the
colloidal stability of labelled gold nanoparticles, and that providing gold nanoparticles with a hydrophobic
lipid coating also enhanced the efficiency of nanoparticle internalization into cells.
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This chapter reviews the reported uses of gold nanoparticles within biomedicine, providing an introduction
into their first discovery, adaptation of synthetic methods, their use as delivery vectors and subsequent appli-
cations in imaging/diagnostics and therapeutics. The chapter also contrasts the archetypal metal lumophores
available, their photophysical properties, and their development as biological imaging probes. The review
then focuses on how surface-labelling gold nanoarticles with a lumophore permits detection within biological
samples using a plethora of imaging, spectroscopic and spectrometric techniques.
1.1 A Brief History of Gold Nanoparticles
The noble element Gold, has long been a subject of scientific research, and currently resides in many diverse
applications throughout a multitude of fields. While colloidal gold nanoparticles have been known to have
been used for centuries in stained glass, they didn’t receive scientific evaluation until Michael Faraday began
in 1852 [1]. Nanoparticles are defined as ultrafine particles with lengths in two or three dimensions that
fall within the boundaries of 1 and 100 nm, and a facile synthetic route for aqueous gold nanoparticles
was first pioneered by Turkevich in 1951 [2], refined by Fren in 1972 [3], and since then has had a great
number of adaptations. Gold colloids have notable interactions with light and electrons, enabling them
to serve as useful contrast agents within light and electron microscopies. These techniques are two of our
most valuable tools for investigating intracellular structure and function, thus prompting the increasing
presence of gold nanoparticles in contemporary biomedical imaging research. Gold nanoparticles have also
strongly influenced the field of theranostics, first appearing in the literature in 2002 [4, 5] where the potential
for incorporating diagnostic and therapeutic tools into a single structure is becoming more promising. In
contemporary research, gold nanoparticles have been applied to drug delivery [6], DNA delivery [7], plasmonic




Light microscopy has revolutionised the way biologists are able to peer inside a cell and visualise intracel-
lular structure and processes. Static environments can be imaged through fixed cell imaging, or functional
processes through live-cell imaging[13] [14]. Three very attractive features of light microscopy include firstly
the sensitivity, where it is possible for single molecules to be detected, depending on the intrinsic proper-
ties of the fluorophore, and within the context of imaging biosystems, also dependent on the amount of
background autofluorescence [15]. Secondly, the timescale of fluorescence is rapid, typically ranging from
nanoseconds to microseconds depending on the molecular emitter [16], permitting visualisation of rapidly
occurring biomolecular processes in real-time, with new adaptations of the technique continuing to push the
limits of available temporal resolution.[17] And finally, contemporary super-resolution techniques such as the
sophisticated far field techniques of Stimulated Emission Depletion (STED)[16, 18, 19, 20] and Structured
Illumination (SIM)[21] along with the pointillism techniques of Photo-activated Localization (PALM)[22, 23]
and Stochastic Optical Reconstruction (STORM) [24], which are capable of pushing the spatial resolution
to less than 20 nm are becoming more and more routine [25].
1.2.1 Principles of Luminescence
Luminescence is the release of electromagnetic radiation, in the form of light, from a substance that did not
receive any heat input. Luminescence was first reported by Sir George G. Stokes in 1852 when he reported red
light emission when the mineral fluorospar was illuminated with utraviolet light, and later when he reported
a blue glow from a quinine solution under ultraviolet excitation [26]. Luminescence requires an energy
input, and although some substances will luminesce after chemical reactions (chemiluminescence), physical
agitation (mechanoluminescence), or application of an electical current (electroluminescence) by far the
most common form of luminescence is photoluminescence where the absorption of light provides the energy
required for emission. The specific energy levels that are involved in luminescence transitions are specific
to the luminescent species, and will each have their own unique energy and symmetry. Generally speaking
however, in photoluminescence a molecule absorbs incident light and transitions into an electronically excited
state, upon which a fraction of moleules that reside in that excited state will relax back to their ground state
by radiative decay mechanisms. The time a molecule spends in its excited state can range from femtoseconds
to milliseconds depending on the molecular emitter, and the time taken for the number of emitting molecules
to decay to 1/e (36.8%) is termed the luminescent lifetime. Additionally, another useful measure of a species
luminescence is the luminescence quantum yield (ΦF ) which is a ratio of the number of photons absorbed
and the number of photons emitted. Becquerel was the first to report that the wavelength of the emission
light was longer than the incident wavelength [27], George Stokes also noticed this and this statement later
became the Stokes law, with the wavelength difference between incident and emission light being termed the
Stokes shift.
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1.2.2 Classes of Luminescent Microscopy Agents
Luminescence imaging requires initial staining or transfection of biological specimens with fluorescent markers
(fluorophores), often with the intention of marking a specific intracellular compartment or process. Amongst
the literature lies a vast arsenal of fluorescent probes with which a microscopist can use. Such probes
include organic fluorophores (e.g. fluorescein, BODIPY and anthracene families), inorganic fluorophores
(e.g. metallocomplexes, quantum dots) and fluorescent proteins (GFP, RFP, YFP, etc). Unsurprisingly,
each class of fluorophore offers advantages and drawbacks.
Organic Dyes as Biological Lumophores
Organic fluorophores may covalently bind to, or associate with their target biomolecule, forming their re-
spective conjugates and there is a very substantial library of organic fluorophores with emission across the
UV, visible and Near-IR regions of the electromagnetic spectrum. However, organic fluorophores often un-
dergo radiative decay from their first excited singlet state (S1), leading to small Stokes shifts, and in cases
to self-absorption (in the case of fluorescein) making the separation of emission and excitation channels
more difficult. They typically have high quantum yields (typically ranging from 40 - 90%) but have similar
fluorescent lifetimes to tissue autofluorescence from natural organic components (1 - 10 ns), making time
resolved studies difficult. In many cases they are not very photostable, with complicated synthesis, with
often poor aqueous solubility [28].
Fluorescent Proteins as Biological Lumophores
Fluorescent proteins have become a powerful tool for imaging living cells or organisms [29, 30]. Gene
transfection techniques have provided a remarkable means of studying transgenic organisms, ranging from
microorganisms and mammalian cell lines [31], to much larger organisms such as mice [29], zebrafish [32],
and the frog Xenopus Laevis [33]. The proteins are naturally occurring, and therefore non-toxic, with
similar quantum yields to that of organic dyes. However, some disadvantages include firstly their unfolding
requirement in order to become fluorescently active, which can take hours, hence they are unsuitable for
imaging rapidly occurring intracellular processes. Secondly, their larger size can affect the functionality, and
kinetics of the species being tagged [34], and thirdly they typically exhibit short luminescence lifetimes.
Quantum Dots as as Biological Lumophores
Quantum dots are fluorescent semiconductor nanocrystals [35]. They have had wide use in optical imaging as
they offer high fluorescence quantum yields, narrow band luminescence and resistance to photobleaching [36].
In addition, as QDs have heavy metal cores with sufficient electron density, they can be used as imaging
agents in electron microscopy [37]. However, while the main photophysical attributes are ideal, QDs are
susceptible to blinking behaviour, where periods of no emission between fluorescent periods are common
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[38, 39] tailoring size and emission wavelength independently is difficult, their cellular toxicity is under high
debate [40].
Inorganic Metal Complexes as as Biological Lumophores
Luminescent metal complexes have found increased widespread use, offering desirable chemical and photo-
physical attributes not available to their organic competitors. Such general attributes include larger Stokes
shift (typically ≈100 nm, as opposed to ≈30 nm from organic fluorophores) owing to luminescence from
higher multiplicity states, and significantly longer luminescence lifetimes than organic fluorophores (from
hundreds of nanoseconds to microseconds) as luminescence often arises from Laporte forbidden transitions,
which are much slower than organic transitions. The complexes are often water soluble, and their synthesis
relatively simple often with simple stepwise addition of ligands to the metal centre.
Luminescent metal complexes can be subdivided further to those consisting of a central lanthanide ion,
and those consisting of a central transition element ion. The use of lanthanides as luminescent probes is
extensive [41, 42]. Some of the advantages lanthanides offer over transition elements are i) longer lumines-
cence lifetimes, more suitable for time-resolved studies, and ii) sharp emission lines, thus permitting use
of more fluorescent channels without unwanted luminescence bleedthrough. There are also disadvantages,
firstly the lanthanides are poor absorbers as their electronic transitions are Laporte forbidden, and very
weak vibronic coupling exists among lanthanides as orbitals are primarily non-bonding. Therefore in order
to electronically excite Lanthanides, light absorbing ligands (sensitizers) must be used, which does to an
extent limit the functionality of the complex. Additionally, the luminescence quantum yields of lanthanide
complexes are typically lower than that of transition metals.
The transition metal series offers a wealth of luminescent species with a range of chemical characteristics
and photophysics not accessible to organic molecules; furthermore the relative ease of tuning their spectral
properties over organic fluorophores is also appealing. Contrasting with organic fluorophores; fluorescent
proteins; luminescent lanthanide complexes and quantum dots; the transition metal series offer i) direct
excitation within the visible region of the electromagnetic spectrum, ii) reasonable luminescence quantum
yields iii) long luminescence lifetimes, iv) good photostability, v) large Stokes shift (≈ 100 nm), vi) relatively
simple synthesis, vii) solubility in water, and viii) are reactively inert, imperative for use as biological
imaging agents. The lifetime of transition metal complex emission is very sensitive to the environment of
the complex, and as a result will be impacted upon by any change in pH, concentration, O2 concentration,
dielectric constant and potential [43]. This is advantageous as a wealth of luminescence lifetime experiments
can be performed, and possession of a long luminescence lifetime increases the sensitivity within time resolved
studies.
The archetypal luminescent transition metal complex is ruthenium(II) tris-bipyridine [Ru(bpy)3]
2+ (Fig.
1.1). Although [Ru(bpy)3]
2+, is not functionally very useful by itself, it is still a good molecular probe
starting point as the metal ion in its +2 oxidation state (d6) will oxidise relatively easily, and the presence of
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Figure 1.1: UV/Vis absorption, excitation and emission spectra of ruthenium(II) tris-bipyridine (13 µM) in
water. Excitation scans were taken with the emission monochromator set to 650 nm, with a 590 nm long
pass filter, and for emission measurements the excitation monochromator was set to 465 nm with a 500 nm
long pass filter.
strongly π−accepting bipyridine ligands leads to metal-to-ligand charge transfer (MLCT) transitions to low
energy excited states, where energy input required to induce an MLCT transition is in the visible region of
the electromagnetic spectrum. This is ideal for compatibility with standard visible lasers which are not as
damaging to biological specimens as ultraviolet lasers. Fig. 1.1 shows the excitation, emission, and UV/Vis
absorption spectra of [Ru(bpy)3]
2+, and Fig. 1.2 shows a Jablonski diagram illustrating the metal-to-ligand
charge transfer transitions accessible to a ruthenium trisbypyridine complex. The absorption band at 290
nm is a π∗ ←− π transition localised on the bipyridine ligand orbitals. The absorption shoulder band at
350 nm is an electronic transition between two of ruthenium’s d-orbitals. This transition is weak as the
states have the same symmetrical parity which is forbidden by Laporte selection rules, however is allowed
by vibronic coupling. The broad absorption band at 450 nm is a 1MLCT transition where a ruthenium
d electron is promoted to an excited singlet state on a bipyridine π∗ orbital. As a second row transition
element, ruthenium exhibits strong spin-orbit coupling, which is an interaction between an electrons spin
magnetic moment, and its orbital angular momentum. Ruthenium’s possession of a large nuclear magnetic
moment, and therefore a large spin-orbit coupling increases the likelihood of the singlet and triplet states
having similar vibrational energy, rendering the intersystem crossing transition from singlet to triplet states
more favourable [44]. The 3MLCT radiative decay transition under which the excited electron is demoted to
the ground state valency orbital is spin forbidden, therefore proceeds slowly with an approximate radiative
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lifetime of 500 ns [45] (far longer than typical organic lifetimes of 1 −→ 10 ns [46]) and a luminescence
quantum yield of 4.2% in water [47]. As ruthenium exhibits strong vibronic coupling, the electron also
relaxes through a cascade of vibrational levels, this leads to a broad emission band at 650 nm, as seen in the
emission spectrum in Fig. 1.1.
Figure 1.2: Standard Jablonski diagram for a ruthenium polypyridyl complex. Solid lines and dashed lines
are radiative and non-radiative decay processes, respectively.
The use of ruthenium as a luminescent probe in light microscopy is well documented. Unfortunately,
[Ru(bpy)3]
2+ is very poorly uptaken into cells and while cellular uptake is visible after using techniques
such as electroporation, transfection and through use of detergents [43], these are not suitable for live cell
imaging or in vivo studies. However, it is relatively easy to functionalize this complex for use as a biological
luminescent probe by functionalizing the complex ligands. For example it was shown by Puckett and Barton
[48] that increasing the lipophilicity of [Ru(bpy)3]2+ bipyridine ligands permits plasma membrane trans-
duction. They also found that incorporation of phenyl rings onto bipyridine ligands results in dramatically
increased luminescence of the complex [Ru(bpy)2(dppz)]2+ (dppz = dipyrido[3,2-a:2,3-c]phenazine, a known
DNA intercalator) demonstrating the tunability of these complexes. Furthermore, a similar dppz derivative
of [Ru(bpy)3]2+ was demonstrated as a proficient cell viability marker within rat hepatocytes whereby the
Ruthenium luminescence intensity increases upon DNA binding of the intercalating moiety [49]. Ruthenium
also has potential as an oxygen sensor due to the quenching effect of triplet state O2 on rutheniums triplet
excited state [50] where fluorescent lifetime imaging microscopy (FLIM) was used to map O2 concentrations
in macrophages [51, 52]. Further attempts to promote uptake by functionalising [Ru(bpy)3]2+ derivatives
have included tethering it to Cell Penetrating Peptides (CPPs) such as the further work by Puckett and
Barton [53] where the uptake and localization of a Ru-octaarginine conjugate was studied, and the endocytic
path was believed to have changed from passive diffusion of the unconjugated complex to endocytosis for
the conjugate.
Recently, ruthenium-based probes have been adapted for in vivo imaging such as the work by Komatsu et
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al. [54]. In this work, a ruthenium tris-bypyridine complex was used to image ischemia-based hypoxia within
mice, where the quenching effect of molecular oxygen facilitated a boost in signal within hypoxic regions.
Gill et al. [55] also reported the synthesis of a dinuclear ruthenium(II) complex where the metal centres were
conjugated by a phenazine derivative. This complex was then shown to bind to specific membrane structures
such as the lipid-dense endoplasmic reticulum within human breast adenocarcinoma (MCF7) cells, resulting
in a comparable cytotoxic effect with anticancer agent, cis-platin. Ruthenium based probes have also found
applications within multiphoton excitation, such as the work by Baggaley and coworkers [56]. Here they
reported the synthesis of a dinuclear, ruthenium (II) tpphz complex, and demonstrated luminescence lifetime
imaging of human breast adenocarcinoma (MCF7) cells, where the ruthenium probe produced a lifetime of
200 ns within the nuclei, and a shorter lifetime of 124 ns within cytosolic regions. Additionally, the complexes
bound to DNA through a non-intercalative mechanism, switching on their luminescence.
Figure 1.3: Structural formula of the archetypal luminescent rhenium complex, Re(bpy)(CO)3X
Another transition metal complex with very similar properties to ruthenium(II) tris-biypridine is the
carbonylrhenium(I) complex Re(bpy)(CO)3X, where X is a monodentate ligand such as a halide or pyridine
[57]. These complexes also rely on 3MLCT emission as the main luminescent pathway. Rheniums potential as
an imaging agent was explored by Amoroso et al. [58] who synthesized a series of who synthesized a series of
rhenium complexes, with varied lipophilicity and polarity, where it was deemed that the [Re(bisim)L(CO)3]+
series offered good cellular accumulation (apparently through phagocytosis), and retainment of their useful
fluorescent properties in biological systems without compromising cell viability. Recently, Lo [59] reported
the synthesis of a biotinylated thiorea complex that internalized into the golgi apparatus of HeLa cervical
adenocarcinoma cells, however it was also reported that biotinylation rendered the complexes less lipophillic,
and therefore were less efficiently uptaken into cells.
Among other commonly used archetypal luminescent transition metal complexes include those based on
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Figure 1.4: Structural formula of the archetypal luminescent iridium complex, [Ir(NC-ppy)2(NN-bpy)]
+
iridium [Ir(NC-ppy)2(NN-bpy)]
+ [60] and platinum Pt(dpyb)Cl, where their photophysical properties as well
as applications in sensing and imaging have been reviewed [61, 62]. Time resolved emission and two photon
imaging using an inert platinum complex Pt(dpyb)Cl derivative has been demonstrated by Botchway et al.[63]
who reported exceptionally high luminescence quantum yields of upto 70%, and luminescence lifetimes into
the microseconds, as well as demonstrating the ability of this complex to function as an emission label
within a small variety of eukaryotic cell types. Whilst it is often reported that iridium complexes generally
show non-specific localization throughout the cytoplasm, it has been demonstrated that conjugation to DNA
intercalators leads to nucleolar localization as reported by Zhang et al. via co-localization with a nuclear stain
[64]. The efficient cellular and nuclear transduction is attributed to the high lipophilicity and low net charge
of the iridium complex [58]. Additionally, Lo [59] reported the synthesis of a dual-emissive cyclometalated
iridium (III) polypyridine complex that when conjugated to a biotin subunit, produced a 3MLCT emission
band at 602 nm when mixed with calf-thymus DNA, whereas when the complex was conjugated to a n-butyl
group, it produced a vibrationally structured emission spectrum at 490 nm in the presence of avidin. More
recently, a series of luminescent Pt complexes was developed by Mauro and coworkers [62] that offered and
quantum yields as high as 60% in some cases. Chung et al. [65] developed pH-switchable near infrared
emissive platinum complexes that showed efficient uptake into MadinDarby canine kidney (MDCK) cells.
De Cola and coworkers [66] developed a series of Pt complexes that were internalized into HeLa cervical
adenocarcinoma cells within a few minutes, and demonstrated how intracellular complex aggregation lead
to an enhancement of luminescent properties
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Figure 1.5: Structural formula of the archetypal luminescent platinum complex, Pt(dpyb)Cl
1.3 Gold nanoparticles in Biomedicine
The use of gold nanoparticles within biomedicine has greatly expanded over the last 20 years [67, 68]. They
can be synthesised by a variety of facile synthetic methods which offer size and shape tunability throughout
the nanoscale [69, 70], producing stable colloids which can be easily functionalised with substances such
as thiol-containing substrates and other soft metal binders [71]. Applications of gold nanoparticles within
biomedicine include plasmonic photothermal therapy due to their ability to convert light into heat [8, 72];
drug or gene delivery through serving as an inert scaffold which is readily uptaken into mammalian cells
[73]; luminescence imaging applications through coating with chromophores [74, 75]; or using electron or
dark field microscopies where contrast against cell features is provided by high electron density or coherent
scattering through interaction with surface plasmon resonance, respectively [76, 77, 78]. Their resistance
to chemical oxidation or degradation, along with low cellular toxicity has also been reported [79], and no
apparent plasma membrane disruption [80].
1.4 Optical Properties of Gold Nanoparticles
Gold and indeed other noble metal nanoparticles exhibit useful optical properties from their surface plasmon
resonance, an inherent property of some nanoscale materials, where the gold surface electrons coherently
oscillate against the restoring force of gold nuclei upon stimulation using electromagnetic radiation at their
natural frequency [81]. This manifests itself as a broad absorption band in the visible absorption spectrum
(Fig. 1.6), where the band has a Gaussian profile and is modulated by morphology [82], core charge [83],
solvent refractive index [84], inter-particle distance [85] and surface functionalization [86]. The SPR band is
also dependent on particle structure and shape, and manipulation of these factors has shown to permit the
tuning of the SPR band from the visible into the near infrared [87].
Fig. 1.6 shows the size dependency of the SPR band shape, where increasing size of the gold nanoparticle
results in a bathochromic shift and broadening of the SPR. It is partly because of this surface plasmon
resonance that gold nanoparticles exhibit a colour not accessible to individual atoms or bulk solid. Colloidal
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Figure 1.6: UV/Vis absorption spectra showing the nanoparticle size dependency of the surface plasmon
resonance band of citrate stabilised gold nanoparticles. Inset, nanoparticle diameter plotted against SPR
λmax. Experiment repeated from [88].
gold (particle diameter < 100 nm) absorbs strongly in the blue and green regions of the visible spectrum,
but significantly less so in the red region, often giving the particles a deep red colour. As gold nanoparticle
size increases, the SPR band shifts further into the red region of the spectrum, leading to a diminishing of
the particles red colour.
The introduction of polycrystalline gold nanoparticles has prompted the curiosity of many research
groups, due to their unique optical properties and reports of luminescent polycrystalline gold nanoparti-
cles, without the need for a luminescent surfactant began to emerge in the literature [89, 90]. This class
of luminescent gold nanoparticles is divided into molecular luminescent nanoparticles and plasmonic lumi-
nescent nanoparticles, and their emission bands can be tuned by controlling grain size, particle size, surface
ligands and valence state [91]. The class of molecular luminescent nanoparticles are devoid of any surface
plasmon resonance due to a low number of free electrons, but nevertheless offer emission within the visible
and near infrared regions. As the size of the gold nanoparticles approaches the electron Fermi wavelength
of gold metal (0.5 nm), the continuous band structure breaks down into discrete energy states, therefore
no longer supporting plasmon resonance but will more closely resemble molecular transitions [92]. Plas-
monic gold nanoparticles, and can be synthesised by tuning grain size of a polycrystalline AuNP, and retain
their plasmonic properties due to the their continuous band structure. This coexistence of continuous band
structure and discrete energy states within the same particle gives rise to strong singe particle emission [93].
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1.5 Assembly of metal complexes onto gold ganoparticle scaffolds
The first report of labelling gold nanoparticles with surface bound fluorophores was published in 2000 by
Thomas & Kamat [75]. A few years later the first reports of surface labelling of gold nanoparticles with
luminescent metal complexes entered publication [94, 95]. Lewis et al. published the first synthesis of water
soluble luminescent nanobeads consisting of 13 nm diameter AuNPs coated with a luminescent europium
complex [94]. In this approach a neutral europium complex was equipped with terminal thiol groups bound
to the complexes organic antenna which covalently bind to citrate stabilized AuNPs after displacing the
citrate. This facile synthesis of monodisperse luminescent nanoparticles showed promise for application in
cellular imaging. Europium is however, not an ideal cellular imaging lumophore as excitation within the
ultraviolet region of the electromagnetic spectrum is required, and radiation within the ultraviolet range
is particularly damaging to cellular samples. Transition metals offer direct excitation within the visible
region of the electromagnetic spectrum which is far less destructive, and are therefore more suitable for
this application. Transition metal complexes are however often charged, depending on the metal and the
conjugated ligands, and therefore the nanoparticle coating protocol needs to be adapted in order to coat
negatively charged citrate-stabilized nanoparticles with positively charged complexes where nanoparticle
flocculation (aggregation) is avoided. There are a few literature examples where ruthenium complexes
have been tethered to gold nanoparticles (AuNPs) [96, 97] demonstrating their potential use as imaging
probes, furthermore the work of Zedler et al. [98] indicated that the photophysical properties of Ruthenium
complexes fully conjugated to the AuNPs are preserved, or only slightly altered by the nanoparticle-complex
conjugation.
Recently, Rogers and Claire et al [96] developed an approach for the coating of negatively-charged,
citrate-stabilised AuNPs with a positively-charged ruthenium complex. In this work, prior to labelling
nanoparticles with ruthenium, the nanoparticles were labelled with the fluorinated surfactant polymer Zonyl
7950 to provide the nanoparticles with a polar coating before the thiol-equipped ruthenium complex was
titrated into the solution. This approach permitted the stabilization of larger AuNPs (13 & 100 nm diameter)
along with efficient coating of the ruthenium complex.
1.6 Cellular Interactions of Gold Nanoparticles
Recent work in our research group demonstrated that gold nanoparticles labelled with a fluorosurfactant
and a ruthenium complex were still readily uptaken (despite their new coating), and localized in perinuclear
regions of A549 human alveolar adenocarcinoma cells [96]. One complication in the use of AuNPs as cellular
delivery vectors comes when the nanoparticles are exposed to serum proteins within cell media. Exposure to
these proteins leads to the formation of a protein corona [99, 100] that coats the NP and represents what the
cell sees upon plasma membrane transduction, and ultimately determines the initial interaction of the AuNPs
with, or within living cells. This protein corona can have effects on NP charge, size, crystallinity, surface
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instability, electronic states and hydrophobicity [101]. Furthermore, it is known that citrate stabilised AuNPs
can aggregate within the presence of serum proteins, which can influence cellular uptake of the nanoparticles
by three orders of magnitude [102]. Lynch et al. [103] reported a method for quantification of nanoparticle
corona proteins as well as rates of association and dissociation. A further drawback with AuNPs is that
although they are readily taken up by cells, they are often confined to vesicular regions [77]. An ongoing
challenge within the therapeutic industry is to functionalise the AuNPs with substances that mediate their
escape from vesicular compartments, and into the cytosol, where a drug might exhibit its therapeutic action.
1.7 Promoting Cellular internalization of Gold Nanoparticles us-
ing Cell Penetrating Peptides
The use of cell penetrating peptides as delivery vectors to promote cellular delivery of gold nanoparticles has
also been gaining momentum in recent years, particularly for delivery into cancerous cells or tissue. Until
recently, many literature examples of gold nanoparticle uptake into tumours are based on manipulation of
the enhanced permeability and retention (EPR) effect exhibited by tumour tissue [104, 105], or by targeting
specific cancer cell biomarkers [106]. However it has been shown that the EPR effect is small or even non-
existent for certain tumour types [107, 108, 109], and targeting specific tumour biomarkers is complicated by
tumour cell heterogeneity [110, 111]. There are many examples of using peptides to facilitate nanoparticle
delivery into cells [112, 41, 113] and even nuclear targeting [114, 115].
1.7.1 The Trans-activating Transcriptional Activator (TAT) Peptide
The most commonly used CPP is the Trans-activating Transcriptional Activator, a regulatory protein found
within HIV-1 and is involved in viral transcription and replication [116]. Interestingly, the protein has an
unusual ability to leave infected cells, translocate the membrane of a nearby healthy cell and navigate to the
cell’s nucleus [117, 116]. The TAT protein sequence has a selection of important domains vital to its function.
Firstly, there is the domain essential for transactivation (amino acids 21-40) which is rich in cysteine residues.
The next important domain (amino acids 49–72), includes the basic Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg
motif which facilitates nuclear localisation and RNA binding and finally, (amino acids 73-101) the C-terminal
domain contributes to cytotoxic activity in cells [118, 119]. While the full TAT peptide is comprised of 101
amino acid residues, the frequently used truncated version is comprised of 86 amino acids and contains a
cysteine-rich region associated with metal dimerization in vitro [120], and a highly basic region involved in
nuclear and nucleolar localization [121, 122] and causes little disruption to the plasma membrane integrity
[123].
The cytotoxicity of TAT has been shown to be strongly dependent on the length of the peptide used,
as well as the cargo the peptide is tethered to [60]. HeLa cells have been reported to undergo significant
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necrosis when treated with TAT (residues 32 - 60) while this was considerably reduced when treated with
TAT (residues 43 - 60) [124].
Richard et al. [125] reported that the rate of uptake of fluorochrome-tagged TAT derivatives into HeLa
cells was not affected by a low temperature or depletion of the ATP pool, implying a non-dependence on
endocytotic pathways. Different studies have proposed different cell surface proteins as TAT binding sites,
including integrins [126, 127] and a 90kDA surface protein[128].
De la Fuente and Berry [129] demonstrated TAT-mediated delivery of gold nanoparticles into the nuclei of
telomerase-immortalized primary human fibroblasts (hTERT-BJ1). To prepare the particles, the reduction of
chlorauric acid (HAuCl4) with tiopronin (N-(2-mercaptopropionyl)glycine) to form 3 nm diameter tiopronin-
capped AuNPs, and the TAT peptide was subsequently conjugated to the carboxylate group of the tiopronin.
Further work by Berry [119] demonstrated nuclear localisation of TAT-labelled gold nanoparticles with
results very much depending on cell type and size of gold nanoparticles. The uptake and localization of
gold nanoparticles within fibroblasts was studied using Transmission Electron Microscopy (TEM), and it
was found that 30nm gold nanoparticles were present within the nucleus in significant quantities, and only
small amounts remained in vacuoles and mitochondria, thus indicating that the TAT peptide was able to
transport the nanoparticles away from endosomal/lysosomal pathways. Additionally, Torchillin et al. [130]
demonstrated tat-mediated translocation of plain and poly ethylene glycol coated liposomes (up to 200 nm
diameter) into mouse lewis lung carcinoma cells, human breast tumor BT20 cells, and rat cardiac myocyte
H9C2 cells. In this instance, internalization was dependent on both the size of the liposomes and the cell
type. While TAT is an efficient translocator and delivery agent, it offers little specificity between healthy
and cancerous cells. Additionally, the conclusions of almost all reports of TAT-mediated translocation
of gold nanoparticles rely on transmission electron microscopy studies only, leaving conjecture over how
representative TEM-prepared cells are of their original viable state [125]. In fact a recent report by Wei et
al. [131] demonstrated the uptake of TAT-labelled gold nanoparticles into HeLa cervical adenocarcinoma
cells where the TAT peptide mediated little to no nuclear delivery of the gold nanoparticles.
1.7.2 The pH-Low Insertion (pHLIP) Peptide
A promising candidate for the targeting of nanoparticles to cancer cells is the pH-low insertion peptide
(pHLIP). pHLIP is a short peptide derived from bacterial rhodopsin and was first reported in 1997 by Hunt
et al. [132] who reported the spontaneous translocation of a transmembrane helix. pHLIP has received
much attention since the its first publication, with numerous derivatives synthesised and its pH-dependent
translocation has been demonstrated in a variety of cell types and mouse models [133, 134, 135, 136, 137,
138]. This is a particularly interesting feature of a CPP as cancerous cells have been shown to produce more
acidic extracellular regions than healthy cells, owing to higher rates of intracellular glycolysis. This prompted
our choice to use pHLIP variants within our functional imaging probe design, and a more comprehensive
review of the pHLIP literature is in Chapter 3.
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1.8 Detection of Luminescent Gold Nanoparticles within biologi-
cal Samples
The binding of a luminescent substrate onto an electron-rich core of a gold nanoparticle enables detection of
the imaging probe through a variety of light and electron based imaging and cytometric techniques, as well
as certain spectrometric techniques.
1.8.1 Light Microscopy
Biologists have access to a plethora of imaging fluorophores and light microscopy techniques that can be
significantly tailored to suit the sample type and experiment. Light microscopy encompasses a multitude of
microscopy modes in which an image of a sample is constructed by spatially studying its interaction with
light. This interaction can be based on transmission, scatter, reflection or luminescence. While chemical
fixation is commonly used to prepare samples for imaging resulting in images with less blur, live-cell imaging
is also commonly used to image functional processes in real time.
Epifluorescence Microscopy
Fluoresence microscopy is a widely used tool for studying intracellular components and processes. Samples
are pretreated with exogenous fluorescent substrates which are termed fluorophores, and are designed to
target a specific organelle or intracellular component, while being excitable at a specific wavelength such
that they emit light at a useful intensity. The cell biologist currently has access to a wide contemporary
library of fluorophores which enables high specificity for sub micron intracellular components and high
contrast amid weakly fluorescent background depending on the autofluorescent properties of the sample.
The fundamental function of a fluorescence microscope is to irradiate a sample with a specific band and
wavelength of light, collect longer-wavelength light emitted from the sample, filter out unwanted excitation
light and subsequently direct the emitted light to a detector, where ultimately an image of the sample can
be built up. For an epimicroscope, a wide field illumination source such as an arc lamp is used, and the
detection method is commonly a CCD camera. Acquisition is typically rapid, as the imaging system will
concurrently read and process data from the entire field of view, producing a luminescent map of the sample.
Luminescence imaging has high sensitivity, far higher than reflection imaging, and permits the visualisation
of gold nanoparticles too small to be imaged by the reflection modality [139, 140].
Epifluorescence imaging permits rapid collection of light from all depths of the illuminated sample,
however with no intrinsic filters for light arriving from depths outside the imaging focal plane. Therefore
the images often contain significant amounts of image blur, and with limited depth perception it is difficult
to perform co-localisation experiments. The technique has been adapted and derivatised into a multitude of
more specialised techniques since its conception.
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Figure 1.7: Steady state absorption and emission spectra of Hoechst 33258 nucleic acid stain with inset
structural formula.
Confocal Microscopy
Confocal microscopy is a more specialised form of light microscopy where the imaging system features optical
sectioning hardware, a non-invasive technique for building up 2D images of a small depth of field comparable
to 200 nm z-slices of a specimen independently. Confocal Laser Scanning Microscopes (CLSM) are the
most widely used, and a basic representation of the fundamental components of a laser scanning confocal
microscope is shown in Fig. 1.8.
Briefly, one or more focused beams raster across the specimen, and emission light is collected from each
raster point. The emission light is refocused by the objective through the dichroic mirror and into a second
pinhole aperture. This pinhole allows light that has been refocused to its small aperture through, and blocks
out light originating from depths outside the focal plane. The position of this second pinhole aperture is
tunable across the z-dimension, allowing modulation of the chosen image focal plane. Light passing through
the second pinhole is then refocused using a second lens and subsequently channelled to a photomultiplier
tube detector, and processed into an image.
The principle limitations of this technique revolve around the physical properties of light, where there is
a physical limitation on accessible spatial resolution due to the diffraction limit of light. As light propagates
away from a point source (i.e a molecular fluorophore), it aberrates and diffracts around objects on its path
to collection by the microscope objective. As light aberrates and diffracts, it interferes with itself in either
constructive or destructive manners, resulting in the detected signal appearing as a central bright cone,
surrounded by a series of diffraction rings, known as a 2-dimensional airy function. The central cone is
known as the zeroth-order diffraction spot, and its diameter is dependent on the wavelength of the light and
the numerical aperture of the microscope. The size of the zeroth order diffraction spot, as a consequence
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Figure 1.8: Fundamental components of a laser scanning confocal microscope.
of the imaging system, is governed by the diffraction limit which defines the minimum distance between
two resolvable point sources. For two or more point sources that are nearer in space than the diffraction
limit, their airy functions will overlap too considerably for them to be discernible, and instead of appearing
as individual point sources, appear as a single point source. The mathematical definition of the diffraction
limit is defined as (Abbe Resolutionx,y) = λ/2NA where λ is the wavelength of light, and NA is numerical
aperture, which itself is defined as NA = n ∗ sin(θ), where n is the refractive index of the imaging medium
(e.g, air, water or oil) and θ is the aperture angle. Additionally, there is also a limit on achievable temporal
resolution which is primarily due to the time required to raster across the field of view, however that is being
countered with more contemporary spinning disk methods [141].
Most contemporary confocal microscopes can also be operated in reflectance mode, and individual and
clusters of gold nanoparticles that are of a diameter close to the diffraction limit can be easily visualised
by surface plasmon resonance scattering [142, 143]. The technique of confocal microscopy has facilitated in
somewhat routine imaging of luminescent gold nanoparticles within cells [144, 145, 146, 139, 96].
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Figure 1.9: Confocal microscopy image of cells treated with Hoechst 33258 nucleic acid stain. Hoechst
luminescence from excitation at 405 nm (left) and an overlay of hoechst emission and transmitted light
image at 488 nm (right).
1.8.2 Imaging Mediated by the Enhancing Properties of Gold Nanoparticle
Plasmon Resonance
Recent advances have been made within the application of gold nanoparticles within raman and dark field
microscopies due to the enhancing nature of gold nanoparticle plasmonic interactions with incident light.
Aioub et al [147] recently developed a technique that revolutionised dark field imaging by utilising the
plasmonic properties of gold nanoparticles. It was found that the irradiation of cells treated with spherical
gold nanoparticles with light at their surface plasmon resonance frequency, the cells rayleigh scattering
underwent a significant enhancement [148, 142]. The intensity of this resonantly scattered light is sensitive
to nanoparticle size and aggregation state [149]. This technique, referred to as Plasmon Enhanced Rayleigh
Scatter Imaging Spectroscopy (PERSIS) offers real time imaging without photobleaching, or the imaging
complications of using multiple fluorescent channels. Aioub et al. applied this technique to the study of
anticancer drug efficacy. In short, human oral squamous carcinoma were sequentially treated with gold
nanoparticles and an anticancer drug, and the time resolved effect of the drug was monitored by measuring
changes in scattered light from cells. Initially the cell’s rayleigh scattering remained normal, but increased
as cell death progressed [150].
Since the introduction of raman confocal microscopy, where spatially-resolved vibrational raman spectra
are taken of the sample in a label free acquisition, spatial resolution improvements have been sought due to
the intrinsically weak raman signal arising from intracellular constituents [151, 152]. Gold nanoparticles have
been demonstrated to enhance the raman signal of neighbouring biological molecules during the formation
of nanoaggregates [153]. Kang et al used targeted plasmonically enhanced single-cell imaging spectroscopy
(T-PESCIS), a technique that combines raman imaging with AuNP plasmon enhanced dark field imaging
to study cell apoptosis. Briefly, apoptosis was induced in human oral squamous cell carcinoma cells that
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had been treated with nuclear targeted-AuNPs, and time resolved monitoring of scattered light intensity
provided an assessment of apoptic progression, whereas raman imaging permitted the identification and real
time monitoring of cellular events such as protein denaturation, proteolysis, and DNA fragmentation [154].
1.8.3 Transmission Electron Microscopy
Transmission Electron Microscopy (TEM) is a technique that studies the interaction of matter with a plane
of projected electrons. A transmission electron microscope consists of three sections: i) the electron source
ii) the image producing system & iii) the image recording system. The electron source consists of an electron
gun (most commonly a tungsten filament), and a condenser lens that focuses the beam of electrons onto the
specimen. Upon transmission through the specimen, some electrons are scattered by regions of high electron
density within the specimen, while electrons passing through regions of low electron density are only weakly
scattered. Once the beam of electrons has passed through the specimen, a series of sequential lenses magnify
the transmitted electron beam for detection by a fluorescent screen. Gold nanoparticles offer good contrast
within electron microscopy, as their dense electron clouds scatter incident electrons efficiently. For instance
Mat et al. reported imaging of 10, 25 & 50 nm gold nanoparticles within autophagosomes. The technique
offers far superior spatial resolution than light microscopy alternatives owing to the much smaller de broglie
wavelength of electrons versus visible light. However, biological samples require extensive sample preparation
for the ultra high vacuum of an electron microscope, and resultantly are imaged in a state not always truly
representative of the original viable sample. Due to the electron dense nature of gold nanoparticles, and
the spatial resolution of TEM, there have been many reports of using TEM to visualise gold nanoparticles
internalized by cells [119, 130, 139, 146, 96, 77, 155].
Most contemporary electron microscopes are equipped with Energy Dispersive Analysis of XRays (EDAX)
detectors, because incident electrons have enough energy to eject electrons from core atomic orbitals. When
a core electron is removed, a valence electron drops down to the core orbital from its valence orbital via a
radiative process. The energy of the emitted radiation is within the X-ray region of the electron spectrum,
and as elements have unique arrangements of electrons, EDAX provides a way of identifying elements within
the sample. Fig. 1.10 shows the EDAX spectrum of untreated HeLa cells, overlaid with the EDAX spectrum
of HeLa cells treated wth 13 nm diameter AuNPs, where the EDX emission bands at 2, 9 and 11 eV are
consistent with reported gold EDX signal [156].
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Figure 1.10: Energy Dispersive Analysis of XRays (EDAX) spectrum of HeLa cervical cancer cells treated
with 13 nm diameter gold nanoparticles. Inset, TEM image of the region used for spectrum acquisition.
Work repeated from [96].
1.8.4 Flow Cytometry/ Fluorescence-Activated Cell Sorting
Flow cytometry, also commonly referred to as Fluorescence-Activated Cell Sorting (FACS) is a technique that
passes a fluid of single particles (usually cells) through a beam of light in order to simultaneously measure
and record physical characteristics of the particles from their light interaction. These characteristics include
size, density, granularity and relative fluorescence intensity.
A FACS cytometer has a flow system that runs the fluid containing the suspended cells through a laser
intercept. The particles scatter light as they pass through the laser beam, and fluorescent species on or
within the cell are excited, and emission light is separated from excitation light by a combination of filters
and dichroic mirrors which also channel the light to the appropriate detectors. Light scattering can be
compartmentalised into Forward Scattered light (FSC) and Side Scattered light (SSC). FSC light’s main
contribution is diffracted light, and detector is positioned at a small angle off the axis of the incident laser
line. The principle cell characteristics that affect forward scatter are size and surface topology. Conversely,
detected SSC light is constituted of reflected and refracted light, and is more dependent on granularity and
internal complexity. If gold nanoparticles are uptaken by HeLa cervical cancer cells, the granularity of the
cells increases, leading to more reflection of incident light resulting in greater side scatter signal as depicted
by Fig.1.11. The relative increase in SSC signal resultant from AuNP uptake is strongly dependent on
quantity of internalized particles, as well as the size of individual particles, both of which impose a strong
influence over light reflectance. Experiment repeated from Rogers et al [96].
Fluorescence, as described above, is the photoinduced release of light from a substance. The higher-energy
excitation and lower-energy emission light occupy an energy difference known as the Stokes shift and is, along
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Figure 1.11: Flow Cytometry Forward and Side scatter measurements of HeLa adenocarcinoma cells treated
with ruthenium-labelled Au100NPs for two hours. Experiment repeated from [96].
with the quantum yield (the quantifiable measure of fluorescence efficiency), characteristic of the molecular
emitter. Flow cytometers are commonly equipped with a variety of laser lines, enabling multiplexing of
numerous fluorophores, using suitable filters and dichroic mirrors to separate emission channels prior to
detection. However, multiplexing with too many fluophores within a single experiment can incur significant
bleedthrough and crosstalk problems.
If fluorescent subtrates are uptaken by cells, while assuming the concentration of the subtrate and the
fluorescence quantum yield of the subtrate are both large enough to release a useful quantity of emission
light after photo-illumination. Often the quantity of autofluorescent emission light emanating from cells upon
excitation is well within the sensitivity range of the instrument, therefore when measuring the luminescence
of cells treated with a luminescent substrate it is important to analyse the luminescence of untreated cells
in order to establish the magnitude of their contributions to overall signal, as shown in Fig. 1.12 where
HeLa cervical adenocarcinoma cells were treated with ruthenium-labelled AuNPs according to the protocol
reported by Rogers et al. [96].
22
Figure 1.12: Flow cytometry luminescence histograms of HeLa adenocarcinoma cells treated with ruthenium-
labelled Au100NPs for two hours. Experiment repeated from [96].
1.8.5 Inductively Coupled Plasma Mass Spectrometry
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is an technique for determining & quantifying
elemental composition of a sample. The technique can be applied to solid, liquid or gaseous samples, although
prior to atomisation, solid samples require vaporisation, and liquid samples require nebulisation. Detection
limits for ICP-MS are as low as parts per trillion (ppt) and can discriminate between isotopes of the same
element.
Figure 1.13: Constituents of an inductively-coupled plasma mass spectrometer and the process of data
acquisition.
An example of an ICP-MS system is outlined in Fig. 1.13. The sample introduction system consists of
a peristaltic pup, a nebulizer and a spray chamber. The ICP torch generates the plasma, and serves as the
ion source of the instrument. In the interface, cooled conical aperture plates are used to extract sample ions
from the central plasma channel. The vacuum system provides a high vacuum for the ion optics, quadrupole
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mass analyser, and detector. The quadrupole mass analyser scans the elemental mass range (3 - 250 amu)
while using oscillating currents to channel selected mass:charge ratios (m/z) to detection while deflecting
undesired m/z. The detection system commonly involves either direct current measurements via an ion
collector or consists a secondary ion generation system that feeds into a multiplier before channelling into
an ion collector. Quadrupole mass analysers are more sensitive for higher amu elements than lower ones due
to effects such as the zero blast effect, where analysis of small elements is complicated by larger amu ions
reach detection despite mathematically unstable paths. Moreover, The use of ICP techniques to quantify
AuNP uptake into cells is used relatively routinely [155], and the technique can also be applied to assess the
number of heavy metals occupying surface space of gold nanoparticles as studied by Lewis et al [94]. Data
included in this thesis all had R2 values of greater than or equal to < 0.99.
1.9 Project Aims & Thesis Outline
The goal of this work was to develop cancer cell-targeting imaging probes by surface labelling gold nanopar-
ticle scaffolds, whereby sequential labelling processes would provide the nanoparticle with a functional sur-
factant intended to promote cellular delivery, and a luminescent label to permit visualization. The functional
surfactants investigated include cell penetrating peptides, an anionic fluorosurfactant and a lipid carboxylate,
and these were each chosen because of their desired interactions with eukaryotic cells. We were also inter-
ested in developing the use of inorganic metal complexes as biological lumophores, and to demonstrate the
advantages they provide within luminescence imaging of biological samples. The structural, physicochemical
and luminescence properties of all labelled nanoparticles were comprehensively characterized, and protocols
were refined until labelled-nanoparticles offered good labelling homogeneity and monodispersity, as well as
being suitably luminescent for application within fluorescence microscopies and flow cytometry. Addition-
ally, labelled-nanoparticle interactions, internalization and stability within human cervical adenocarcinoma
cells was investigated, and the impact of nanoparticle internalisation on cell viability was also assessed. This
project represents the opening steps towards the synthesis of nanosized, cancer cell-targeting photothermal
therapy agents.
Chapter 1 contains a broad literature review and is a useful prelude to all chapters, however each chapter
contains its own introductive literature as a preface to the results. Chapter 2 focuses on the synthetic ele-
ments of the project, documenting the synthesis of the luminescent complex RubpySS and gold nanoparticles,
and subsequently the labelling of the gold nanoparticles with a pH low insertion peptide and a ruthenium
lumophore. The labelled-AuNPs are characterized with a plethora of structural, physicochemical and lu-
minescent characterisation techniques while addressing the benefits and difficulties of synthesising imaging
agents using gold nanoparticles and transition metal complexes. The chapter then focuses on how colloidal
dispersion and stability of the labelled-AuNPs is affected by adjusting the pH of the colloidal solution to
either side of the peptide’s pH insertion window (pH 6.5 & 7.4), characteristic of cancerous and healthy cell
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peripheral microenvironments. Chapter 3 reports pH-dependent, peptide-mediated delivery of luminescent
gold nanoparticles into cancer cells, using a multitude of techniques to study relative and quantified uptake
of internalized gold nanoparticles. Cell viability assessments were then performed to study any cytotoxic
effects of nanoparticle internalisation. Chapter 4 reports how the concentration of intracellular glutathione,
the mammalian cells most prevalent reducing agent, exerts an effect on labelled-AuNP stability and in-
ternalization into human cervical adenocarcinoma cells. Chapter 5 reports the synthesis of hydrophobic
luminescent gold nanoparticles and demonstrates the effect of the hydrophobic coating on the efficiency of
nanoparticle internalization into cancer cells. Chapter 6 provides an overall evaluation of project results and
describes what the next direction of the project should be. Chapter 7 reports all materials and methods,








Luminescence imaging is a powerful tool that allows the microscopist to image at high sensitivity, low
background intensity, and with routine spatial resolutions of approximately 200 nm. These boundaries are
continually being pushed, for example the introduction of the Confocal imaging system permitted ’optical
sectioning’ of specimens, thereby significantly reducing the detection of unwanted unfocused light. Addi-
tionally, novel super resolution microscopy techniques such as Stochastic Optical Reconstruction Microscopy
(STORM) have pushed spatial resolution limits to around 10 nm [24], and Spinning Disk Confocal Microscopy
has reduced the time taken for confocal image acquisition from seconds down to milliseconds [141].
Transmission electron Microscopy (TEM) is an imaging technique that offers nanometer resolution, far
superior to that of conventional fluorescence microscopies, and can be applied to biological or materials
sciences. The technique involves the measurement of how a plane of electrons projected at a sample are
scattered through interactions with the electrons of sample atoms. Regions of high electron-density scatter
electrons more so than regions of low electron-density, and image contrast is drawn in a ’bright field’ format
with white-to-dark scale, where highly scattering elements or structures result in darker regions appearing
in the TEM image, and poorly scattering regions appear as brighter regions. When TEM is applied to
biological cells, exposure of cell monolayers to an ultra-high vacuum is disastrous for cell integrity, so samples
are embedded into a resin for protection from the destructive vacuum. Additionally, most available TEM
instruments run at a voltage where electrons projected at a sample are fully attritioned after a path of 200
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nm into the specimen, therefore cells are sectioned into slices of 100 nm prior to analysis. For these reasons,
there is debate over how representative samples prepared for TEM are of the original, unmodified viable cell
sample [157].
2.1.1 Designing Multimodal Imaging Probes based on Gold Nanoparticles
Synthesis of Stable and Monodisperse Colloidal Gold Nanoparticles
The synthesis of colloidal gold was first pioneered by Turkevich in 1951 [2], and later built on by Frens in
1972 who brought attention to the effect that tuning citrate concentration had on particle size [3]. Later
Grabar et al. improved the Turkevich method by provided a protocol for more uniformly spherical particles
[158], and a number of further adaptations to the Turkevich method have been published [159] including
nucleation methods for yielding larger particles while maintaining spherical shape often lost during the
synthesis of large gold nanoparticles by direct citrate reduction [69]. There has also been a large focus on
biosynthesis of colloidal gold, in order to establish more renewable synthetic protocols. Ahmad et al. [160]
developed a protocol for AuNP synthesis using the alkalothermophilic actinomycete, Thermomonospora sp.
The enzyme-mediated synthesis yielded 8-9 nm monodisperse particles, without the need for toxic reagents.
Singaravelu et al. [161] continued the trend of development of eco-friendly, semi-spherical, gold nanoparticles
using an extract of the marine alga Sargassum wightii.
Labelling Gold Nanoparticles with Luminescent Substrates
The labelling of gold nanoparticles with luminescent substrates presents the opportunity to develop a mul-
timodal, nanosized imaging probes where the rich electron density provides useful contrast for electron and
light reflectance microscopes, and the luminescent substrate provides the option of luminescence detection
by fluorescence microscopies and flow imaging techniques.
Thomas & Kamant [74] developed gold nanoparticles labelled with an organic fluorophore in order to
study the fundamental interactions between a metal core and a surface-bound molecular emitter. Wilton
later applied this approach to metal complexes, where he studied the binding of transition metal complexes
to gold nanoparticles via thiol linkers for catalytic applications and sensing [95], which was later expanded
on by Knight et al. [162].
Lewis at el [94] was first to demonstrate the labelling of 13 nm-diameter gold nanoparticles with a lumines-
cent europium complex. The complex was equipped with thiol moieties bound to the complexes phenylamide
sensitiser groups that rapidly bind to gold via dative covalent bonds. The labelling process modulated a
change in the nanoparticle’s surface electric field, resulting in an adjustment of the natural frequency of gold
electrons oscillating about the surface of the gold nanoparticles, and this was easily monitored by UV/Vis
absorption spectroscopy. After labelling, the particles were purified using a size exclusion resin to remove
any unbound complex, upon which steady state and time resolved luminescence experiments confirmed the
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unquenched luminescent signal of europium emission. Furthermore, laser doppler velocimetry confirmed an
increase in particle hydrodynamic diameter upon europium labelling.
Rogers & Claire et al. [96] developed an approach for the coating of negatively-charged, citrate-stabilised
AuNPs with a positively-charged ruthenium complex. Citrate ions initially provide the gold colloid with its
stability, and displacement of citrate anions for cationic species can cause nanoparticle flocculation, however,
the polar fluorinated surfactant polymer Zonyl 7950 was used to coat the nanoparticles in aqueous solution
before the ruthenium complex RuSH was titrated into the solution. This approach permitted the synthesis
of monodisperse, stable colloids that bear the luminescent signature of ruthenium. Unlike lanthanide-based
chromophores which require ultraviolet excitation, ruthenium is excited by visible light ( 450 - 490 nm)
making it a more desired chromophore.
This zonyl fluorosurfactant approach was then applied by Lewis et al. [163] to 500 nm silica nanoparticles.
In this instance, a luminescent iridium (I) complex had been incorporated into the silica particles, before
treating the prticles with the zonyl 7950 fluorosurfactant which firstly improved colloidal stability, and offered
greater luminescence intensity than the unsurfacted analogue by protecting the environment of the iridium
from quenching.
Enhancing the luminescent properties of AuNP-bound chromophores
There has been a long running debate over the luminescence quenching effects that nanogold imposes over
surface-bound substrates. It has been reported a number of times that a ”near field” effect involving energy
or electron transfer between the molecular emitter and the delocalised gold surface electrons [164, 165].
Osborne et al. [166] investigated firstly the effect the distance between the ruthenium centre and the
gold nanoparticle surface imposed on ruthenium luminescence, and secondly the effect of gold nanoparticle
size on ruthenium’s luminescent properties. It has also long been known that molecular oxygen imposes
a quenching effect on ruthenium luminescence [50], while this has enabled application of ruthenium-based
probes as oxygen sensors [167, 168], for the use of ruthenium as a cellular imaging probe, this is clearly
not advantageous. However, this quenching effect experienced by ruthenium complexes in the presence of
molecular oxygen has been shown to reduce upon addition of hydrophobic surfactants and when the complex
is assembled onto a gold nanoparticle, both for assisting to shield the complex from oxygen diffusion [166,
96]. It has also been reported that local concentrations of Ru(bpy)3 assembled onto AuNP surfaces can exert
luminescence quenching effects. For instance, sufficiently high local concentrations result in photo-mediated
charge transfers such as the transfer of an electron from an excited molecule of Ru(bpy)2+3 to another nearby
Ru(bpy)2+3 molecule producing +1 and +3 oxidation state daughter molecules as shown in Fig. 2.1.
2.1.2 Design of multilabelled AuNPs to target Cancer cells
An enormous benefit of using gold nanoparticles as scaffolds for functional imaging agents lies in the oppor-
tunity to multi-label the surface, which is made facile by using thiol moieties to covalently bind subtrates to
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Figure 2.1: Photo-induced charge transfers in Ru(bpy)3-labelled gold nanoarticles. Mechanism adapted from
work by Pramod et al. [169]
the gold surface. This permits the synthesis of gold nanoparticles co-labelled with a targeting vector and a
metal lumophore. In this chapter, pH-low Insertion Peptides were used as targeting vectors for cancer cells,
while a luminescent ruthenium complex was used as the lumophore. Highlighted here is an introduction to
the pHLIP series.
pH-Low Insertion Peptides
pH Low Insertion peptides (pHLIPs) are a class short peptides (often around 40 residues) which have an
increased affinity for plasma membrane transduction under acidic conditions and does not require binding
to a specific membrane receptor [170]. From the first publication where Hunt et al reported of ’Spontaneous,
pH-dependent membrane insertion of a transbilayer α-helix’ [132] in 1997, to date the pHLIP family has
evolved and expanded to between 20 − 30 published variants. While each variant has a unique primary
structure mainly consisting of neutral hydrophobic amino acids such as Alanine (Ala, A) and Leucine (Leu,
L), the sequence will also contain a number of hydrophillic residues crucial to the peptides pH-switching
insertion. These residues give the peptide an overall negative charge, unlike most other cell penetrating
peptides which tend to have positive charges, to offer electrostatic attraction to membrane phosphate head
groups. The important residues that play an active role in a pHLIP insertion are the Glutamic Acid (Glu,
E) and Aspartic Acid (Asp, D), which have been shown to have effective pKas of ≈ 6.5 in close proximity of
a plasma membrane. An example of a pHLIP variant is illustrated in Fig. 2.2 where the transduction and
flanking domains, as well as positive, neutral and negatively charged residues are highlighted.
Figure 2.2: pHLIP peptide sequence from the 2010 review by Andreev et al. [133] with the transduction and
flanking domains labelled. Positively-charged residues labelled in red; negatively-charged residues in blue,
and neutral residues in black.
At pH 7.4 or greater, pHLIP will exist as soluble unstructured monomer units. In the presence of
phospholipid bilayers at neutral pH, the peptide will adopt an equilibrium, existing as soluble and membrane-
bound unstructured forms, the unprotonated hydrophillic residues anchoring pHLIP at the surface of the
plasma membrane [134]. A fall in pH to 6.5, past the pKa values of Glu and Asp will result in their
29
protonation, rendering the peptide overall more hydrophobic, and increasing its plasma membrane affinity.
With its newfound hydrophobicity, the peptide folds reversibly into an alpha helix to arrange its hydrophobic
functional groups on the outside of the helix, whist keeping its hydrophilic amide groups away from the
hydrophobic environment of the transmembrane space, and inserts itself C-terminus first into the plasma
membrane [134]. Andreev et al. reported some of the kinetics of pHLIPs insertion [133]. pHLIP undergoes
a rapid (0.1s) interfacial conformation change to a helical structure upon plasma membrane binding at pH
6.5. Insertion of the peptide into the bilayer to form a transmembrane helix is much slower, typically taking
≈ 100s. Exit from the bilayer, initiated by a rapid increase in pH leads has a rate 400 times faster than
insertion, with the peptide already beginning to unfold whilst still immersed in the bilayer. This pH window
of 6.5 − 7.4 is an important window, as cancer cell microenvironments often have a pH ≈ 6.5, and healthy
mammalian cells have a pH ≈ 7.4, thus leading to the use of pH as a general cancer biomarker [171, 172]
Current knowledge of members of the pHLIP family, as well as application pHLIPs as imaging agents
and delivery vectors is more extensively reviewed in Chapter 3. pHLIPs posession of an overall negative
charge makes it a good candidate to i) stabilise the gold sol in the absence of citrate, and ii) function as a
cell penetrating peptide with a general preference for uptake into cancer cells.
Zonyl FSA Polymeric Fluorosurfactant
In order to assess the efficiency and pH dependency of pHLIP mediated uptake of AuNPs, suitable non-pH
switchable control particles are required for comparisons. Zonyl FSA fluorosurfactant has been used by
the group as a surfactant for gold nanoparticle coating prior to the labelling of a ruthenium complex. The
surfactant consists of a fluorinated alkyl chain with a polar hydrophilic head group, and its binding to gold
nanoparticle surfaces through its hydrophillic head group has been reported [173, 174]. Recently, Rogers &
Claire et al. reported coating of gold nanoparticles with Zonyl variant permitted subsequent efficient coating
with a ruthenium complex, and demonstrated their application as fluorescence imaging agents [96]. Later,
Osborne et al. synthesised gold nanoparticles colabelled with Zonyl FSA and a ruthenium complex, and
reported an increase in ruthenium luminescence lifetime and quantum yield when Zonyl was added to the
solution [166]. Zonyl & RubpySS labelled AuNPs will also have similar size and zeta potential to peptide &
RubpySS labelled AuNPs, making the class of Zonyl-Au-RubpySS particles suitable control samples.
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2.2 Results and Discussion
In this chapter, the luminescent complex, RubpySS, was prepared by the protocol according to Adams et
al. [175]. RubpySS was chosen due its high photostability, excitation by blue light, emission within the red
region (reducing likelihood of re-absorption by biological media), large Stokes shift and long luminescence
lifetime. Gold nanoparticles of diameters 13 and 100 nm were prepared, and were co-labelled with a pHLIP
variant and the RubpySS lumophore via a sequential labelling procedure as shown in Fig. 2.3.
Figure 2.3: Schematic for sequential co-labelling of aqueous AuNPs with a pHLIP variant and ruthenium
complex, RubpySS.
The labelled gold nanopparticles were subjected to numerous structural, morphological, physicochemical
and luminescence characterisation techniques. The three pHLIP variants, along with their primary structures
and charges are shown in Table 2.1. pHLIP is the peptide most widely studied and reported within our group,
having a very similar sequence to the original pHLIP sequence reported by Hunt et al. in 1997 [132]. The
sequence consists of a central transduction domain with terminal flanking domains on either side, with a
mixture of aspartic acid (D) and glutamic acid residues (E) throughout its sequence that control the peptide’s
pH-switching nature. The peptide is 38 amino acids long with a charge of -5. kpHLIP is an analogue of
pHLIP which has undergone lysine substitution for two aspartic acid residues within the transduction domain,
reducing its pH switchable nature, thus serving as a suitable control for cell treatments. The peptide is 38
amino acids long with a charge of -3. pHLIPvar3 is a recently created variant published by Weerakkody et
al. [176]. This variant had been truncated from the original pHLIP sequence, removing much of the flanking
domains on either side of the transduction domain, and the amino acid residues responsible for pH-switching
are exclusively aspartic acid residues. The pHLIPvar3 peptide is also shorter with only 28 residues, and has






Table 2.1: Primary structures of pHLIP (38 residues), kpHLIP (38 residues), and pHLIPvar3 (28 residues)
peptides used in this work.
2.2.1 Preparation of [Ru(bpy)2(4,4-di-(5-lipoamido-1-pentoxy)-2,2-bipyridine)]
2+,
RubpySS
Ruthenium trisbypyridine (Ru(bpy)3) is the archetypal luminescent transition metal complex, and has been
very well studied [177, 178, 179]. RubpySS Fig. 2.4 is an analogue of Ru(bpy)3 designed to bind to gold
surfaces whilst maintaining the luminescent signature of Ru(bpy)3. The complex has a ruthenium centre,
with two unmodified bipyridine chelates and a third bipyridine chelate equipped with long legs to distance
the ruthenium centre from quenching effects on the gold surface [166], and terminal thiol moieties for gold
nanoparticle binding. RubpySS was prepared using the protocol developed by Adams et al. [175].
Figure 2.4: Structural formula of [Ru(bpy)2(4,4-di-(5-lipoamido-1-pentoxy)-2,2-bipyridine)]
2+, RubpySS
The yielded complex was synthesised with PF6 counterions, and was subjected to ion exchange in Dowex
8x1, 200 MESH ion exchange resin in an acidic environment, to substitute the PF6 counterions for chloride
counterions in order to permit solubility in methanol. The resultant complex exists as a dichloride in aqueous
solution (RubpySS.Cl2) but is herein abbreviated to RubpySS.
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Figure 2.5: UV/Vis absorption spectra of citrate stabilised gold nanoparticles of 13 nm (1.6 nM), 25 nm (0.7
nM), 50 nm (80 pM) and 100 nm (20 pM) diameters in H2O.
2.2.2 Preparation of Citrate-coated AuNPs
13 nm diameter spherical gold nanoparticles were prepared by previously published methods [158, 159].
Au13NP seeds were then grown up to approximately 100 nm diameter particles using the seeded growth pro-
tocol of Ziegler & Eychmuller [69]. This procedure involved growing 13 nm diameter gold nanoparticle seeds
(Au13NPs) into 25 nm AuNPs (Au25NPs), followed by another growth step into 50 nm gold nanoparticles
(Au50NPs) and a final growth step into 100 nm gold nanoparticles (Au100NPs). These citrate stabilized
AuNPs were characterized by dynamic light scattering (DLS) intensity distribution and number distribution
along with zeta potential (ζ) measurements and a size dependent characteristic gold surface plasmon res-
onance (SPR) band in the UV/Vis absorption spectrum. In this work, only Au13NPs and Au100NPs were
subjected to surface labelling and cellular uptake experiments.
The UV/Vis absorption spectra of all citrate coated gold nanoparticles are shown in Fig. 2.5, illustrating
the size dependency of the surface plasmon resonance band shape and position. The concentration was
calculated for each particle size and the pH of the AuNPs was adjusted to 6.5-7.4 before coating.
Coating of AuNPs displaces negatively citrate ions that provide stabilization to the colloidal suspension,
in which it was found that direct addition of RubpySS or ruthenium trisbipyridine (Ru(bpy)3) to citrate
stabilised gold nanoparticles resulted in nanoparticle flocculation as shown in Fig. 2.6. A solution of
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Figure 2.6: UV/Vis absorption spectra (top) monitoring of Au100NPs (4.8 nM, 1.5 ml) during the addition
of Ru(bpy)3 (13 µM in H2O), where inserted arrows indicate the trend of SPR band profile change, and inset
SPR λmax shifts as a function of Ru(bpy)3 concentration. And TEM micrographs (bottom) of nanoparticles
prior to addition (left) and post-addition (right) of Ru(bpy)3 (13 µM in H2O).
Ru(bpy)3 (13 µM) was titrated into a rapidly stirred solution of Au
13NPs (4.8 nM, 1.5 ml) and before 1 µM
of complex had been added, the solution turned a deep purple and the SPR band within the solution’s UV/Vis
absorption spectrum had bathochromically shifted more than 100 nm as shown in Fig. 2.6. Aggregation was
then confirmed by transmission electron microscopy of the particles. Direct addition of RubpySS was also
performed, and also resulted in flocculated AuNPs (data not shown).
For co-labelling gold nanoparticles with a pHLIP variant, and the RubpySS complex, coating with the
pHLIP variant was performed before labelling with RubpySS, in order to coat the particles with a negatively
charged substrate, suitable to stabilize the gold nanoparticles in the absence of citrate.
2.2.3 Monitoring Nanoparticle Coating via UV/Vis Absorption Spectroscopy
Three measurements provide us with an indication of surface changes within the nanoparticle colloid, i)
bathochromic or hypsochromic shifts of the SPR band, ii) Absorbance and iii) SPR band full-width-at-half-
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maximum (FWHM) broadening/narrowing. In order to extract more sensitive information from UV/Vis
data, for each sample a Gaussian model was fitted to the SPR band of the sample’s absorption spectrum
(Fig. 2.40). The model was fitted to the data using a Levenberg-Marquandt non-linear fitting algorithm,
which iterated until acceptable solutions to the SPR λmax, the band intensity and sigma values were found.
The LM algorithm incorporates Gradient Descent and Gauss-Newton algorithms, and will switch between
the two depending on how close to convergence the algorithm is. With each iteration the parameters of the
gaussian model were initially adjusted using the a Gradient Descent approach, and as the algorithm neared
convergence, the Gauss-Newton method was predominantly used.
2.2.4 Synthesis of pHLIP-stabilised, ruthenium-luminescent Au13NPs
Binding of pHLIP and RubpySS to Au13NPs
Figure 2.7: UV/Vis absorption spectra monitoring of pHLIP-Au13 preparation. Au13NPs (4.8 nM) were
stirred rapidly while 3 µl aliquots of pHLIP (0.5 mM in 5% DMF in PBS) were added upto a final pHLIP
concentration of 6 µM.
Au13NPs (4.8 nM, 1.5 mL) were stirred rapidly using a magnetic stirrer such that a stir vortex appeared
within the colloid. pHLIP (0.5 mM) was titrated into the stirred AuNP solution in 3 µl aliquots, acquiring a
UV/Vis absorption spectrum inbetween each addition. As shown in Fig. 2.7, the SPRλmax bathochromically
shifted with each addition of pHLIP. This bathochromic shift of the gold SPR band λmax (Fig. 2.7, inset)
upon pHLIP titration was characteristic of a saturation binding curve, consistent with that reported by
Davies et al [139], and ceased to redshift after 6 µM of pHLIP had been added to the AuNPs indicating no
further changes were occurring on the surface of the nanoparticles. The FWHM of the SPR band did not
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show any significant change up to 6 µM addition suggesting no significant aggregation was occurring within
the colloid. For the repeat of the procedure, a single aliquot of pHLIP (0.5 mM, 20 µL) was added and
colloid was left to stir for 5 minutes. After pHLIP addition, it was noteable that gold SPR had undergone
a bathochromic shift (λmax increased to 522 nm), the hydrodynamic diameter of the colloid increased to 15
± 4 nm, and Zeta potential decreased to -23 ± 7 mV.
After the labelling of Au13NPs with pHLIP, a titration of RubpySS into pHLIP-Au13 was performed im-
mediately afterwards, and was also monitored using UV/Vis Absorption Spectroscopy, acquiring a spectrum
inbetween each 10 µl titre as shown in Fig. 2.8. With each addition of RubpySS, the SPRλmax shifted to a
longer wavelength, where the shift eventually plateaued after 7 µM of RubpySS had been added, where the
∆SPRλmax as a function of RubpySS concentration again resembles a saturation binding curve (fig. 2.8,
inset).
Figure 2.8: UV/Vis absorption spectra monitoring of pHLIP-Au13-RubpySS preparation. pHLIP-Au13
nanoparticles were stirred rapidly while 10 µl aliquots of RubpySS were added upto a final concentration of
(7 µM) which induced an 5 nm SPR bathochromic shift. The arrow indicates the trend.
A repeat of the procedure whereby a single aliquot of RubpySS (7 µM) was added to pHLIP-Au13 resulted
in another SPR bathochromic shift (λmax increased to 527 nm), the hydrodynamic diameter of the colloid
increased to 19 ± 5 nm, and Zeta potential decreased to -36 ± 8 mV. This SPR bathochromic shift of 5 nm
is consistent with other reports on the effect of thiol binding on the dielectric constant at a gold nanoparticle
surface [86, 180]. It is noteworthy that Lewis et al. [94] reported the labelled 13 nm AuNPs with a methanol-
solubilised europium complex where there was no solvatochromic contribution to the SPR of citrate stabilized
AuNPs from methanol, so it can be assumed that all contributions to SPR shift are from changes to the
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gold surface dielectric constant, resultant from thiol binding. Again the change in SPR λmax as a function
of RubpySS concentration resembled a saturation binding curve, with a final RubpySS concentration of
7 µM. The prepared pHLIP-Au13-RubpySS nanoparticles were purified by size exclusion chromatography
using fine Sephadex G-25 size exclusion resin with H2O as the eluent. The functionalised AuNPs eluted
rapidly off the column, while uncoated AuNPs and unbound subtrates were retarded by the gel. Fig. 2.9
shows the final UV/Vis absorption spectra from monitoring the preparation of pHLIP-Au13-RubpySS after
each stage of preparation. It is noteworthy that the molecular weights of pHLIP and RubpySS both lie
within the fractionation region of sephadex-G25, and that uncoated citrate particles aggregated within the
column. After purification, particles were subjected to size, charge, dispersity, morphological, elemental and
luminescence characterisation, which is presented in future sections.
Figure 2.9: UV Vis absorption spectra monitoring of pHLIP-Au13-RubpySS (4.8 nM) preparation. Au13NPs.
Given the nature of dithiol groups to spontaneously form, the possibility of pHLIP and RubpySS binding
directly was studied by UV/Vis absorption. Lewis et al. [94] reported the assembly of a heterometallic Lan-
thanide macrocycle bound via a disulfide bond. The binding event between the macrocycles was monitored
using UV/Vis absorption where formation of the disulfide bind resulted in displacement of pyridyl-2-thione
from the Terbium macrocycle, which induced the creation of a pyridyl-2-thione absorbance band over time.
pHLIP possesses the same pyridyl-2-thione group conjugated to its cysteine residue, so release of the pyridyl-
2-thione would indicate the presence of a binding event. The same protocol used by Lewis was applied to
pHLIP and RubpySS. RubpySS (25 µM in H2O, 1 mL) was stirred rapidly before pHLIP (25 µM) was
added in a single aliquot to the vortex of the solution. The Absorption spectrum of the solution was taken
at regular intervals for an hour and the final solution was analysed using electrospray mass spectrometry.
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However no band appeared within the 300 - 400 nm range of the visible absorption spectrum indicating no
binding event, and no conjugate was detected using electrospray mass spectrometry, concluding no conjugate
between pHLIP & RubpySS spontaneously forms in aqueous solution.
Binding of pHLIPvar3 and RubpySS to Au13NPs
Au13NPs (4.8 nM, 1.5 mL) were stirred rapidly using a magnetic stirrer such that a stir vortex appeared
within the colloid. pHLIPvar3 (0.65 mM) was titrated into the rapidly stirred Au nanoparticles in 3 µl
aliquots, and a UV/Vis absorption spectrum was acquired inbetween each addition. Fig. 2.10 shows the
change in the absorption of Au13NPs as a function of pHLIPvar3 concentration, revealing an SPR(λmax
bathochromic shift upon each pHLIPvar3 addition which plateaued after 7.7 µM of pHLIPvar3 had been
added.
Figure 2.10: UV/Vis Absorption spectrum monitoring the titration of pHLIPvar3 (0.65 mM in 5% DMF in
PBS) into Au13NPs (4.7 nM, 1.5 mL).
For the repeat of this procedure, a single aliquot of pHLIPvar3 (0.65 mM, 20 µL) was added and colloid
was left to stir for 5 minutes. After pHLIPvar3 addition, it was noteable that gold SPR had undergone a
bathochromic shift (λmax increased to 522 nm), the hydrodynamic diameter of the colloid increased to 15 ±
4 nm, and Zeta potential decreased to -54 ± 14 mV.
The bathochromic shift of the gold SPR band λmax (Fig. 2.10, inset) upon pHLIP titration was charac-
teristic of a saturation binding curve, which is again consistent with the SPR bathochromic shift reported by
Davies et al [139] and ceased to redshift after 7.7 µM of pHLIPvar3 had been added to the AuNPs indicating
no further changes were occurring on the surface of the nanoparticles. The FWHM of the SPR band did
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not show any significant change up to 7.7 µM addition suggesting no significant aggregation was occurring
within the colloid.
After the labelling with pHLIPvar3, the titration of RubpySS into pHLIPvar3-Au13 nanoparticles was
performed immediately afterwards, and was also monitored using UV/Vis Absorption Spectroscopy.
Figure 2.11: UV/Vis Absorption spectrum monitoring the titration of RubpySS (0.15 mM in 10% MeOH in
H2O) into pHLIP-Au
13NPs (4.7 nM, 1.5 mL).
Aliquoted addition of RubpySS into pHLIPvar3-Au13 nanoarticles (Fig. 2.11) resulted in another bathochromic
SPR response which plateaued after 8.4 µM of RubpySS had been added.
Repetition of this coating procedure, where a single aliquot of RubpySS was added to the pHLIPvar3-Au13
nanoarticles resulted in another SPR bathochromic shift (λmax increased to 527 nm), the hydrodynamic di-
ameter of the colloid increased to 16 ± 5 nm, and Zeta potential increased to -30 ± 8 mV. The bathochromic
shift of the gold SPR upon RubpySS addition is again consistent with other reports of gold SPR bathochromic
shifts induced by thiol binding [86, 180]. Again the change in SPR λmax as a function of RubpySS con-
centration resembled a saturation binding curve, with a final RubpySS concentration of 7 µM. Labelled
nanoparticles were purified by size exclusion chromatography using fine Sephadex G-25 size exclusion resin
with H2O as the eluent. The functionalised AuNPs eluted rapidly off the column, while uncoated AuNPs
and unbound subtrates were retarded by the gel. Fig. 2.12 shows the final UV/Vis absorption spectra from
monitoring the preparation of pHLIPvar3-Au13-RubpySS after each stage of preparation.
39
Figure 2.12: UV/Vis Absorption spectrum of Au13NPs (4.7 nM, 1.5 mL) before and after the sequential
additions of pHLIPvar3 (7.7 µM) and RubpySS (8.4 µM).
Binding of kpHLIP and RubpySS to Au13NPs
13 nm AuNPs (4.8 nM, 1.5 mL) were stirred rapidly using a magnetic stirrer such that a stir vortex appeared
within the colloid. kpHLIP was dissoluted in the same solvent mixture as pHLIP for continuity, however
dissolution yielded a cloudy solution, indicative of peptide aggregation as reported for more hydrophobic
variants of pHLIP [181, 182]. The gold SPR band was monitored while 5 µl aliquots of kpHLIP (0.5
mM in 5%DMF in PBS) was titrated into the rapidly stirred colloid. The UV/Vis absorption spectra of
13 nm AuNPs during the titration of the kpHLIP peptide is shown in Fig. 2.13. The change in SPR
λmax as a function of kpHLIP concentration (Fig. 2.13, inset) this time did not resemble a saturation
binding curve, no plateau had been reached even after three times the concentration of pHLIP (which
only required 6 µM before saturation), had been added. Subsequent addition of 1 µM of RubpySS into
the kpHLIP-Au13 solution yielded a purple solution where the gold SPR had strongly redshifted (data
not shown). Dynamic light scattering analysis of this solution confirmed the formation of large aggregates
znd high polydispersity amidst the inefficient loading with RubpySS (reported in the next section). As
the homogeneity of the labelling process along with colloidal stability of kpHLIP-labelled gold nanoparticles
could not be sufficiently controlled, kpHLIP-Au13-RubpySS and kpHLIP-Au100-RubpySS were not subjected
to in vitro cell experiments.
40
Figure 2.13: UV/Vis Absorption spectrum monitoring the titration of kpHLIP (0.5 mM in 5% DMF in PBS)
into Au13NPs (4.8 nM, 1.5 ml). Inset, analysis of SPR absorbance, λmax & FWHM as a function of kpHLIP
concentration.
Binding of pHLIP and RubpySS to Au100NPs
100 nm AuNPs (Batch 1, 40 pM, 1.5 mL) were stirred rapidly using a magnetic stirrer such that a stir vortex
appeared within the colloid. Prior to addition of surfactants, gold SPR = 597 nm, hydrodynamic diameter
= 108 ± 27 nm, and Zeta potential = -45 ± 27 mV. pHLIP (0.5 mM, 10 µL) was added and colloid was
left to stir for 5 minutes. After pHLIP addition, it was noteable that gold SPR increased to 600 nm and
hydrodynamic diameter increased to 115 ± 28 nm.
Subsequently, RubpySS (0.15 mM, 50 µL) was added to the rapidly stirred colloid in 5 x 10 µL aliquots,
and left for 5 minutes. The gold SPR λmax increased to 602 nm (UV/Vis absorption spectra of unlabelled &
labelled particles are shown in Fig. 8.7), the hydrodynamic diameter of the particles remained at 115 ± 27
while the zeta potential slightly increased to -42 ± 12 mV. Labelled particles were then purified using size
exclusion chromatography using H2O as the eluent, where particles rapidly eluted off the column leaving a
brown colloidal solution.
Binding of pHLIPvar3 and RubpySS to Au100NPs
100 nm AuNPs (Batch 2, 40 pM, 1.5 mL) were stirred rapidly using a magnetic stirrer such that a stir vortex
appeared within the colloid. Prior to addition of surfactants, gold SPR = 571 nm, hydrodynamic diameter
= 108 ± 27 nm, and Zeta potential = -45 ± 13 mV. pHLIPvar3 (0.65 mM, 10 µL) was added and colloid
was left to stir for 5 minutes. After pHLIPvar3 addition, it was noteable that gold SPR underwet a small
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increase to 572 nm, hydrodynamic diameter increased to 87 ± 25 nm, and Zeta potential = -42 ± 12 mV.
Subsequently, RubpySS (0.15 mM, 50 µL) was added to the rapidly stirred colloid in 5 x 10 µL aliquots,
and left for 5 minutes inducing a larger SPR λmax shift to 578 nm (Fig. 8.8). The hydrodynamic diameter
increased to 99 ± 29 and the zeta potential decreased to -47 ± 9 mV. Labelled particles were then purified
using size exclusion chromatography using H2O as the eluent, where particles rapidly eluted off the column
leaving a brown colloidal solution.
Synthesis of Zonyl–Au13-RubpySS and Zonyl–Au100-RubpySS nanoparticles
Zonyl FSA fluorosurfactant labelled, RubpySS-luminescent gold nanoparticles were synthesised according to
the procedure of Osborne et al. [166], and are herein used as control samples for pH-dependent cell uptake
experiments as outlined in Chapter 3, section: pH-Resolved Uptake of Peptide-labelled, Luminescent Gold
Nanoparticles.
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2.2.5 Structural & Morphological Characterisation of Peptide-labelled, Lumi-
nescent AuNPs
Hydrodynamic Diameters of Labelled Gold Nanoparticles
Hydrodynamic diameter is the diameter of a colloidal particle plus the extra distance between the particles
hard surface, and the limit of its solvent coordination sphere. It is an important piece of particle charac-
terisation as it is a good estimate of particle size, and can be measured through completely non-invasive
techniques such as dynamic light scattering.
Figure 2.14: Diagram showing distinction between particle diameter, and hydrodynamic diameter of a spher-
ical particle coordinated to solvent molecules in solution.
The hydrodynamic diameters of citrate-coated and labelled AuNPs were measured using Dynamic Light
Scattering (DLS), a non-invasive technique that utilizes a particle’s Brownian motion, the random thermal
motion of the particle through its solvent, to calculate the particles size. Smaller particles rebound less with
solvent molecules and therefore move through solution relatively quickly, and conversely larger particles that
undergo more colliding events tumble more slowly. DLS measures hydrodynamic diameter, and not particle
diameter because the particles coordination sphere influences the particles Brownian motion, see Fig. 2.14
for the distinction between particle diameter and hydrodynamic diameter.
Figure 2.15: The Einstein-Stokes equation, a model function for a particles Brownian motion, where Dh =
hydrodynamic diameter; Dt = translational diffusion coefficient; kB = Boltzmann constant; T = temperature
and η = solvent dynamic viscosity.
Briefly, the sample is illuminated using a 633 nm laser, and scattered light is either collected at a 90◦
or 173◦ from the illumination path. Collection of this optical signal as a function of time produces ’noise
like’ data that is processed in real time by a time correlator, which studies how the intensity of scattered
light changes over time, and plots an autocorrelation function as a function of delay time. Analysis of
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the autocorrelation function provides the translational diffusion coefficient (Dh), which if inserted into the
Einstein-Stokes equation (Fig. 2.15), provides calculation of particle hydrodynamic diameter.
Figure 2.16: Number-weighted hydrodynamic diameter distributions of Au13NPs (0.5 nM in H2O) before
and after labelling with pHLIP & RubpySS (top), pHLIPvar3 & RubpySS (middle) and kpHLIP (bottom),
as measured by dynamic light scattering.
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Sample Hydrodynamic Diameter / nm PdI
Au13NPs 11 ± 3 0.13
pHLIP-Au13 15 ± 4 0.14
pHLIP-Au13-RubpySS 19 ± 5 0.19
pHLIPvar3-Au13 15 ± 4 0.26
pHLIPvar3-Au13-RubpySS 16 ± 5 0.19
kpHLIP-Au13 18 ± 5 0.29
Table 2.2: DLS number distribution data of Au13NPs, before and after particles were coated with pHLIP,
pHLIPvar3, kpHLIP and subsequently with RubpySS, in H2O.
Fig. 2.16 shows number distributions of hydrodynamic diameter monitoring the labelling of Au13NPs
with pHLIPs and RubpySS. The addition of pHLIP and pHLIPvar3 to Au13NPs increased the number
distribution average of 11 ± 3 nm to 15 ± 4 nm, whereas the addition of kpHLIP to Au13NPs increased
the value to 18 ± 5 nm, a greater increase in hydrodynamic diameter or solvation coordination. Subsequent
additions of RubpySS to pHLIP & pHLIPvar3-Au13NPs induced further increases in hydrodynamic diameter
to 19 ± 5 & 16 ± 5 nm for pHLIP-Au13-RubpySSS and pHLIPvar3-Au13-RubpySS, respectively.
DLS was also used to monitor the hydrodynamic diameter of Au100NPs during the labelling with pHLIPs
and RubpySS, as shown in Fig. 2.17. Although labelling Au100NPs with pHLIP & pHLIPvar3 induced a
modest increase in hydrodynamic diameter, the diameter increased markedly when kpHLIP was added, from
79± 23 nm to 129 ± 30 nm. This continues to suggest that kpHLIP does not provide much stabilisation to the
gold colloid, and that particles are significantly more polydisperse. However, pHLIP and pHLIPvar3 peptides
suitably stabilised the colloidal nanoparticles during the RubpySS-labelling, providing small polydispersity
indexes (PdI), which is a measurement equivalent to the full width at half maximum of the intensity weighted
distribution of nanoparticle hydrodynamic diameters. This measurement effectively provides an indication
of the range of hydrodynamic diameters, and is often used as a measurement of polydispersity, where the
index value lies between 0 and 1. Smaller PdI values indicate more monodisperse nanoparticles, and it is
often assumed within the literature that PdI values < 0.2 indicate a significantly monodisperse nanoparticle
ensemble. This was important for us to achieve as it demonstrates an efficient labelling process, and provides
homogenously labelled particles which should all interact with cells and biological media in a consistent
fashion. Additional analysis of the particles with the Nanosight particle tracker show the dispersity of
pHLIP-Au100-RubpySS and pHLIPvar3-Au100-RubpySS, luminescence images were also taken showing the
particles are excitable using a 488 nm laser and a 520 nm dichroic mirror to remove scattered illumination.
Scatter and luminescence images both show largely monodisperse particles that are luminescent under 488
nm excitation thus demonstrating that they’re excitable using conventional lasers and also demonstrate
potential for flow imaging.
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Figure 2.17: Number-weighted hydrodynamic diameter distributions of Au100NPs (2 pM in H2O) before and
after labelling with pHLIP & RubpySS (top), pHLIPvar3 & RubpySS (middle) and kpHLIP (bottom), as
measured by dynamic light scattering. Inset, for pHLIP-Au100-RubpySS and pHLIPvar3-Au100-RubpySS,
in flow images of nanoparticle scatter (left) and luminescence (right) were acquired by nanosight.
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Sample Hydrodynamic Diameter / nm PdI
Au100NPs (Batch 1) 108 ± 27 0.03
pHLIP-Au100 115 ± 28 0.03
pHLIP-Au100-RubpySS 115 ± 28 0.03
Au100NPs (Batch 2) 79 ± 23 0.06
pHLIPvar3-Au100 87 ± 25 0.05
pHLIPvar3-Au100-RubpySS 99 ± 29 0.06
kpHLIP-Au100 129 ± 30 0.02
Table 2.3: Hydrodynamic Diameters, Polydispersity Indexes (PdI), Zeta Potentials (ζ) and Zeta Potential
standard deviations of functionalised Au100NPs in H2O.
Zeta potential (ζ) of Labelled Gold Nanoparticles
Zeta potential is the potential difference between particle surface and particle’s slipping plane, the edge of a
colloidal particle’s solvent coordination sphere (Fig. 2.18) and is useful for an understanding of how particles
behave in solution, in particular providing an indication of colloidal stability.
Figure 2.18: Graphic illustrating Zeta Potential, the potential difference between particle surface and parti-
cle’s slipping plane.
Zeta potential is commonly measured by Laser Doppler Micro-electrophoresis electrophoresis or elec-
trophoretic light scattering, and both study the mobility of particles while an electric field is applied to
them. In a Laser Doppler Micro-electrophoresis acquisition, an electric field is applied to the colloidal solu-
tion, upon which the particles start moving at a speed related to their zeta potential. Particle electrophoretic
mobility is then measured by Phase Analysis Light Scattering, a patented technique produced by Malvern
Instruments.
Zeta potential measurements reveal that displacement of citrate ions on Au13NPs (ζ = −37± 7mV , pH
5.0) for pHLIP resulted in an increase in zeta potential to -23 ± 7 mV, whereas displacement for pHLIPvar3
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Table 2.4: Zeta potentials of Au13NPs, pHLIP-Au13 and pHLIP-Au13-RubpySS in H2O (pH 5.0), as measured
using Laser Doppler Microelectrophoresis.
resulted in a large decrease in zeta potential to -54 ± 14 mV. Although pHLIP bears a change of -5 and
pHLIPvar3 bears a charge of -4, pHLIP var3 is 74% the size of pHLIP, making it more densely charged,
perhaps explaining the difference in zeta potential. Upon addition of RubpySS to both colloids the zeta
potential of newly coated pHLIP-Au13-RubpySS decreased to -36 ± 8 mV, and conversely the zeta potential
of newly coated pHLIPvar3-Au13-RubpySS increased to -30 ± 8 mV. These results generally indicate stable
colloids, where zeta potentials < -30 mV or > 30 mV are generally considered stable for a colloid stabilised
by electrostatic repulsion [183].
Zeta potential measurements of labelled and unlabelled Au100NPs are shown in Table 2.5. For co-labelling
Au100NPs with pHLIPvar3 & RubpySS, after labelling particles with pHLIPvar3 the zeta potential remained
close to -42 (± 7) mV, however after labelling the particles with RubpySS the zeta potential dropped to -47
(± 9) mV. Au100NPs labelled with pHLIP & RubpySS exhibited a similar Zeta potential of -49 (± 9) mV,
a strong indication of a stable colloid.






Table 2.5: Zeta potentials of labelled and unlabelled Au100NPs in H2O (pH 6.2), as measured using Laser
Doppler Microelectrophoresis.
Elemental Ratios of Labelled Gold Nanoparticles by ICP-MS
ICP-MS analysis of the pHLIP-Au13-RubpySS and pHLIPvar3-Au13-RubpySS colloid indicated a RubpySS
coverage of 13 nm gold nanoparticles of 141 and 230 complexes per nanoparticle, respectively. pHLIPvar3
is 10 residues shorter than pHLIP (74% of pHLIP size), and the higher loading efficiency of RubpySS onto
pHLIPvar3-Au13NPs, is perhaps explained by easier access of the RubpySS complex to a less crowded gold
nanoparticle surface, but will require further investigation to confirm. The area coverage of a molecule of
RubpySS on an Au13NP was calculated to be 3.8 nm2 and 2.3 nm2 for pHLIP-Au13-RubpySS and pHLIPvar3-
Au13-RubpySS, respectively. This calculation was based on particle diameters measured by dynamic light
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scattering, and transmission electron microscopy leading to a calculated particle surface area of 530.93
nm2. ICP-MS analysis of the pHLIP-Au100-RubpySS and pHLIPvar3-Au100-RubpySS colloids indicated a
RubpySS coverage of 100 nm gold nanoparticles of 35,784 and 66,068 complexes per nanoparticle, respectively.
It is interesting that coating gold nanoparticles with the pHLIPvar3 peptide permits more efficient subsequent
coating with the RubpySS complex, correlating well with the 13 nm analogues of pHLIP & pHLIPvar3-Au100-
RubpySS. The area coverage of a molecule of RubpySS on an Au100NP was calculated to be 3.5 nm2 and 1.9
nm2 for pHLIP-Au100-RubpySS and pHLIPvar3-Au100-RubpySS, respectively. This calculation was based
on particle diameters measured by dynamic light scattering, and transmission electron microscopy leading
to a calculated particle surface area of 126,000 nm2.
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Transmission Electron Microscopy Images of Labelled Gold Nanoparticles
Figure 2.19: Transmission electron micrographs showing pHLIP-Au100-RubpySS nanoparticles with overlaid
Energy Dispersive Analysis of Xrays spectrum. Xray signals from gold and copper atoms labelled.
To study the size, mophology and dispersity of peptide labelled, luminescent AuNPs, the particles were
dried onto a copper grid for visualisation using transmission electron microscopy. The Energy Dispersive
Analysis of Xrays (EDAX) spectrum of the gold nanoparticles was also taken to confirm the presence of gold
and ruthenium. Fig. 2.19 shows a TEM image of pHLIP-Au100-RubpySS nanoparticles overlaid with the
particles’ EDAX spectrum. The characteristic bands for gold are clearly visible at 9, 12 & 14 keV, however
the characteristic ruthenium band at 18 keV is not visible, most likely indicating that the concentration
of ruthenium is too low for the sensitivity of the technique. Additionally, neither pHLIP-Au13-RubpySS,
pHLIPvar3-Au13-RubpySS or pHLIPvar3-Au100-RubpySS particles exhibited ruthenium EDAX bands (data
not included), also indicating that Ru concentration is too low for detection. In order to visualise the expected
corona around the labelled nanoparticles, peptide-labelled and citrated-coated AuNPs were treated with a
1% phosphotungstic acid aqueous solution prior to TEM sample preparation. With this treatment the gold
particle core is visible due to its high electron scattering character, the periphery of the nanoparticle coating
is outlined by the phosphotungstic positive contrast stain, leaving a white corona between the AuNP surface
and the positive contrast halo.
Post preparation of pHLIP-Au13-RubpySS and pHLIPvar3-Au13-RubpySS, a drop of each colloid was
spotted onto a 3 mm 200 MESH copper grid, and permitted to dry. A separate volume of each sample (200
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Figure 2.20: Transmission electron micrographs showing citrate-coated gold nanoparticles (A), citrate-coated
gold nanoparticles with the positive contrast stain (B), pHLIP-Au13-RubpySS (C) and pHLIP-Au13-RubpySS
with the positive contrast stain (D).
µL, 4.8 nM) was added to a 1% Phosphotungstic acid solution (200 µL) and left for 20 minutes. The stained
colloid was then centrifuged (13,000 rpm, for 30 minutes), the supernatant was removed and the particles
were redispersed in H2O. A drop of each sample was spotted onto a 3 mm 200 MESH copper grid, and
permitted to dry overnight before imaging.
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Fig. 2.20 shows TEM micrographs of citrate-coated gold nanoparticles and pHLIP-Au13-RubpySS, with
and without treatment with 1% phosphotungstic acid. Untreated pHLIP-Au13-RubpySS particles appear
spherical, monodisperse and with an average diameter of 13 nm. Citrate-coated particles, imaged after
treatment with 1% phosphotungstic acid showed little evidence of a peripheral corona around the gold core.
pHLIP-Au13-RubpySS particles imaged after treatment with 1% phosphotungstic acid showed distinct white
coronas around particle peripheries with consistent homogeneity, indicating an increase in coating diameter
between citrate-stabilised AuNPs and AuNPs coated with pHLIP and RubpySS.
Figure 2.21: Transmission electron micrographs showing citrate-coated gold nanoparticles (A), citrate-coated
gold nanoparticles with the positive contrast stain (B), pHLIPvar3-Au13-RubpySS (C) and pHLIPvar3-Au13-
RubpySS with the positive contrast stain (D).
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Fig. 2.21 shows TEM micrographs of citrate-coated AuNPs and pHLIPvar3-Au13-RubpySS particles
offering visualisation of their mophology, size, dispersity and coating radii. pHLIPvar3-Au13-RubpySS par-
ticles appear spherical, with diameters comparable to the unlabelled citrate nanoparticles indicating that
the labelling process has not induced particle aggregation. Additionally, as with pHLIP-labelled AuNPs,
pHLIPvar3-labelled AuNPs treated with 1% PTA also show a peripheral halo, indicating an increase in
nanoparticle coating radius upon labelling with pHLIPvar3 and RubpySS.
Visualisation of the coating corona on labelled Au100NPs was also performed using TEM via positive
contrast staining. Post preparation of pHLIP-Au100-RubpySS and pHLIPvar3-Au100-RubpySS, a drop of
each colloid was spotted onto a 3 mm 200 MESH copper grid, and permitted to dry. A separate volume of
each sample (200 µL, 40 pM) was added to a 1% Phosphotungstic acid solution (200 µL) and left for 20
minutes. The stained colloid was then centrifuged (13,000 rpm, for 2 minutes), the supernatant was removed
and the particles were redispersed in H2O. A drop of each sample was spotted onto a 3 mm 200 MESH
copper grid, and permitted to dry before imaging.
Figure 2.22: TEM micrographs showing pHLIPvar3-Au100-RubpySS colloid dried onto copper grids. Un-
treated particles (left) and particles treated with positive contract phosphotungstic acid stain (right)
Fig. 2.22 shows TEM images of unstained pHLIP-Au100-RubpySS and pHLIP-Au100-RubpySS treated
with a 1% solution of Phosphotungstic acid. The image of unstained pHLIP-Au100-RubpySS shows inde-
pendent, monodisperse particles that have grouped together on the copper grid possibly from the drying
process, but without physical agglomeration into larger particles. As discussed earlier, DLS indicated (Fig.
2.17) that particles had not significantly changed hydrodynamic diameter during the labelling process, so it
was expected that particle size had not significantly changed either. The image of stained particles shows
a more dense positive contrast border around the particles, similar to that of the pHLIP-Au13-RubpySS
images (Fig. 2.20), with a white interface between the positive contrast and the gold core. The presence of
the white corona is indicative of an increase in coating thickness, upon labelling with pHLIP & RubpySS.
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Figure 2.23: TEM micrographs showing pHLIPvar3-Au100-RubpySS colloid dried onto copper grids. Rows
show untreated particles (top) and particles treated with positive contract phosphotungstic acid stain (bot-
tom), each frame showing magnifications of 50,000x, 120,000x and 250,000x, respectively.
Fig. 2.23 shows an image selection of unstained pHLIPvar3-Au100-RubpySS (top row) and pHLIPvar3-
Au100-RubpySS with the positive contrast stain (bottom row) with different electronic magnifications. Im-
ages of unstained particles again show monodisperse particles, that in some cases have associated possibly
during the drying process, but no indications of large particle agglomeration are present. Images of stained
particles also remain monodisperse, with no large aggregates present, and with a significant white corona
between the gold particles and the positive contrast stain, indicating an increase in coating thickness.
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2.2.6 Luminescent Characterisation of pHLIP-labelled, luminescent AuNPs
Steady State Luminescence Characterisation of labelled-AuNPs
Being in a +2 oxidation state (d6), RubpySS will oxidise relatively easily, and the presence of strongly π-
accepting bipyridine ligands leads to Metal-to-Ligand Charge Transfer (MLCT) transitions to low energy
excited states. This is manifested as a strong absorption at approximately 465 nm ( ε = 14, 600M−1 for
Ru(bpy)3 [177]), corresponding to the
1MLCT transition, (π∗L ←− πM ). As a second row transition element,
ruthenium exhibits strong spin-orbit coupling, which is an interaction between an electrons spin magnetic
moment, and its orbital angular momentum.
Figure 2.24: Electronic transitions of archetypal transition metal complex, ruthenium trisbypyridine.
Ruthenium’s possession of a large nuclear magnetic moment, and therefore strong spin-orbit coupling
increases the likelihood of the singlet and triplet states having similar vibrational energy, rendering the
intersystem crossing (ISC) transition from singlet to triplet states more favourable. After ISC conversion of
an electron from a singlet excited state into a triplet excited state, the electron relaxes back to the ground
state via a 3MLCT transition. This demotion of the electron from a triplet excited state back down to
its singlet ground state orbital is spin forbidden, therefore proceeds slowly with an approximate radiative
lifetime of 500 ns [45] (far longer than typical organic values of 1 −→ 20 ns) and an overall photoluminescence
quantum yield of 0.042 (in H2O) [47]. As ruthenium exhibits strong vibronic coupling, the electron also
relaxes through a cascade of vibrational levels, this leads to a broad emission band at 650 nm. In addition
to MLCT transitions, Ligand − Ligand charge transitions are inducable under UV excitation (π∗L ←− πL),
and as ruthenium polypyridyl complexes are octahedral, promotion of a d-electron through the eg ←− t2g
transition (σ∗M ←− σM ) is also radiative (Fig. 2.24).
The steady state absorbance and luminescence spectra of pHLIP-Au13-RubpySS and pHLIP-Au100-
RubpySS are shown in Fig. 2.25. For pHLIP-Au13-RubpySS, the absorption profile shows the ruthenium
π∗ ←− π absorption at 290 nm along with the gold surface plasmon resonance, the band with a gaussian
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Figure 2.25: Top) Steady state absorption and luminescence spectra of pHLIP-Au13-RubpySS (4.8 nM). For
excitation scans, the instrument’s emission monochromator was set to 650 nm, and for emission scans, the
excitation monochromator was set to 465 nm (Abs = 0.72). Long pass filters were used to prevent detection
of scattered light. Bottom) Steady state absorption and luminescence spectra of pHLIP-Au100-RubpySS (40
pM). For excitation scans, the instrument’s emission monochromator was set to 650 nm, and for emission
scans, the excitation monochromator was set to 465 nm (Abs = 0.83). Long pass filters were used to prevent
detection of scattered light.
profile, at 530 nm. For pHLIP-Au100-RubpySS, the absorption profile shows the ruthenium π∗ ←− π ab-
sorption at 290 nm along with the gold surface plasmon resonance, the band with the broadened and skewed
gaussian profile, at 575 nm. For both the 13 & 100 nm particles, the excitation spectra show the π∗L ←− πL
electronic transition at 290 nm, the eg ←− t2g transition at 330 nm and the 1MLCT (π∗L ←− πM ) transition
at 465 nm, confirming the luminescence from the labelled particles is originating from ruthenium photo-
luminescence. Both emission spectra show the broad emission band resultant from radiative decay of the
3MLCT transition, however the λmax for pHLIP-Au
13-RubpySS and pHLIP-Au100-RubpySS are 627 nm
and 641 nm, respectively. Hypsochromic shifts of the emission band of ruthenium complexes during interac-
tion with biological structures has been previously reported [184], and is often associated with exposure of
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the ruthenium complex to a less polar environment than water, where charge localisation on the bipyridyl
groups during the MLCT state is less favourable.
Figure 2.26: Top) Steady state absorption and luminescence spectra of pHLIPvar3-Au13-RubpySS (4.8 nM).
For excitation scans, the instrument’s emission monochromator was set to 650 nm, and for emission scans, the
excitation monochromator was set to 465 nm (Abs = 0.53). Long pass filters were used to prevent detection
of scattered light. Bottom) Steady state absorption and luminescence spectra of pHLIPvar3-Au100-RubpySS
(40 pM). For excitation scans, the instrument’s emission monochromator was set to 650 nm, and for emission
scans, the excitation monochromator was set to 465 nm (Abs = 0.82). Long pass filters were used to prevent
detection of scattered light.
The steady state absorption and luminescence spectra of pHLIPvar3-Au13-RubpySS and pHLIPvar3-
Au100-RubpySS are shown in Fig. 2.26. For the 13 nm particles, the absorption profile shows the ruthenium
π∗ ←− π absorption at 290 nm along with the gold surface plasmon resonance, the band with a gaussian
profile, at 530 nm. For the 100 nm particles, the absorption profile shows the ruthenium π∗L ←− πL absorption
at 290 nm along with the gold surface plasmon resonance, the band with a gaussian profile, at 575 nm. For
both the 13 & 100 nm particles, the excitation spectra show the π∗ ←− π electronic transition at 290 nm,
the eg ←− t2g transition at 330 nm and the 1MLCT transition at 450 nm (π∗L ←− πM ). Both emission
spectra show the broad emission band resultant from radiative decay of the 3MLCT transition, however
the lambdamax for pHLIPvar3-Au
13-RubpySS and pHLIPvar3-Au100-RubpySS are 637 nm and 645 nm,
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respectively. This hypsochromic shift of the emission bands is indicative of increased exposure of RubpySS
to a less polar environment than water, which is most prominent for pHLIPvar3-Au13-RubpySS. The zeta
potentials of pHLIPvar3-Au13-RubpySS and pHLIPvar3-Au100-RubpySS (-30 ± 8 & -47 ± 9, respectively)
indicate that pHLIPvar3-Au13-RubpySS constitutes a less polar environment, and as a result, the MLCT
state is not as stable.
Figure 2.27: The effect of peptides and gold nanoparticles on the steady state emission of RubpySS. A)
pHLIP (6 µM) & co-labelling of Au13&100NPs, B) pHLIPvar3 (7.7 µM) & co-labelling of Au13&100NPs,
C) The effect of pHLIP (6 µM), pHLIPvar3 (7.7 µM) & kpHLIP (6 µM) variants on the emission of free
RubpySS (7 µM) and D) Enlargement of lambdamax region from (C). Spectra were corrected for instrument
response.
To investigate how the steady state emission of RubpySS is affected by each peptide, as well as their co-
labelling onto Au13 & Au100 nanoparticles, the emission of RubpySS within each of these samples was probed
by luminescence spectroscopy. For pHLIP and pHLIPvar3 (Fig. 2.27, A & B, respectively), addition of the
peptide to free RubpySS in H2O induces a hypsochromic shift of the
3MLCT transition. Additionally when
pHLIP-Au13-RubpySS and pHLIPvar3-Au13-RubpySS are studied, the same effect is observed. However
when pHLIP-Au100-RubpySS and pHLIP-Au100-RubpySS are studied this effect is not observed, and the
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emission band of labelled Au100NPs overlays well with the emission band of the free complex. Each pHLIP
variant has a similar effect on the steady state emission of RubpySS, inducing a hypsochromic shift relative
to free RubpySS in H2O (Fig. 2.27, C & D). No significant difference was observed between the effect of
each variant on RubpySS emission wavelength.
Interestingly, steady state emission from pHLIP-Au13-RubpySS and pHLIPvar3-Au13-RubpySS exhib-
ited blueshifted emission λmax whereas pHLIP-Au
100-RubpySS and pHLIPvar3-Au100-RubpySS exhibited
emission curves that almost perfectly overlaid with the emission spectrum of free RubpySS in water, Fig.
2.28. This suggests there is a plasmon effect on the emission of RubpySS, most markedly exhibited by the
Au13NPs and insignificantly by the Au100NPs. Rogers & Claire et al. [96] and Osborne et al. [166] reported
small surface plasmon resonance λmax shifts when 13 nm AuNPs were labelled with a ruthenium complex.
Prior to ruthenium complex labelling, these Au13NPs were labelled with the Zonyl 7950 or FSA fluorosur-
factant, in respective publications. Upon steady state luminescence measurements, both studies concluded
there were no plasmon effects contributing to the luminescence properties of the ruthenium complex. In this
work, the SPR λmax shifts are far greater for Au
13NPs (≈ 6 nm when labelling pHLIP-Au13 or pHLIPvar3-
Au13 with RubpySS) suggesting that the pre label (peptides or fluorosurfactants in these cases) may impose
desensitising effects on the gold’s surface plasmon resonance. If true, this may explain why Au13 and Au100
nanoparticles labelled with pHLIP or pHLIPvar3, experienced different luminescent properties.
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Figure 2.28: Steady state luminescence spectra of RubpySS, pHLIP-Au13-RubpySS (4.8 nM), pHLIPvar3-
Au13-RubpySS (4.8 nM), pHLIP-Au100-RubpySS (40 pM) & pHLIPvar3-Au100-RubpySS (40 pM) resultant
from excitation at 465 nm. Spectra were corrected for instrument response and 590 nm long pass filters were
used to filter out Rayleigh scattering.
Time Resolved Luminescence Characterisation of Labelled-AuNPs
Luminescence lifetime is the time taken for the number of excited molecules to undergo radiative decay to 1/e
or 36.8% of the original excited population, and is a more robust measurement than emission intensity because
it is not dependent on intensity of excitation or fluorophore concentration. Acquisition of luminescence
lifetime data was performed using the Time Correlated Single Photon Counting (TCSPC) module of an
FLS920 fluorescence spectrometer and analysed using FAST lifetime fitting software. Upon acquisition of
the lifetime data, the data was fitted by a Levernberg-Marquandt non-linear fitting algorithm using an
arrhenius model function (Fig. 2.29, 2)
Figure 2.29: Equations for luminescence lifetime fitting. Equation 1) the model function for exponential
component fitting of lifetime data, and 2) governs the relationship between the number of excited and
decayed molecules with luminescence lifetime.
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Figure 2.30: Time-resolved luminescent studies of the 3MLCT radiative transition of RubpySS (7 µM),
RubpySS + pHLIP (6 µM), RubpySS + kpHLIP (6 µM) and RubpySS + pHLIPvar3 (7.7 µM) resultant
from 444 nm excitation and 650 nm detection. The normalised instrument response is also shown and was
also recorded using excitation and detection at 444 nm.
All recorded lifetimes in this study are biexponential, with a small component occupying a small per-
centage of the overall signal, and a longer component occupying a majority of the overall signal. There is
evidence to suggest that the small component is resultant from quenching of the RubpySS excited state either
by energy or electron-transfer processes, however for ruthenium polypyridyl complexes assembled onto on
gold nanoparticles, this quenching is more characteristic of electron-transfer processes [169]. It is also note-
worthy that the RubpySS complex does not fall victim to previously reported AuNP-mediated luminescence
quenching of ruthenium polypyridyl complexes [185] because for all lifetimes of labelled-AuNPs recorded in
this study, all of them exhibit longer lifetimes than free complex.
As shown in Fig. 2.31 and tabulated in Table 2.6, Free RubpySS holds a luminescence lifetime of 97 (2%)
and 287 (98%) ns and this lifetime increases when either peptide is added to the solution, or if the complex
is used as a label for gold nanoparticles. Upon the addition of pHLIP to the solution, the RubpySS lifetime
increased to 101 (9%) and 328 (91%) ns, which is believed to be a resultant from a favourable hydrophobic
association between the peptide and the complex, helping to shield the complex from quenching by molecular
oxygen [50]. The lifetime of the RubpySS triplet excited state subsequently increased to 114 (13%) and
438 (87%) ns when co-labelled with pHLIP onto Au13NPs, significantly longer than the lifetime of free
complex, and free complex mixed with pHLIP. When RubpySS is co-labelled with pHLIP onto Au100NPs,
the lifetime increased markedly to 103 (7%) and 417 (93%) ns, significantly longer than the lifetime of the
free complex, somewhat shorter than the observed lifetime of pHLIP-Au13-RubpySS however as the lifetimes
are within 10% of each other, this difference is not deemed statistically significant. This increase in lifetime
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Figure 2.31: Time-resolved luminescent studies of the 3MLCT radiative transition of RubpySS, RubpySS
+ pHLIP, pHLIP-Au13-RubpySS and pHLIP-Au100-RubpySS resultant from 444 nm excitation and 650 nm
detection. The normalised instrument response is also shown and was also recorded using excitation and
detection at 444 nm. Linear (main) and log (inset) plots both included.
for nanoparticle-bound complex is also believed to be indicative of a reduction in O2 quenching.
As shown in Fig. 2.32 and tabulated in Table 2.6, upon the addition of pHLIPvar3 to a solution of
RubpySS, the lifetime of the RubpySS excited state increased from 97 (2%) and 287 (98%) ns to 140 (11%)
and 450 (89%), again believed to be resultant from a reduction in quenching by molecular oxygen. The
luminescence lifetime of pHLIPvar3-Au13-RubpySS was significantly greater than free complex, and slightly
greater than free complex mixed with pHLIPvar3 at 51 (5%) and 499 (95%), and the lifetime of pHLIPvar3-
Au100-RubpySS was 137 (18%) and 434 (82%), similar to the lifetime of free complex mixed with pHLIPvar3
but again shorter than the pHLIPvar3-Au13-RubpySS lifetime.
While each peptide offered an increased effect on RubpySS lifetime, this effect was most substantial
for the kpHLIP peptide. Being the most hydrophobic peptide studied, it likely has an energetically more
favourable interface with RubpySS, resulting in a more effective shielding from molecular oxygen. It is also
interesting that the luminescence lifetimes of Au13NPs co-labelled with RubpySS and a pHLIP variant are
longer than the RubpySS lifetime of the Au100 analogues, (Fig. 2.33 and Table 2.6). This nanoparticle size
dependency of the RubpySS excited state’s lifetime indicates an interaction between the surface plasmons
and the RubpySS excited state.
Attempts were made to measure the luminescence quantum yield (φF ) of all functionalised gold nanopar-
ticles. However, the accuracy of direct quantum yield measurement of is very dependent on how accurately
scattered light is measured. For this procedure, in addition to synthesising the luminescent gold nanoparticles
for measurement (luminescent sample), peptide coated gold nanoparticles which were devoid of ruthenium
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Figure 2.32: Time-resolved luminescent studies of the 3MLCT radiative transition of RubpySS, RubpySS
+ pHLIPvar3, pHLIPvar3-Au13-RubpySS and pHLIPvar3-Au100-RubpySS resultant from 444 nm excitation
and 650 nm detection. The normalised instrument response is also shown and was also recorded using
excitation and detection at 444 nm. Linear (main) and log (inset) plots both included.
Figure 2.33: Time-resolved luminescent studies of the 3MLCT radiative transition of RubpySS, pHLIP-
Au13-RubpySS, pHLIPvar3-Au13-RubpySS, pHLIP-Au100-RubpySS and pHLIPvar3-Au100-RubpySS resul-
tant from 444 nm excitation and 650 nm detection. The normalised instrument response is also shown
and was also recorded using excitation and detection at 444 nm. Linear (main) and log (inset) plots both
included.
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Sample Emission Band λmax / nm Lifetime / ns χ
2
RubpySS 647 97 (2%), 287 (98%) (1.071)
RubpySS + pHLIP 649 101 (9%), 328 (91%) (1.016)
RubpySS + pHLIPvar3 636 140 (11%), 450 (89%) (0.937)
RubpySS + kpHLIP 652 208 (18%), 524 (82%) –
pHLIP-Au13-RubpySS 627 114 (13%), 438 (87%) (1.069)
pHLIPvar3-Au13-RubpySS 637 51 (5%), 499 (95%) (1.072)
pHLIP-Au100-RubpySS 641 103 (7%), 417 (92%) (1.011)
pHLIPvar3-Au100-RubpySS 645 137 (18%), 434 (82%) (1.023)
Table 2.6: Emission band λmax (nm) and luminescence lifetimes (ns) of the emissive
3MLCT transition
of RubpySS before and after the addition of pHLIP peptide, and after complex has been assembled onto
pHLIP-coated AuNPs. Steady state spectra were acquired using excitation at 465 nm, and a 444 nm
picosecond-pulsed diode laser was used for time resolved studies. Luminescence lifetimes were fitted using an
arrhenius model equation with a Levenberg-Marquandt non-linear fitting algorithm to iterate until suitable
an acceptable convergence. χ2 values are included as a measure of lifetime fitting accuracy.
complex was also prepared for control measurements (reference sample). The concentrations of each were
adjusted until the absorbance of each sample’s SPR band was equal, before transferring to the Integrated
Sphere module of the FLS920 time correlated fluorescence spectrometer for quantum yield measurement.
For luminescent and reference samples, scatter scans were performed where the excitation was set to 465
nm, and the emission monochromators were scanned from 455 − 475 nm. In an accurate experiment, the
scatter spectrum resultant from luminescent samples has lower intensity than the scatter of reference samples
as the luminescent sample absorbs a portion of incident photons. When attempting this protocol however,
the scatter of pHLIP-Au13 was of lower intensity than pHLIP-Au13-RubpySS. Surface plasmon resonance
ultimately contains absorption and scattering contributions, and as pHLIP-Au13 and pHLIP-Au13-RubpySS
have SPR λmax 5 nm apart, it is the authors opinion that unlabelled AuNPs are not truly representative of
gold scattering due to SPR-dependent spectroscopic interactions. Therefore no quantum yield measurements
are included in this work.
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2.2.7 Structural & Luminescent Properties of labelled-AuNPs within Buffered
Environments
In the previous section, the pH-dependent cellular uptake of labelled-AuNPs was investigated using a cancer
model of HeLa cells treated with Tyrode’s buffer at physiological pH (pH 7.4, healthy cells) and low pH (pH
6.5, cancerous cells). The purpose of this section is to study the effect that experimental parameters had on
recorded nanoparticle internalization data. Firstly, the pH dependency of RubpySS luminescence was inves-
tigated. AuNPs were co-labelled with a pHLIP peptide and the RubpySS complex, and photoluminescence
from RubpySS was used as a measure of nanoparticle internalization in flow cytometry and light microscopy
experiments. Secondly, a series of techniques were used to study pH-dependent colloidal stability.
The effect of pH on RubpySS luminescence
The steady state luminescence of RubpySS was studied as a function of pH using range that spanned the
entire range of pH solutions used in previous cell treatments. Fig. 2.34 shows the steady state luminescence
spectra of RubpySS (20µM) in a series of Tyrode’s buffers (0.08 mM) ranging from pH 4.0 - 7.8. pH appears
to have little effect on the luminescence intensity of RubpySS, with a small insignificant reduction in intensity
at pH 5.2, but no net correlation with pH. Additionally, the λmax of the
3MLCT band is also unmodulated
by pH of the solution.
Figure 2.34: Steady state luminescence of RubpySS (20µM) dispersed in Tyrodes buffers (0.08 mM) in a pH
range of 4.0 to 7.8. λex = 465 nm, λem = 525 - 825 nm. Inset, data normalised to max intensity of pH 4.0
spectrum.
65
The effect of microenvironment pH on stability of labelled gold nanoparticles
In order to study the pH dependency of colloidal stability, solutions of pHLIP-Au13&100-RubpySS and
pHLIPvar3-Au13&100-RubpySS were dispersed in Tyrode’s solutions (pH 6.5 or pH 7.4) and subjected to
i) dynamic light scattering analysis to study, hydrodynamic diameter of the colloid. ii) UV/Vis absorption
spectroscopy to study the response of the gold surface electrons, and iii) TEM to study size and morphology
of the colloid.
Figure 2.35: A) UV/Vis Absorption, B) Dynamic Light Scattering, C & D) Transmission Electron Micro-
graphs of pHLIP-Au13-RubpySS (1 nM) dispersed in Tyrodes Buffer (0.08 nM) pH 6.5 (TEM, Image C) and
pH 7.4 (TEM, Image D).
For UV/Vis absorption analysis, the SPR λmax was reported for samples of gold nanoparticles dispersed
in water and Tyrodes solutions at pH 6.5 & 7.4. As previously discussed, the SPR band has a Gaussian
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profile and is modulated by morphology [82], core charge [83], inter-particle distance [85] and surface func-
tionalization [86]. The band also significantly broadens and loses intensity upon nanoparticle aggregation,
and is a useful measure of colloidal stability. For DLS analysis, the colloid was dispersed into water or one
of the tyrode’s buffers, and the hydrodynamic diameter of the colloid was measured using dynamic light
scattering. Often multiple peaks were present within the DLS histograms, which the program would express
each peak as a percentage of total integration. For example, Fig. 8.36 shows the raw number distribution
of hydrodynamic diameters of pHLIP-Au13-RubpySS (1 nM) dispersed into Tyrode’s buffer (pH 6.5, 0.08
mM). The two bands in the histogram are expressed as 689 nm (22.1%) and 161 (77.8%), where the weighted
average of the two equates to 277 nm. For ease of comparing the DLS data in this section, the weighted
averages of the number distribution are reported and contrasted.
pHLIP-Au13-RubpySS (1 nM) was dispersed in Tyrode’s solutions (0.08 mM, pH 6.5 or 7.4), and analysis
by UV/Vis absorption (Fig. 2.35, A) showed the gold SPR λmax was initially at 527 nm, and dispersion of
the colloid in Tyrode’s solutions resulted in an SPR shift of 5 nm for pH 6.5 (532 nm), and 5 nm for pH
7.4 (532 nm). This small 5 nm shift was identical for both samples, and no significant peak broadening or
reduction in band intensity occurred post-dispersion, indicating no colloidal flocculation.
For DLS analysis of pH-dependent colloidal stability, upon dispersion into Tyrodes solutions the particle
hydrodynamic diameter increased to 277 nm and 177 nm for pH 6.5 and 7.4, respectively, (Fig. 2.35, B).
Particles dispersed in H2O had a hydrodynamic diameter of 19 nm as previously in a previous chapter.
This indicates that particles are associating in close proximity in both samples, but particles in the pH 6.5
solution are in motion as larger clusters. TEM imaging revealed that particles dispersed in either buffer had
not flocculated into larger particles, but did appear to be associating together in larger clusters (Fig. 2.35,
C - pH 6, D - pH7), supporting both the DLS and UV/Vis data. Additionally, the effect of serum proteins
on colloidal stability was also investigated, as it is known that negatively charged colloidal nanoparticles
can flocculate upon exposure to positively charged serum proteins[102]. For this experiment, pHLIP-Au13-
RubpySS particles were dispersed into water, serum-free media & serum-containing media and the colloids
were studied by UV/Vis Absorption Spectroscopy Fig. 8.25 (Appendices). Dispersion of pHLIP-Au13-
RubpySS particles within water or serum-free media had negligible effects on the SPR band shape or λmax,
however dispersion of the nanoparticles into serum-containing media induced a 5 nm bathochromic shift of
the SPR λmax. However, a 5 nm SPR λmax bathochromic shift is small relative to shifts characteristic of
flocculating particles. Additionally, the band retained its gaussian shape and no additional bands appeared.
This indicates no significant flocculation had occurred, suggesting that serum proteins are affecting the
Au surface dielectric constant through proximal interactions, but are not destabilising the nanoparticles
sufficiently to flocculate the colloid.
For pHLIP-Au100-RubpySS, analysis by UV/Vis absorption (Fig. 2.36, A) indicated that the gold
SPRλmax moved from 614 nm to 624 nm for nanoparticles dispersed in Tyrode’s pH 6.5, and did not move
for particles dispersed at pH 7.4. This is indicative of pH-dependent changes on the gold surface leading to
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Figure 2.36: A) UV/Vis Absorption, B) Dynamic Light Scattering, C & D) Transmission Electron Micro-
graphs of pHLIP-Au100-RubpySS (8 pM) dispersed in Tyrodes Buffer (0.08 nM) pH 6.5 (TEM, Image C)
and pH 7.4 (TEM, Image D).
electrons oscillating at a lower frequency at in the Tyrode’s pH 6.5 solution. Number distributions of particle
hydrodynamic diameter were also recorded (Fig. 2.36, B), indicating that particles in water had an average
diameter of 92 ± 29 nm, and particles dispersed at pH 6.5 and 7.4 had hydrodynamic diameters of 123 ±
40 nm and 116 ± 22 nm, respectively. Transmission electron microscopy revealed clustered association of
nanoparticles in both samples, however it was notable that particles were still spherical and no flocculation
into large aggregates was visible, indicating that any surface changes at the gold surface were not resulting
in sufficient degradation of the nanoparticle’s surfactant layer.
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Figure 2.37: A) UV/Vis Absorption, B) Steady State Luminescence, C) Dynamic Light Scattering, D)
Time-resolved Luminescence, and E) Transmission Electron Micrographs of pHLIPvar3-Au13-RubpySS (1
nM) dispersed in Tyrodes Buffer (0.08 nM) pH 6.5 (TEM, Image C) and pH 7.4 (TEM, Image D).
For pHLIPvar3-Au13-RubpySS, in addition to UV/Vis absorption, DLS, and TEM analysis, luminescence
measurements were also taken to study whether they corroborated the former measurements. Particles (1
nM) were dispersed into a Tyrode’s solution (0.08 mM, pH 6.5 & 7.4) and subjected to the following
techniques.
Analysis of the UV/Vis absorption spectrum of dispersed particles indicated an SPRλmax shift to 536
nm (+ 9 nm) and 529 (+ 2 nm) for pH 6.5 and 7.4, respectively. The full-width at half-maximum of the
SPR band also changed markedly for each sample, increasing from 90 nm for citrate-labelled AuNPs to 146
nm and 130 nm for pH 6.5 and 7.4, respectively. The hydrodynamic diameters of pHLIPvar3-Au13-RubpySS
were also modulated in a pH dependent fashion upon dispersion into Tyrode’s solutions. The hydrodynamic
Solvent Emission Band λmax / nm Lifetime / ns χ
2
Water 637 51 (5%), 499 (95%) (1.072)
Tyrodes pH 6.5 636 3 (23%), 66 (9%), 363 (68%) (1.080)
Tyrodes pH 7.4 649 3 (22%), 30 (4%), 273 (73%) (1.096)
Table 2.7: Emission band λmax (nm) and luminescence lifetimes (ns) of the emissive
3MLCT transition of
pHLIPvar3-Au13-RubpySS ( 1 nM) before and after the dispersion of the particles into tyrode’s solutions
(0.08 mM, pH 6.5 or 7.4). Steady state spectra were acquired using excitation at 465 nm, and a 444 nm
picosecond-pulsed diode laser was used for time resolved studies. Luminescence lifetimes were fitted using an
arrhenius model equation with a Levenberg-Marquandt non-linear fitting algorithm to iterate until suitable
an acceptable convergence. χ2 values are included as a measure of lifetime fitting accuracy.
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diameter of the colloid in water was 16 ± 3, and dispersion into the buffers increased the diameters to 21
± 8 and 17 ± 5 for pH 6.5 and 7.4, respectively. Particle sizes according to TEM imaging remained at
approximately 13 nm, with no evidence of large aggregates. However particles dispersed in Tyrodes pH
6.5 were associating in larger clusters significantly more so than particles dispersed in Tyrode’s pH 7.4.
Luminescence measurements were also quite revealing. Time-resolved luminescence measurements show a
decrease in luminescence lifetime from 51 (5%), 499 (95%) in water, to 3 (23%), 66 (9%), 363 (68%) for pH
6.5, and 3 (22%), 30 (4%), 273 (73%) for pH 7.4. Expressed as weighted averages, the luminescent lifetime
of pHLIPvar3-Au13-RubpySS in water, Tyrode’s pH 6.5 & Tyrode’s pH 7.4 was 476 ns, 247 ns and 199
ns, respectively. The steady state measurements show a hypsochromic shift of the RubpySS 3MLCT band
from 637 nm in water to 636 nm at pH 6.5, and a bathochromic shift to 649 nm for pH 7.4. It is therefore
the conclusion that lower buffer pH has caused the particles to associate in much closer proximity, either
due to displacement mechanisms or charge imbalances. This is reflected by an increase in the SPRλmax,
the frequency of the oscillating gold surface electrons, which is sensitive to nearby particles [85]. This is
supported by DLS measurements that show larger solvation structures tumbling through solution, and TEM
which shows the colloid is still comprised of 13 nm spherical particles. Luminescence measurements show a
pH dependent change in steady state and time resolved modes. Both modes indicate that emission flux from
particles decreases upon dispersion into the buffers. It is not clear however whether this is a consequence
of a pH-dependent cleaving effect of RubpySS from the gold surface, leading to shorter lifetimes or if it’s
resultant from a proximal effect between nearby particles (as indicated by DLS data) that perhaps contribute
a quenching effect on RubpySS luminescence.
For pHLIPvar3-Au100-RubpySS, hydrodynamic diameter measurements of the colloid upon dispersion
into the buffers increased from 99 ± 29 nm to 150 ± 93 nm and 122 ± 45 nm, respectively. TEM imaging
again did not indicate that nanoparticle flocculation had occurred, and instead indicated that the particles
remained monodisperse. Again it appears that particles are associating in clusters, however it is not clear
what effect that will exert on pHLIPvar3-mediated delivery of particles into eukaryotic cells.
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Figure 2.38: A) UV/Vis Absorption, B & C) Transmission Electron Micrographs of pHLIPvar3-Au100-
RubpySS (8 pM) dispersed in Tyrodes Buffer (0.08 nM) pH 6.5 (TEM, Image C) and pH 7.4 (TEM, Image
D).
2.3 Conclusions
In summary, monodisperse Au13NPs and Au100NPs were synthesised and sequentially labelled with a pHLIP
variant and the luminescent transition metal complex, RubpySS. Particles were then subjected to a plethora
of structural and luminescent characterisations, in order to confirm the coating, and establish the effect
of the coating on colloidal properties. The kpHLIP peptide, being the most hydrophobic variant studied,
would not fully disperse in 5% DMF in phosphate buffered saline, and dynamic light scattering confirmed that
when kpHLIP was used to label Au13NPs, the particles were highly poly disperse and aggregated when small
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amounts of RubpySS complex was added. As the labelling procedure, and ultimately particle monodispersity
could not be controlled for kpHLIP-labelled AuNPs, these particles were neglected from further study in
cellular uptake experiments. The nature of labelling gold nanoparticles that are initially stabilised by negative
charge, with a positively charged substrate involved a significant trade off between efficiently coating the
particles with the ruthenium complex, and maintaining good colloidal stability and monodispersity. Protocols
were developed and tuned until strong luminescent signal was observed with narrow particle size distributions
and low polydisersity indexes (PdI < 0.2) indicating excellent monodispersity, which was also confirmed by
transmission electron microscopy of the labelled AuNPs. The coating of peptide labelled Au13&100NPs
with RubpySS proved more efficient when labelling pHLIPvar3-coated AuNPs, possibly due to pHLIPvar3
being a smaller peptide, forming a thinner sheath around the gold, rendering the surface more accessible
to incoming RubpySS. Steady state luminescence measurements indicated a destabilisation of the MLCT
excited state of RubpySS when mixed with pHLIP variants, or when bound to Au13NPs most likely due
to charge destabilisation of the 3MLCT state as a result of the complex being in a less polar environment
[184]. However when bound to Au100NPs the steady state luminescence very closely resembled that of free
complex. It has been suggested in this work that the luminescence properties of the AuNP-bound ruthenium
complex may be co-dependent on AuNP size-dependent plasmon effects and the co-label. Luminescence
experiments in this work along with referral to previous work by the group [96, 166] indicated that the AuNP-
bound co-label (peptides or fluorosurfactant) may impose a desensitising effect on gold surface plasmon
resonance, which is reflected by the λmax of RubpySS’ steady state emission. However this will require
further investigation. Across the board, mixing RubpySS with pHLIP peptides in solution resulted in an
increased luminescent lifetime, which was increased further when the complex and peptides were assembled
onto Au13NPs. Lifetimes of pHLIP-Au100-RubpySS and pHLIP-Au100-RubpySS were shorter than their 13
nm analogues. pH dependent colloidal stability measurements indicated a pH-dependent response in the size
of associated nanoparticles, particularly for pHLIPvar3 labelled-AuNPs. This does raise a question of pHLIP
mediated uptake that to the knowledge of the author, has not been raised in a previous pHLIP publication.
During it’s pH mediated internalization into POPC liposomes pHLIPs have been shown to fold reversibly into
an α-helix, permitting its transduction across the plasma membrane [132, 170, 181, 176], and indeed the same
has been shown when pHLIP has been tethered to an AuNP [137]. How this translates into a more dynamic
and complex cellular environment is not clear, particularly as aggregation of nanoparticles has been shown
to strongly affect cellular uptake [102] and that many proteins have strong affinities for charged particle
surfaces [103]. Although neither pHLIP-Au13&100-RubpySS or pHLIPvar3-Au13&100-RubpySS flocculated in
the buffers that were used in these cell treatments, the effect that clustered association of nanoparticles has
on nanoparticle internalization is unclear, and this should be a major component of future research.
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2.4 Future Work
Additional work for this chapter would be to more fully characterise the bonding between the peptide’s
and the gold surfaces. pHLIPvar3’s binding to gold surfaces would need to be investigated, particularly as
pHLIPvar3 has two soft bonding donors from its two cysteine residues. X-ray photoelectron spectroscopy
would be used to better understand the bonding configurations between pHLIPvar3 and gold surfaces.
Additionally, analysing the effect of nanoparticle flocculation and the cleaving of RubpySS from Au surfaces
on ruthenium luminescence would also be an interesting addition and useful when characterising the integrity
of the surface labelling when nanoparticles are internalized into cells. Additional measurements of the effect
that nanoparticle-bound surfactants impose on ruthenium luminescence will permit elucidation of why there
is an apparent AuNP size-dependent emission λmax for RubpySS in this work.
2.5 Experimental
pHLIP, kpHLIP and pHLIPvar3 peptides were purchased from Peptide Synthetics and used without any
further purification. Peptides were dissolved in 5% DMF in PBS, and were used in stock solutions of 0.5
mM, 0.5 mM and 0.65 mM, respectively.
2.5.1 Synthesis of luminescent ruthenium complex, RubpySS
Synthesis of [Ru(bpy)2(4,4-di-(5-lipoamido-1-pentoxy)-2,2-bipyridine)]
2+, RubpySS, was synthesised accord-
ing to Adams et al. [175] and was characterised by 1HNMR, 13C 1H PENDANT NMR, Electrospray Mass
Spectrometry, UV/Vis Absorption Spectroscopy and Elemental Analysis. RubpySS was prepared via a mod-
ification to a method outlined by Sullivan et al. [186]. Briefly, a solution of bpySS (68.6 mg, 0.11 mmol)
and Ru(bpy)2Cl2 (100.17 mg, 0.21 mmol) in ethanol (10 mL) was heated under reflux for 16 hours. The
resultant red/orange solution was cooled to room temperature, whereby H2O (35 ml) was added to the
solution, forming a fine cream precipitate, which was filtered. A saturated methanolic solution of ammo-
nium hexafluorophosphate (0.25 g, 1.5 mmol in 2 ml EtOH) was added to the solution, giving a red/orange
precipitate. The precipitate was filtered and washed with ice-cold H2O, followed by ice-cold Et2O to give
the crude product as an orange/red solid. The solid was dissolved in a minimal amount of acetonitrile and
the solvent was removed in vacuo to give a red crystalline solid RubpySS (79.9 mg, 51%); Found: C, 45.9;
H, 4.9; N, 7.4; Calc: C, 46.8; H, 4.9; N, 7.8; δH(300 MHz; CDCl3), 1.67 1.73 (2H, m, H-53,72), 1.84 (4H,
t, J = 7.2, H-47,64), 2.19 2.32 (4H, m, H-48,71), 2.85 3.10 (4H, m, H-44,61), 3.34 3.46 (2H, m, H-58,68),
4.04 (4H, t, J = 6.5, H-40,57), 6.24 (2H, s, NH), 6.75 (2H, dd, J = 6.5, 2.6, H-27,36), 7.20 (4H, dd, J = 6.6,
1.2, H-,25,26), 7.26 (4H, dd, J = 6.6, 1.2, H-2,8,17,22), 7.63 (4H, dd, J = 3.6, 0.77, H-3,7,16,23) 7.68 (4H,
dd, J = 5.6, 0.8, H-3,7,16,23), 7.88 (6H, m, H-1,9,18,21,24,28), 8.24 (4H, dd, J = 8.0, 3.1, H-6,10,19,20);
δC(100 MHz; CDCl3), 23.6 (C-42,59) 25.2 (C-28,35), 28.8 (C-49,66), 29.4 (C-41,58), 35.3 (C-51,67), 36.3
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(C-47,64), 39.2 (C-54,71), 39.3 (C-44,61), 41.0 (C-53,72), 57.4 (C-52,68), 70.6 (C-40,57), 111.3 (C-29,34),
115.1 (C-27,36), 125.0 (C-6,10,19,20), 128.4 (C-2,8,17,22), 138.3 (C-1,9,18,21), 153.7 (C-3,7,16,23), 158.2
(C-5,11,13,14), 167.6 (C-46,63); MS (ESI+) m/z 1294 [(M PF6)+].
2.5.2 Ion Exchange of RubpySS.(PF6)2 for RubpySS.(Cl2)
Dowex R© 1x8 200 MESH Ion Exchange Resin (10 g) was equilibrated in 30 mL deionised water, whereby
the pH was lowered to pH 5 by dropwise addition of hydrochloric acid (1.2 M) followed by vigorous stirring
for 1 hr. The Dowex R© was collected by suction filtration and re-diluted in 30 mL methanol, to which
RubpySS.(PF6)2 (100 mg) was added and the mixture was stirred vigorously for 2 hrs. The Dowex was then
filtered off and washed through with methanol (3 x 10ml). The filtrate was collected and solvent removed in
vacuo to give RubpySS.Cl2 as a dark-red solid (86.0mg and 2.3mg respectively). RubpySS ES MS(+): m/z
1027.3 [M - Na+].
2.5.3 Synthesis of colloidal gold
13 nm citrate-stabilized AuNPs were synthesized by the method according to Schulz et al.[159] and subse-
quently a seeded growth protocol by Ziegler et al. [69] was used with 13 nm AuNP seeds to synthesise 100
nm diameter AuNPs. Particles were characterized by dynamic light scattering, capilliary electrophoresis,
transmission electron microscopy and UV/Vis absorption spectroscopy. The approximate concentrations
have also been estimated as 1.6 nM for Au13NPs and 40 pM for Au100NPs.
Synthesis of Au13NPs
For Au13NPs, the method of Schulz et al.[159] was followed with a few modifications. Briefly, a solution of
trisodium citrate (60.6 mg), citric acid (13.3 mg) and ethylenediaminetetraacetic acid (1.0 mg) in H2O (100
mL) was brought to reflux with rapid stirring. Rapid addition of HAuCl4 (8.0 mg) in H2O (25 mL) to the
vortex of the solution resulted in a colour change from pale colourless to a deep wine red, approximately
30 seconds post-addition. Boiling was continued for an additional 10 minutes, the heating mantle was
then removed and stirring was continued until particles had cooled to room temperature. The colloid was
characterized by a UV/Vis absorption at 517 nm, a zeta potential (ζ) of -37 ± 7 mV (pH 6.2), and DLS
number distribution indicated a particle size of 11 ± 3 nm. Transmission electron microscopy also confirmed
the synthesis of approximately 13 nm seeds (Fig. 8.3).
Synthesis of Au25NPs
Au13NPs (34 mL) were diluted to 40 mL with H2O, and stirred rapidly in a roundbottom flask equipped
with a reflux condenser. Solutions of i) trisodium citrate and ascorbic acid in H2O (20 mL) and ii) HAuCl4
in H2O were both simultaneously added to the colloidal solution in a dropwise fashion. After addition
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was complete, the mixture was heated at 150◦C for 30 minutes, and then allowed to cool slowly to room
temperature.
Synthesis of Au50NPs
Au25NPs (9 mL) were diluted to 40 mL with H2O, and stirred rapidly in a roundbottom flask equipped with
a reflux condenser. Solutions of i) trisodium citrate and ascorbic acid in H2O (20 mL) and ii) HAuCl4 in H2O
were both simultaneously added to the colloidal solution in a dropwise fashion. After addition was complete,
the mixture was heated at 150◦C for 30 minutes, and then allowed to cool slowly to room temperature.
Synthesis of Au100NPs
Au50NPs (40 mL) were stirred rapidly in a roundbottom flask equipped with a reflux condenser. Solutions
of i) trisodium citrate and ascorbic acid in H2O (20 mL) and ii) HAuCl4 in H2O were both simultaneously
added to the colloidal solution in a dropwise fashion. After addition was complete, the mixture was heated
at 150◦C for 30 minutes, and then allowed to cool slowly to room temperature. DLS, 108 ± 27 nm; SPR,
572 nm; Zeta potential (ζ) = -41 ± 6 mV (pH 2.95).
Calculation of AuNP Concentrations
For Au13NPs: HAuCl4 starting mass = 8 mg; Au% by mass = 3.94 mg; 3.94/196.67 (Au RAM) = 1.99x10
−5
moles of Au; Moles (M) of Au = 1.99x10−5/125x10−5 = 0.00159 M; volume of 13 nm AuNP =2.74x10−25
m3; volume of gold atom = 2.74x10−30 m3; No. of atoms per AuNP = 100081.9; Conc Au (M) / No. atoms
per AuNP = 1.59x10−9 M or 1.6 nM. For Au25NPs, multiply by Au13/Au25 dilution ratios: 1.6 x (34/80)
= 0.68 nM. For Au50NPs, multiply by Au25/Au50 dilution ratios: 0.68 x (9/80 x 1000) = 78 pM. For
Au100NPs, multiply by Au50/Au100 dilution ratios: 1.6 x (20/40) = 38 nM.
Figure 2.39: Hydrodynamic diameter of colloidal 13 nm (left) and 100 nm (right) gold nanoparticles. Dis-
tributions based on numerical analysis of dynamic light scattering intensity distributions. Inset both, trans-
mission electron micrographs of particles studied.
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2.6 Data Analysis Methods
UV/Vis of colloidal gold nanoparticle samples was analysed by fitting the SPR band with a gaussian model.
A gaussian curve is a good model for doppler, natural and collision broadening experienced by molecules
interact with light, and was fitted to the SPR band using a Levenberg-Marquandt Non-linear fitting algorithm
that iterated until it had successfully converged upon parameters of λmax and Absorbance. The Full Width
at Half Maximum (FWHM) of the gaussian profile fitted to the SPR band was then subsequently fitted using
a FWHM algorithm written by Patrick Egan and obtained through MathsWorks.
An example of an analysed dataset is shown in Fig. 2.40. The original data is shown followed by the
fitting of each individual UV/Vis absorption spectrum of the dataset. The results are then compiled into a
graph where the change in SPR λmax and FWHM are displayed as functions of ligand concentration.
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Figure 2.40: Sample UV data with a Gaussian function fitted to each SPR band, followed by the sequentially
calculated lambda max, Full Width at Half Maximum (FWHM) and Last Squares Error.
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Chapter 3
pHLIP-mediated uptake of AuNPs
into Cancer Cells
3.1 Introduction
Tumour targeting delivery of anticancer drugs has attracted much attention over the past few decades because
of the potential to deliver a drug to cancerous tissue whilst leaving healthy tissue unaffected, reducing the
overall side effects of the drug. The major categories of tumour targeting drug delivery are i) the Enhanced
Permeability and Retention (EPR) effect, where it has been shown that tumour cell angiogenesis results in
irregular, dilated, and sometimes defective blood vessels with large fenestrations amongst endothelial cells
permitting the leaking of macromolecules such as nanoparticles from the blood plasma into the tumour
tissue [104, 105]; and ii) the targeting of specific cancer biomarker proteins [106]. It has however been
shown that the EPR effect is small/non-existent for some tumour types [187, 109, 108] and the targeting
of biomarkers is often complicated by tumour cell heterogeneity [110, 111]. Furthermore, many biologically
active compounds, including large biomolecules need to be delivered to intracellular destinations to exert
their therapeutic action, and often the lipophilic nature of the plasma membrane restricts which species of
biomolecules are capable of internalization. A novel approach to deliver such molecules involves tethering
them to peptides that translocate through the cellular membranes, thereby enhancing their delivery into
the cell. These Cell Penetrating Peptides (CPPs), sometimes referred to as Protein Transduction Domains
(PTDs), have several advantages over conventional techniques as they are often efficient over a range of cell
types, can be applied to cells en masse, and have potential therapeutic applications [188]. CPPs often possess
a net positive charge often from high abundance of arginine residues, and initial attraction of the CPP to
the plasma membrane is resultant from the electrostatic attraction between the positively charged PTD and
negatively charged surface proteoglycans. It was first demonstrated in 1999 that nanoparticles could be
ferried across the plasma membrane by CPPs [189] where super-paramagnetic iron oxide nanoparticles were
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derivatized with the PTD from the transactivating transcriptional activator (TAT) protein of HIV-1. Since
then, CPP-mediated transport of cargo across the plasma membrane has been reviewed for nanoparticles
[190], liposomes[190, 112] and double stranded DNA [188], peptides [188, 191] and proteins [192, 193].
3.1.1 Acidosis: A property of Tumour Cell Microenvironments
It was long believed that intracellular pH of tumour cells held acidic values, from Warburgs first observations
of the ”remarkable extent to which living tumour cells are able to convert carbohydrate into lactic acid”
[194], until Griffiths and coworkers employed the non-invasive 31P NMR and indicated that tumour cell
pH was around neutral, and sometimes slightly alkaline [195]. It is now known that acidic tumour pH is
characteristic of extracellular tumour fluid, and not from within tumour cells themselves [196]. Tumours
have high rates of glycolysis, and although the reason for this has not been proven, it has been suggested
that tumour cells resort to high rates of glycolysis to fill the ATP deficit resultant from the poorer abundance
of mitochondria in cancer cells [197]. Protons generated through glycolysis are combined with the lactate
counter ion and are removed from the cell by the monocarboxylate/H1 co-transporter in order to maintain
the cells normal operational pH. The effect of acidosis provides a universal pH biomarker of cancer cells and
continuing attempts to exploit this phenotype are being pursued [171, 172, 198].
3.1.2 The pH Low Insertion Peptide (pHLIP)
The spontaneous membrane-insertion of small peptides (< 60 residues) was first reported ca. 1994, and
these were followed with reports of suggested methods design and development [199, 200, 201]. The pH-low
insertion peptide (pHLIP) was first reported by Hunt et al. in 1997 [132, 202] where they reported the
spontaneous, rapid and reversible, pH-dependent insertion of a bacterially derived transmembrane α-helix.
The peptide has been shown to undergo membrane insertion by a three step process, centred around an
insertion trigger at approximately pH 6.0. It was found that this pH insertion threshold coincided with the
pH of tumour cell micoenvironments, this prompted use as imaging and diagnostic tools for cancer [203, 204,
170, 205], inflammation [206] and ischemic myocardium[136]. Over the last twenty years there has been a
strong expansion of the range of applications the peptide has been applied to, as well as an expansion of the
pHLIP library, with new bespoke derivatives of pHLIP synthesised to suit applications.
Structure and physical properties
The pHLIP peptide was based on the Helix-C of the primary structure of bacteriorodopsin, and its original
sequence consisted of 36 amino acids. The peptide is one of few anionic cell penetrating peptides, of which
glutamic acid (Glu) & aspartic acid (Asp) residues lie responsible for the peptides net charge of -5, and con-
tribute to a net hydrophilic property. The peptide was shown to weakly associate with phospholipid bilayers
at neutral pH, and as a result was easily recoverable using sedimentation methods. The primary structure
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of this peptide was theoretically shown to satisfy the hydrogen bonding requirements of the polypeptide
backbone while burying its hydrophobic chains into the hydrophobic core of the plasma membrane. Circular
dichroism experiments of pHLIP-membrane interaction revealed the appearance of α-helix bands during its
insertion process, and revealed a pH threshold of membrane insertion of approximately pH 6.0. Table 3.1
shows the original Wt-pHLIP sequence reported by Hunt et al in 1997 [132]. Since then, over 20 variants of
the peptide have been studied.
Figure 3.1: Wt-pHLIP peptide sequence from the 2010 review by Andreev et al. [133] with the transduction
and flanking domains labelled. Positively-charged residues labelled in red; negatively-charged residues in
blue, and neutral residues in black.
Stability & Solubility
The original pHLIP peptide (Wt-pHLIP), is water soluble and has been shown not to aggregate in aqueous
solution, mediate pore formation, or form its α-helical structure while on the surface of the plasma membrane
[170, 207]. However, it was shown that substitution of the aspartic acid residues within the transduction
domain for alanine residues induced peptide aggregation in aqueous solution, and substitution of glutamic
acid for asparagine rendered the peptide ineffective for tumour cell targeting [181, 182].
Process of pHLIP’s Binding to Phospholipid Bilayers
In aqueous solution, the pHLIP monomer exists in a conformational equilibrium of three states and a
solubility equilibrium also exists between monomeric pHLIP and oligomeric and aggregated analogues. The
position of the conformational equilibrium is dependent on pH of the peptide’s microenvironment and plasma
membrane accessibility. Fig. 3.2 illustrates each component of the equilibrium, illustrating the conformation
of the peptide at each stage. In state 1, when the pH of the solution > 6.5 and where plasma membranes are
absent, the peptide adopts a free, unstructured and monomeric form. In state 2, In the presence of plasma
membranes, and at > pH 6.5, the peptide will loosely bind to the membrane periphery in an unstructured
monomeric state. In state 3, when in the presence of plasma membranes and with pH < 6.5, the peptide’s
aspartic/glutamic acid residues become protonated, and the peptide folds into an α-helical structure inserting
itself C-terminus first into the plasma membrane [204, 205]. At face value, pHLIP’s insertion pH is unusual
as the pKas of glutamic acid & aspartic acid are 4.1 and 3.9, respectively. Despite these low pKas, pHLIP’s
tranducting domain appears to undergo its pH switch at ≈ pH 6.0. This increased pKa is associated with a
reduction of the dielectric constant of the peptide’s environment when the peptide is proximal to a plasma
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membrane. On this subject, there is a large amount of experimental data along with theoretical calculations
that indicate the pKa of an amino acid could be significantly modified while on the border of, or within a
plasma membrane [208, 209, 210, 211].
Figure 3.2: Schematic of conformation changes of the Wt-pHLIP peptide during it’s pH-dependent membrane
insertion, taken from [132].
At high and neutral pH, the peptide adopts an equilibrium between stage 1 and stage 2, with a dissociation
constant largely influenced by electrostatic effects between the anionic peptide (-5 at pH 7.4) and anionic
phosphate head groups. Favourable hydrophobic interactions drives the initial association of the peptide
with plasma membranes, and thereafter membrane binding is dominated by N-terminal segments of the
pHLIP peptide [212]. At neutral pH, the peptide is anchored at the surface of the membrane by pHLIP’s
hydrophilic residues, Glu & Asp.
Process of pHLIP’s Insertion into Phospholipid Bilayers
Membrane insertion operates in a series of discrete stages. If the pH of a system of plasma membranes
in aqueous solution is lowered to the insertion pH, the protonation of the Aspartic acid residues D14 and
D25 side chains becomes the first instigator of insertion. This leads to the formation of two membrane-
embedded pHLIP structure populations; one population (approximately 70% of total population) exists as
a non-structured peptide which has been drawn deeper into the membrane than in Stage II (Stage II), with
the second population (approximately 30% of total population) adopting an inserted motif with an α-helical
structure between residues A10 - A27 (Stage III) as shown in Fig. 3.3. If system pH was further lowered to
pH 5.3, an increased majority of pHLIP peptide will exist as a transmembrane helix [212].
The kinetic properties of pHLIP’s pH-triggered insertion, stage II) to stage III), complied with first-order
kinetics, as determined by tracking fluorescence changes and performing circular dichroism measurements
upon insertion of pHLIP into POPC vesicles. pHLIP’s insertion begins with rapid helix formation, and while
it is not experimentally clear exactly how many helixes are formed, two folding intermediates were identified,
occurring at 8 and 12 ms. The process of transbilayer insertion happens much slower, and there is a distinctly
different, significantly more rapid process of peptide withdrawal which occurs within 100 ms of pH triggering
81
[133]. The change in Gibbs Free Energy (∆G) of pHLIPs binding to a POPC surface (transition from State I
to State II) at 37◦C = -7 kcal mol−1 and the additional free energy of folding and insertion of pHLIP across
a POPC bilayer = -2 kcal mol−1 (transition from State II to State III) [213]. It is theorized that this energy
difference between States II & III, could be used to partition a cargo across the lipid bilayer. The overall
insertion time has been reported as ≈ 40 seconds for Wt-pHLIP [176].
Figure 3.3: Schematic of pHLIP insertion process from Stage II to Stage III. In state II (pH 7.4), the N-
terminal A10 (5.7 Å) and A13 (7.6 Å) residues are in close proximity to the head group phosphates. The
C-terminal A27 (410 Å) is depicted as outside the membrane. In the adsorbed state II’ at pH 6.4, pHLIP
sinks deeper into the bilayer (with A10 at 7.6 Åand A13 at 410 Å), pulling A27 (6.4 Å) into close distance
to head group phosphates. In state III (at both pH 6.4 and 5.3), A10 (5.7 Å) and A13 (7.8 Å) are located
deeper in the membrane than in state II (pH 7.4) but maintain similarly close distances to phosphates,
whereas A27 is still 410 Åaway from head group phosphates of the opposing monolayer lipids. Figure and
caption taken from [212].
The effect of pHLIP’s Primary Structure on Membrane Insertion
The pH threshold, window and insertion mechanism are bespoke according to the primary structure of the
variant being studied. For example, the pH of insertion threshold of Wt-pHLIP moved from pH 6.0 to
pH 6.5 after two key aspartic acid residues were substituted for glutamic acid, another hydrophilic amino
acid, within the peptide sequence [181, 182]. Fendos et al. reported the how the location of these aspartic
acid residues within the pHLIP sequence affected the penetration depth of pHLIP’s insertion, and thereby
affect pHLIP’s insertion pKa and exhibited an effect on insertion reversibility and peptide aggregation.
In the case of particular variants, this study revealed that pHLIP peptides with a lower threshold of pH-
insertion and increased resistance to aggregation could be engineered by tuning the location of particular
Asp residues [214]. Substitutions of specific aspartic acid residues Asp14 and Asp25 within the Wt-pHLIP
sequence yielded adjustments to the pH insertion window. Substitution of Asp25 for α-aminoadipic acid,
increased the threshold of pHLIP insertion to pH 6.74, and substitution of Asp14 for γ-carboxyglutamic acid
narrowed the insertion window to 0.5 pH units. These effects were also additive when both substitutions
were performed to the same sequence [215].
Peptide hydrophobicity has shown to have an effect on the number of transition states involved in pHLIP’s
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insertion [216]. Typically, if the peptide possesses a charge or a polar cargo attached at the C-terminal
end, a helical interfacial intermediate will form prior to peptide insertion. The authors also note that the
driving force for transmembrane insertion might be from lipid distortion by partial peptide insertion. This is
supported by an earlier report from Bohinc et al. [217] of how membrane tension and stability are disrupted
by the insertion of a helical polypeptide.
Process of pHLIP’s Exit from Phospholipid Bilayers
pHLIP’s exit from a phospholipid bilayer occurs orders of magnitude faster than insertion, completing ap-
proximately 100 ms after a sudden pH increase. This implies that the path of membrane exit differs from
the bath of membrane insertion, and likely involves partial unfolding within the plasma membrane, before
the peptide’s exit from the bilayer [133].
Non-Specific Uptake of pHLIPs
Andreev et al. and Musial et al. reported on nonspecific uptake of the pHLIP peptide [181, 182]. An analogue
of pHLIP (kpHLIP) was prepared, where the two aspartic acid residues within the peptide’s transduction
domain were substituted for lysine residues, and was shown not to exhibit tumour cell targeting. It was
also reported in this study that substitution of pH-switchable aspartic acid residues for lysine rendered the
peptide too polar to insert into the membrane at neutral or acidic pH.
Derivatives of Wt-pHLIP
Weerakkody et al. considerably expanded the reservoir of pHLIP variants in 2013 [176]. They modified the
original Wt-pHLIP sequence using various reforms, including residue addition, substitution, and truncation.
16 new variants were synthesised based on a multitude of modifications, and each was subjected to routine
circular dichroism and luminescence experiments to assess the new variants ability to interact with a phos-
pholipid bilayer in a pH dependent manner. All variants exhibited a pH-dependent affinity for the plasma
membrane, where the insertion threshold (peptide pKas) ranged from pH 4.5 - pH 6.5 for entry into POPC
vesicles, and insertion time ranged from tens of milliseconds to minutes. The variants also exhibited a range
of Gibbs Free Energy differences (∆∆G = ∆GpH4.0 − ∆GpH8.0) between insertion at pH 8.0 and pH 4.0,
indicating that the insertion of some variants was energetically more favourable, or more switchable than
others. For example, some variants exhibited very favourable energetics of membrane insertion at low pH,
but also exhibited similar affinities for insertion at high pH resulting in poor insertion switching.
Having previously known that the hydrophilic constituents of pHLIP (Asp or Glu) were responsible for
pH-switching, the effect of choosing one over the other was investigated. Variants equipped with Glu residues,
rather than Asp, exhibited higher affinities for the plasma membranes at due to the presence of an extra
methylene group in Glu that renders the peptide more hydrophobic.
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For the most part, the series of truncated variants offered lower insertion affinities at low pH due to
the reduction or absence of protonatable residues within the transduction domain. It was also apparent
that truncated variants, which had hydrophobic sections removed from the sequence, offered lower plasma
membrane affinities at neutral pH than non-truncated variants. However, truncated variants that still
possessed three hydrophilic residues within the transduction domain exhibited very favourable ∆∆G values.
Previous work by Karabadzhak et al. [216] demonstrated that the number of protonatable residues on
the C-terminal end of the peptide, along with the presence of polar cargo, offer an effect on the timescale of
peptide insertion. Indeed it was seen that variants with this truncation of the insertion end of the peptide,
such that fewer protonatable residues remained, resulted in faster membrane insertion. Interestingly, the
reverse sequence of Wt-pHLIP offered faster insertion kinetics than Wt-pHLIP itself.
Figure 3.4: pHLIP variants 3, 4, 5 & 7 sequences from the 2013 article by Weerakkody et al. [176]. Positively-
charged residues labelled in red; negatively-charged residues in blue, and neutral residues in black.
Of the 16 variants, several performed notably well in the study, and the following discussion focuses on
4 such variants, 3, 4, 5 & 7 ( Fig. 3.4). Variant 3 was designed for a faster insertion rate than Wt-pHLIP,
by removing a number of protonatable residues from the peptide’s C-terminus, while keeping Asp residues
within the transduction domain in position to handle the pH triggering. Variant 4 was identical to variant 3,
except the peptide employed Glu residues for pH triggering. Variant 5 was a truncated version of Wt-pHLIP
containing pH-triggered Asp residues, with variant 7 as it’s Glu-populated equivalent.
Variants 3, 5 & 7 exhibited favourable energetics of pH-triggered insertion. Variant 3 (Asp-populated)
exhibited a ∆∆G value of 2.23 kcal mol−1 whereas variant 4 (Glu-populated), resulted in a ∆∆G value of
1.79 kcal mol−1, reflecting a less efficient pH-switching mechanism for pHLIP variant 4. Variants 5 & 7
showed similar energetic favourability of pH-triggered insertion into plasma membranes with ∆∆G values
for pHLIPvar5 (Asp-populated), and variant 7 (Glu-populated) of 2.31 kcal mol−1 and 2.39 kcal mol−1,
respectively.
The pKas of each of these four variants: 3; 4; 5 & 7 were 5.06, 5.31, 4.88 and 5.50, respectively. In general,
the Glu-populated variants offered higher pKas than Asp-populated analogues. the pKas of variants 4 and 7
fall most appropriately into the acidotic window, with variant 3 only just scraping pH 5.0. In particular, the
pKa of variant 5 was undesirably low, and while pHLIP’s insertion is an equilibrium process, more extreme
proton concentrations will be required to drive the equilibrium towards peptide insertion, conditions that
are less likely to overlap with the proton concentrations of tumour cell microenvironments.
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pHLIP Variant ∆∆G/ kcal mol−1 pKa Insertion time/ ms
3 2.23 5.03 30 - 50
4 1.72 5.31 30 - 50
5 2.31 4.88 30 - 50
7 2.39 5.50 30 - 50
Table 3.1: pH resolved change in Gibbs Free Energy (∆∆G), Acid dissociation constants (pKa) and insertion
rates of the pH-dependent insertion process of pHLIP variants into POPC vesicles. Taken from Weerakkody
et al. [176]
.
Each of the four variants displayed similar kinetics of membrane insertion with insertion times of ap-
proximately 30 - 50 milliseconds, significantly faster than the Wt-pHLIP which has an insertion time of
approximately 40 seconds.
This paper illustrates well how the change in Gibbs free energy of insertion ∆∆G, insertion time and
peptide pKa all influence peptide insertion, and therefore the desirability of each variant. Variants 3 & 7
were put forward for further study due to highest tumour/kidney accumulation ratios, with significantly
less accumulation in the liver in the case of variant 3, and high tumour targeting efficiency along with
fastest measured blood clearance for variant 7. Additionally, pH-insensitive analogues of both peptides
were synthesised with key hydrophilic residues replaced with Lysine residues (pHLIPs k-var3 & k-var7), and
neither showed significant tumour targeting in vitro.
3.1.3 pH Low Insertion Peptides as Cargo Delivery Agents
pHLIP’s ability to translocate cargo into cells was first demonstrated by Reshetnyak et al. [204] who
conjugated pHLIP to a 20-base unit oligonucleotide with a FITC organic dye via a disulfide bridge to the
peptides c-terminal cysteine residue. HeLa cells were then treated at pH 7.4, 7.0, 6.5 and 5.5, and mean
% fluorescence was quantified at 18%, 48%, 78% and 100%, respectively. In the same publication, it was
also shown that pHLIP could mediate the translocation of a cell-impermeable toxin, phalloidin. Phalloidin
binds to filamentous actin, and was fluorescently labelled with a rhodamine dye enabling easy visualisation
by fluorescence microscopy.
Wijesinghe et al [218] demonstrated how the hydrophobic nature of pHLIP’s conjugated cargo affects
overall peptide stability, and translocation efficiency. The cargo molecule in this instance was a phallicidin
derivative, where the original phallidicin unit was conjugated to an alkyl chain via amide coupling to one
of phallicidin’s carboxylic acid terminals. The alkyl chains consisted of 4, 6 & 8 carbon atoms, and were
called phall-C4, phall-C6 and phall-C10, respectively. Phallicidin binds to filamentous actin, preventing
polymerisation/depolymerisation and thus preventing all future cell mobility, eventually leading to cell death
[219]. It was found in this study that overall peptide solubility was critical, and the most hydrophobic
variant pHLIP-phall-C10 aggregated when exposed to the low pH environment, which significantly hindered
the peptide’s translocation efficiency. For cell treatment with pHLIP-phall-C4 and pHLIP-phall-C6, an
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antiproliferative effect was observed in both cases, with a concentration-dependent manner. The observed
effect was strongest for pHLIP-phall-C6, being the most hydrophobic of the two variants, which emphasises
the importance in the trade-off between hydrophobicity and solubility in cargo design.
Daumar et al. [220] demonstrated 18F labelling of the Wt-pHLIP variant by conjugation to a 2- ethynyl-
6-[18F]fluoro-pyridine unit, and used the radiolabelled variant to monitor in vivo stability, of which only
mild defluorination was observed. Macholl et al. [135] later reported a robust and effective method of
labelling pHLIP with the Single Positron Emission Computed Tomography (SPECT) agent 99mTc, and
further optimised the agent to offer good clearance from the point of injection
Wijesinghe et al. [221] reported pHLIP-mediated delivery of conductive nano-pores, comprised of the lin-
ear hydrophobic peptide, gramicidin A into three carcinoma cell lines. pHLIP was demonstrated to promote
the uptake of the liposomes into the cell’s plasma membrane, resulting in liposomes-membrane fusion. The
pores within the gramacidin A liposomes have an affinity for sodium ion channelling, and incorporation of
these sodium ion channels into the membrane induced an increase in sodium ion internalization. This disrup-
tion of the cytoplasmic ion balance resulted in cytosolic acidification, subsequent mitochondrial polarisation,
and ultimately cell death.
Davies et al. [139] were the first to report pHLIP-mediated transduction of AuNPs. In this work,
human platelets were dosed with pHLIP-coated 13 nm AuNPs colabelled with a europium dye, and exclusive
uptake was observed after a short incubation demonstrating a method of cellular delivery where transfection
techniques are not possible. Yao et al [137] later took a very promising step in demonstrating pHLIPvar3-
mediated, pH-dependent uptake of 1.4 nm gold nanoparticles into human cervix carcinoma cells.
A fluorescence reporter system was based on pHLIP-mediated delivery was demonstrated by Karabadzhak
et al. [222] who conjugated the pHLIP peptide to a fluorophore reporter by a cleavable disulphide linker,
where luminescence imaging experiments confirming significant dequenching of the fluorophore by the cells
reducing environment when HeLa cells were treated at low pH.
pHLIP peptides have been shown to tether cargos to the plasma membrane, or transduct cargos into
the cytoplasm and release them via cleaving of a di-sulphide bond. Successful cellular injection has to date
been demonstrated for organic dyes, phalloidin-rhodamine, peptide nucleic acids,[204] gold nanoparticles
[221, 139, 136, 137], liposomes [221] Positron Emission Tomography (PET) radionucleotides [223] and Single
Photon Emission Computed Tomography (SPECT) contrast agents [135], both applied to in vivo tumour
imaging.
3.1.4 pH Low Insertion Peptides as Delivery Agents for Therapeutics
The uptake of pHLIP into mouse breast adenocarcinoma models was reported by Andreev et al. [170]
where the pHLIP peptide was conjugated to a near-infrared dye construct (pHLIP-NIR) and accumulation
of the construct within tumours and organs was probed by intravital microscopy. The pHLIP-NIR constructs
demonstrated high affinity for tumour accumulation within early and advanced stages of tumour development,
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offering luminescence signal stable for days, and signal from within tumours was approximately 5 times
more intense than signal from healthy tissue. Significant accumulation within mouse kidneys was also noted,
resulting from reported acidic regions of kidney cells, being a site of catabolism of low-molecular-weight
proteins. [224] Additionally, it was determined that kidney accumulation of the pHLIP-NIR was slower if
the mice were pre-fed with bicarbonate-containing drinking water (pH 8.2) prior to the injection of pHLIP-
NIR.
Moshnikova et al [225] developed a pHLIP-based drug delivery system by conjugation of the peptide to
α−amanitin, a toxin that induces cellular apoptosis within 48 hours. The toxin is too polar to traverse
plasma membranes by itself, with the exception of the membranes of liver cells which have a specialised
transport system [226]. The peptide was bound to the toxin by a −S − S− cleavable linker in order to
release the toxin into the cell. It was also interesting that amanitin bound to pHLIP via a non-cleavable
linker was not able to induce cell death, and translocation efficiency could be tuned by incorporation of more
or fewer hydrophobic moieties into the linker.
Zhao et al. [227] reported pHLIP-mediated transduction of large mesoporous silica nanoparticles (MSNs)
across the plasma membrane. In this work, the 140 nm MSNs were initially loaded with Doxorubicin, an
anti-cancer drug. The pHLIP peptide was then conjugated to MSNs via a disulfide bridge, in order to cap
the pores after drug loading, yet cleave after membrane translocation, triggering the release of the loaded
Doxorubicin into the cell.
pHLIP variant 7 was applied to detection of ischemic myocardium [136], where pHLIP-coated liposomes
were shown to have high affinity for binding to ischemic regions of myocardium, and low affinity for binding
to normal regions.
Antosh et al [228] recently demonstrated pHLIP’s potential application in binary radiation therapy, the
process of targeting cells at the biological level with a non-cytotoxic agent before activating the agent’s
cytotoxic action using low level radiation. In this work, pHLIP-conjugated gold nanoparticles offered an
enhancement of the X-ray radiation effect felt by human lung carcinoma cells via stimulation of heat release
from irradiated gold nanoparticles. pHLIP’s pH trigger enabled higher affinity for cell uptake at low pH, and
irradiation of treated cells resulted in a higher cell mortality over irradiation of untreated cells. This was
recently adapted by Yu et al. [229] who constructed a photothermal/photodynamic theraputic constructed
from hollow gold nanoparticles and the anticancer theraputic Chlorin e6 (Ce6) held in association by electro-
static interactions. The photothermal/photodynamic activity were both activated by ablation with a 670 nm
laser that served to release (Ce6) and supply the energy input for the photothermal effect. Upon ablation,
70% of the loaded Ce6 was released along with a sharp increase in temperature of over 45◦C reached within
a minute of constant ablation.
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3.1.5 Introduction Summary
Contemporary pHLIP research is currently expanding the library of cargos that pHLIP is able to deliver
across plasma membranes, along with lengthening the list of diseases and conditions that pHLIPs are able
to target. In addition, there has been a large swing towards theraputic delivery involving small molecule
inhibitors, or large nano structures where therapy is administered by photothermal ablation.
Contrasting with the Trans-activating Transcriptional Activator peptide (TAT), pHLIP offers a prefer-
ence for cancer cell uptake whereas the cell specific uptake of TAT is more difficult to manipulate. Novel
variants of pHLIP are demonstrating rapid phospholipid bilayer entry times. pHLIP variants have had
low reported toxicity, whereas certain TAT variants have been shown to have highly toxic effects on cells.
Additionally, both demonstrate an independence from active-uptake mechanisms, TAT’s entry is receptor
mediated whereas pHLIP’s transduction is reliant on hydrophobic interactions, however both have been
demonstrated to deliver gold nanoparticles into cells.
In this work, (Wt-)pHLIP and pHLIPvar3 were selected for the application of pH-triggered transporta-
tion of luminescent gold nanoparticles into cancer cells. (Wt-)pHLIP was used as the group has previous
experience with this variant, and has previously reported the pH dependent delivery of gold nanoparticles
into human platelets [139], and pHLIPvar3 was chosen as another option as it possibly represented a faster
more efficient alternative to pHLIP.
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3.2 Results and Discussion
This section is divided into four subsections, i) Preliminary Treatments of HeLa cells with labelled-AuNPs,
where samples of pHLIP-Au13-RubpySS and Zonyl-Au13-RubpySS were prepared and their internalization
into HeLa cervical adenocarcinoma cells was studied using confocal microscopy to identify appropriate con-
centrations and treatment times to ensure significant nanoparticle uptake, as well as study internalization
and localisation within the cells. ii) the pH-dependency of labelled nanoparticle internalization was then
investigated. The cell culture model used for all pH-dependency experiments was HeLa cervical adeno-
carcinoma cells incubated in a solution of Tyrode’s buffer at pH 6.5, and 7.4 representing cancerous and
non-cancerous cells, respectively. Relative uptake of labelled gold nanoparticles was assessed and quantified
using flow cytometry and luminescence & reflection microscopies, the latter also provided a spatial assessment
of nanoparicle uptake. Additionally, live cell and fixed cell microscopies were both employed to demonstrate
that particle uptake was not strongly influenced by formalin fixation. Absolute uptake was measured by
quantifying the gold concentration of treated cells using Inductively Coupled Plasma Mass Spectrometry
(ICP-MS), and Transmission Electron Microscopy (TEM) was used to study spatial distribution of inter-
nalized 13-nm labelled gold nanoparticles. iii), to assess the effect of any of the conditions used in these
experiments on cell viability, the 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
reduction assay was performed on treated HeLa cells, where all treatment parameters were individually as-
sessed to identify any treatment-induced cell viability compromise. And iv), the effect of pH on the colloidal
stability of the labelled gold nanoparticles used in this study was examined using a variety of spectroscopic
and spectrometric techniques.
3.2.1 Preliminary Cellular Uptake Experiments
To investigate whether pHLIP & RubpySS co-coated AuNPs were readily uptaken by cancer cells, the widely
studied HeLa cervical adenocarcinoma cell line were used as our cell model. Cells were grown in complete
media, routinely passaged using a trypsin-EDTA protocol, and plated for experiments in cell culture well
plates containing sterilised glass coverslips and grown to approximately 60% confluency before treatment
with AuNPs. After treatment, cells were fixed using 4% paraformaldehyde, stained with the Hoechst 33258
nucleic acid stain before imaging.
For each sample, internalized particles were visualised by two confocal microscopy modes i) luminescence
mode (λex = 488nm, λem = 561 − 750nm), and ii) reflection mode (λex/em = 633nm). The structure and
morphologies of treated and non-treated cells were also visualised by two microscopy modes, i) transmission
imaging (λex/em = 488nm) and ii) reflection imaging (λex/em = 488nm). Additionally, the DNA minor
groove-binding Hoechst 33258 nucleic acid stain was used to mark the locations of cell nuclei in order to
assess particle affinity for nuclear internalization (λex = 405nm and λem = 400− 500nm).
Fig. 3.5 shows confocal images of HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) in complete
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Figure 3.5: Confocal Microscopy images of Hela cells treated with pHLIP-Au13-RubpySS in complete media
for two hours at 37◦C. A) Hoechst 33258 nucleic acid stain, B) Ruthenium luminescence, C) Reflection
at 633 nm, D) Overlay of luminescence (red channel), and Hoechst (blue channel) images, E) Overlay of
Reflection (gray channel), luminescence (red channel), and Hoechst (blue channel) images, and F) Profile
plot of Reflection, Luminescence & Hoechst channels.
media for two hours at 37◦C. Strong ruthenium luminescence signal is observed after a two hour treat-
ment, indicating efficient uptake within the treatment time and suggesting minimal quenching of ruthenium
emission from the gold nanoparticles, despite previous reports of surface-bound lumophore luminescence
quenching mechanisms from gold surfaces [230, 74, 231]. Additionally, the internalized nanoparticle density
appears to be evenly distributed throughout the cells cytoplasmic regions. The nucleic acid stain Hoechst
33258, was used to mark cell nuclei in order to establish the affinity of pHLIP-labelled AuNPs to internalise
into cell nuclei. While there are examples of strong signal from perinuclear regions of some cells, the lumi-
nescence signal does not appear to colocalise significantly with signal from the Hoechst 33258 nucleic acid
stain, indicating little internalization into cell nuclei. This is reillustrated by analysis of the line profiles from
ruthenium and hoechst luminescence images. A line was drawn across a multi channel image of Hoechst and
ruthenium signals, in which the line intersected cell nuclei and areas of strong ruthenium luminescence, and
the luminescence intensities of the two channels across the line were plotted against distance coordinate (Fig.
3.5, F). The centre of the profile is strongest in Hoechst luminescence signal, and this region is mostly devoid
of any ruthenium luminescence. The image of reflected 633 nm light (Fig. 3.5, C) shows insignificant signal,
suggesting that no large nanoparticle agglomerates are formed within cell interiors, and the 488 reflection
image shows cell morphologies indicating cells were adopting a spread morphology on glass coverslips after
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treatment and at the time of fixation, suggesting good viability. Non-viable cells were identified by their
spherical shape and their thicker depth as a consequence of becoming partially detached from coverslips.
A time frame of 0 - 2 hours was chosen for future experiments as a significant concentration of pHLIP-
Au13-RubpySS appeared to have internalized after two hours, and HeLa cells are likely to lose viability
upon long durations without media or bovine serum. As nanoparticle diameter falls significantly short of
the diffraction limit in light microscopy, clarification that individual pHLIP-Au13-RubpySS particles had
internalized into HeLa cells was confirmed by transmission electron microscopy (see section: transmission
microscopy evaluation of pH-dependent cellular uptake).
Figure 3.6: Confocal Microscopy images of Hela cells treated with Zonyl-Au13-RubpySS (1 nM) in complete
media for four hours at 37◦C. A) Hoechst 33258 nucleic acid stain, B) Reflection at 633 nm, C) Luminescence
from 488 nm excitation, D) Transmission image, E) Overlay of Reflection (gray channel), luminescence (red
channel), and Hoechst (blue channel) images, and F) Profile plot of Reflection, Luminescence & Hoechst
channels.
The uptake of Zonyl-Au13-RubpySS into HeLa cells was also evaluated by confocal microscopy where
HeLa cells were treated with Zonyl-Au13-RubpySS (1 nM) in complete media for four hours at 37◦C, and
were subsequently prepared for fixed-cell confocal microscopy. Fig. 3.6 shows confocal microscopy images of
HeLa cells treated with Zonyl-Au13-RubpySS, and particles were again visualised by i) luminescence mode
(λex = 488nm, λem = 561− 750nm), ii) reflection mode (λex/em = 633nm).
The 633 nm reflection image (Fig. 3.6, B) shows intense signal that appears to colocalise with ruthenium
luminescence. This signal is believed to be resultant from gold nanoparticles that have flocculated into larger
particles which are now larger than the confocal system’s diffraction limit, and as a result the particles scatter
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incident light with sufficient efficiency for detection. A line was drawn on the image showing nanoparticle
luminescence & reflection overlaid with Hoechst luminescence (Fig. 3.6, F) intersecting regions of strong
nanoparticle signal and Hoechst signal, and the profile was plotted to analyse the colocalisation. Again, the
regions of strong Hoechst signal are devoid of any nanoparticle reflection or luminescence, and the ruthenium
luminescence profile overlays well with the nanoparticle reflection profile, indicating minimal quenching or
disintegration.
Additionally, cells were treated with unlabelled (citrate-stabilised) Au13NPs to determine whether unla-
belled AuNPs were uptaken. Citrate-Au13NPs aggregated upon addition to cell media, turning the solution
dark grey, with dark precipitates of aggregated gold. Subsequent confocal images of these treated cells did
not show significant signal within the nanoparticle emission channel (Fig. 8.26) indicating that unlabelled
(citrate-stabilised) AuNPs do not make suitably stable or sufficiently emissive imaging agents.
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3.2.2 pH-Resolved Uptake of Peptide-labelled, Luminescent Gold Nanoparti-
cles
In order to study the pH-dependency of labelled gold nanoparticle uptake into cancer cells, a model for
cancerous and non cancerous environments was constructed. This cell culture model consisted of HeLa
cervical adenocarcinoma cells incubated in a solution of Tyrode’s buffer. The buffer was adjusted to pH 6.5
or 7.4 using either HCl or NaOH, where HeLa cells incubated at pH 6.5 provided a model of cells with an
acidotic microenvironment and HeLa cells incubated at pH 7.4 was used as a model for non-cancerous cells.
The pH of Tyrode’s buffer is easily adjustable within the 6.5 - 7.4 window of interest, and the buffer has similar
isotonic properties to interstitial fluid, therefore has routine use within tissue culture. Cells were seeded into
a culture well plate, and left to adhere and proliferate for 24 hours before treatment. After treatment, cells
were washed to remove any non-internalized AuNPs before being processed for the appropriate technique
used to measure pH dependency of gold nanoparticle internalization. One of the big advantages of utilising
luminescently labelled gold nanoparticles as cellullar imaging probes is that their internalization into cells can
be measured by a plethora of techniques. In this section, flow cytometry and luminescence microscopies were
used to quantify ruthenium luminescence from treated cells and Transmission Electron Microscopy (TEM)
& Inductively Coupled Plasma Mass Spectrometry (ICP-MS) were used to directly measure the presence of
gold within treated cells.
Flow cytometry evaluation of pH-Dependent Cellular Uptake
Flow cytometry is a sensitive and high throughput technique often used for biomarker detection, or cell
counting and sorting. The technique is discussed more deeply in Chapter 1, and is herein applied to the study
the pH dependence of pHLIP, pHLIPvar3 and Zonyl-mediated uptake of luminescent gold nanoparticles.
Prior to treatment, cells were plated into a 12-well culture plate and allowed to grow to approximately
60% confluency. Cells were then washed with buffers before being treated with particles in a Tyrodes buffer
(0.08 mM, pH 6.5 or 7.4), for a series of incubation times upto three hours. After treatment, cells were
washed with phosphate buffered saline before being trypsinised to detach the cells from the bottom of the
well. Cells were isolated by centrifugation, the supernatant removed and cells were redispersed in PBS. Cells
were then transferred to a FACS tube for acquisition.
Flow Cytometry Analysis Procedure
For each sample, the flow cytometer was set up to record forward and side scatter, and to plot them
against each other as a scatter plot (Fig. 3.7). Mean values for side scatter were used as a measure of gold
nanoparticle internalization because of the ability of the electron-dense gold particles to scatter incident
light. Mean values calculated from scatter plots were normalised to mean values of untreated control cells,
which were set to 100%, and are herein presented as charts. The cytometer was also set to record in
photoluminescence mode via excitation and detection of light emitted by the nanoparticle-bound ruthenium
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Figure 3.7: Example of the analysis procedure of flow cytometry data. Scatter plot (left) and luminescence
histogram (right) of HeLa cells treated with pHLIPvar3-Au100-RubpySS (8 pM) for two hours at 37◦C.
complex, RubpySS. The 488 nm laser was selected and a dichroic mirror at 620 nm was used to block scattered
light from detection. Again, mean values from the recorded luminescence histograms were normalised to the
mean luminescence of untreated cells, which were set to 100%.
pH-resolved Treatment of HeLa Cells with pHLIP-Au13-RubpySS
Fig. 3.8 shows flow cytometry of HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) in Tyrode’s buffer
(0.08 mM, pH 6.5 or 7.4) for up to two hours at 37◦C, where luminescence at > 620 nm was recorded and
expressed as a percentage of untreated cells. Time resolved uptake shows an increase in luminescence signal
over time, where % luminescence reaches between 150 - 200% of the untreated controls within 30 minutes
and between approximately 300 - 400% after a two hour treatment. This increase in % luminescence is
attributed to ruthenium emission as delivered into the cells on a AuNP scaffold. It is not clear yet whether
the complex remains anchored to the particle after cell entry or possibly cleaved once inside the cell. The
latter is however unlikely, as luminescence-in-flow measurements of free complexes have previously shown
that ruthenium luminescence is severely prone to collisional quenching from 3O2 [50]. pH resolved uptake
indicates a general higher affinity for uptake at pH 7.4 than 6.5, which is represented across all treatment
times. After a 30 minute treatment, cells treated at pH 6.5 exhibited a luminescence intensity of ≈ 150%,
whereas cells treated at pH 7.4 exhibited a luminescence of 220%. This trend continued up to the final
time point of two hours, where the final luminescence from cells at pH 6.5 and pH 7.4 were 290% and
390%, respectively. Side scatter measurements did not indicate a change in cell granularity as a function of
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Figure 3.8: Mean Luminescence from HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) in Tyrodes
buffers (0.08 mM, pH 6.5 or 7.4) at 37◦C measured by flow cytometry. Single data set shown, however three
replicates were performed.
treatment time, and based on previous microscopy experiments where pHLIP-Au13-RubpySS was uptaken
very readily by HeLa cells, this suggests that scattered signal from 13 nm particles is not intense enough for
detection. Additionally, it is noteworthy that this experiment was performed multiple times, and the results
of one representative dataset are shown.
Yao et al. [137] previously reported pHLIP-mediated delivery of 1.4 nm AuNPs using the variant 3
modified version of pHLIP. The volume of 1.4 nm AuNPs = 11.5 nm2 and the volume of 13 nm AuNPs =
9202 nm2, an 800-fold increase in volume. Based on this size increase, we theorised that pHLIP-mediated
translocation of 13 nm gold nanoparticles could proceed at a much slower rate, and endocytotic processes
could be competing far more strongly for overall AuNP uptake. It is also noteworthy, that as pHLIP is quite a
hydrophobic peptide, it has a high affinity for binding to the surface of a phospholipid bilayer even at neutral
pH, and this proximal contribution to endocytosis could result in faster endocytotic uptake. Temperature
has shown to be a strong factor on the rate of endocytosis in a variety of cell lines, and culturing cells at
4◦C is a widely employed method of shutting down endocytotic processes [232, 233, 234].
In order to assess pHLIP’s ability to mediate gold nanoparticle uptake in the absence of endocytotic
processes, the uptake experiment was performed at 4◦C in order to inhibit endocytotic processes such that
pHLIP-mediated translocation affords a larger contribution to net AuNP uptake.
Fig. 3.9 shows mean luminescence from cells treated with pHLIP-Au13-RubpySS at 4◦C for treatment
times up to three hours measured by flow cytometry. Again, mean luminescence were normalised to that
of untreated control cells, where mean side scatter & mean luminescence of control cells equated to 100%
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Figure 3.9: Mean Luminescence & Scatter from HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) in
Tyrodes buffers (0.08 mM, pH 6.5 & 7.4) at 4◦C measured by flow cytometry.
signal. Treatment at 4◦C with pHLIP-Au13-RubpySS at pH 6.5 and 7.4 revealed a minimal increase in
cell side scatter of 106 ± 1%, and 102 ± 3%, respectively. However luminescence measurements of the
same experiment revealed a significantly greater sensitivity with pH 6.5 and 7.4 samples displaying mean
luminescence intensities of 210% and 165%, respectively.
Treatment at 4◦C provides evidence that endocytotic uptake of labelled-AuNPs is occurring on a similar
timescale to pHLIP-mediated transduction, and selective shutdown of endocytotic processes reveal a more
efficient uptake of pHLIP-Au13-RubpySS at pH 6.5. This is further investigated by ICP-Mass Spectrometry
and Luminescence Microscopy in future sections of this thesis (see sections: Inductively-Coupled Plasma
Mass Spectrometry (ICP-MS) evaluation of pH-Dependent Cellular Uptake, and Confocal Microscopy eval-
uation of pH-Dependent Cellular Uptake).
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pH-resolved Treatment of HeLa Cells with pHLIPvar3-Au13-RubpySS
Figure 3.10: Mean Luminescence from HeLa cells treated with pHLIPvar3-Au13-RubpySS (1 nM) in Tyrodes
buffers (0.08 mM, pH 6.5 or 7.4) for 2 hours at 37◦C measured by flow cytometry. Data composed of three
biological repeats, presented with ± one standard deviation unit, and Tukey HSD test data was also included,
where statistically significant p-values of <0.05, <0.01, <0.001 are indicated by *, **, and ***, respectively.
Fig. 3.10 shows the mean % luminescence from HeLa cells treated with pHLIPvar3-Au13-RubpySS for
two hours at 37◦C as a function of buffer pH. Four Tyrode’s buffers of ≈ pH 5.0 - 8.0 were prepared, and
sterilised by filtering through 0.22 µm syringe filters. Three biological repeats were performed, and ANOVA
and T-tests were performed on the raw data. Cells treated in the low pH buffers yielded the largest increase in
% luminescence, with pH 5.0 and pH 6.0 at ≈ 1500% and ≈ 2000%, respectively. % luminescence of the cells
treated in the high pH buffers of pH 7.0 and pH 8.0 were 1300% and 1400%, respectively. T-tests on the raw
data revealed a strong statistically significant difference (p < 0.01 in all cases) between the % luminescence
of cells treated at pH 6.0, and cells treated in all other buffers (pH 5.0, pH 7.0 & pH 8.0). Additionally,
a one-way analysis of variance (ANOVA) of control and treated cells indicated that the treatments were
significantly different (p = 1.5x10−5).
Cells treated at pH 5.0 showed a lower % luminescence, believed to be resultant from cytotoxicity of HeLa
cells exposed to the relatively acidic environment, which is corroborated by cell viability measurements later
in this thesis (see section: Assessing the Effect of labelled-AuNP Treatments on Cell Viability using the
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3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) Reduction Assay), along with a
flow cytometry time course experiment of cells treated with at pH 5.0 and 7.4 (Fig. 8.27) that showed a
initial increase in luminescence at pH 5.0 that was greater than analogous cells treated at pH 7.4, however
this was followed by a luminescence depletion after 90 minutes whereas cells treated at pH 7.4 exhibited a
consistent increase in luminescence across the time course. Cells treated at pH 7.0 & 8.0 show significantly
less luminescence than cells treated at pH 6.0, characteristic of pHLIP’s general pH-dependent cell uptake
mechanism. It is interesting that in the case of pHLIPvar3, the treatment pH imposed such a marked
difference in nanoparticle internalization at 37◦C. pHLIPvar3 has been reported to internalise on the order
of 30 - 50 ms, much faster than pHLIP which internalises in approximately 40 seconds [176]. However, as
luminescence is an indirect measurement of nanoparticle internalization, future sections of this thesis focus on
detecting the presence of gold nanoparticles directly was well as quantifying internalized gold concentration.
pH-resolved Treatment of HeLa Cells with Zonyl-Au13-RubpySS
Zonyl-Au13-RubpySS and Zonyl-Au100-RubpySS particles were used as a non-pH-dependent uptake con-
trol in place of the kpHLIP peptide, which as shown in earlier sections, aggregated in aqueous solution. The
internalization of these particles should provide an indication of whether the efficacy of gold nanoparticle
internalization via non-specific/endocytotic processes possesses a pH dependency.
HeLa cells were treated with Zonyl-Au13-RubpySS particles (1 nM) in Tyrode’s buffer (0.08 mM, pH 6.5
or pH 7.4) for a series of incubation times up to 180 minutes at 37◦C. Forward scatter, side scatter, and far
red fluorescence intensities were then recorded by flow cytometry, with mean values expressed as percentages
of untreated cells. The first apparent observation was that intensity of side scattered light from HeLa cells
treated with Zonyl-Au13-RubpySS did show a correlation with incubation time, an example is shown in Fig.
3.11. This differs from cells treated with pHLIP-Au13-RubpySS or pHLIPvar3-Au13-RubpySS where the
intensity of side scatter as a function of treatment time offered negligible correlation. This strong increase in
granularity from cells treated with Zonyl-Au13-RubpySS is investigated in future sections using microscopy
techniques (see section: Confocal Microscopy evaluation of pH-Dependent Cellular Uptake).
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Figure 3.11: Scatter Plot and Luminescence Histograms (inset) of HeLa cells treated with Zonyl-Au13-
RubpySS (1 nM) for five hours in Tyrodes buffer (0.08 mM, pH 7.4) versus untreated cells at 37◦C measured
by flow cytometry.
Figure 3.12: Mean Luminescence from HeLa cells treated with Zonyl-Au13-RubpySS ( 1 nM) in Tyrodes
buffers (0.08 mM, pH 6.5 or 7.4) at 37◦C measured by flow cytometry.
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Fig. 3.12 shows % mean luminescence from HeLa cells treated with Zonyl-Au13-RubpySS by flow cy-
tometry showed a near parallel increase in mean luminescence intensity with mean luminescence reaching
almost 350% of untreated cells after 180 minutes (344% and 348% for samples treated at pH 6.5 and 7.4,
respectively). Side scatter measurements indicate a significant increase in cell granularity upon treatment of
cells with Zonyl-Au13-RubpySS, suggesting that particles may be agglomerating after internalization, result-
ing in a significant increase in scattered light due to the I ∝ r6 relationship between intensity of scattered
light and particle radii. pH appeared to have minimal effect on the luminescence intensity of cells treated
with Zonyl-Au13-RubpySS, where the luminescence intensity of cells treated at pH 6.5 & 7.4 were almost at
equal magnitudes for each treatment time. This parallel trend indicates no pH-dependency in the uptake of
Zonyl-Au13-RubpySS, suggesting that non-specific internalization of gold nanoparticles through endocytotic
mechanisms is proceeding at a rate independent of pH.
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pH-resolved Treatment of HeLa Cells with pHLIP-Au100-RubpySS
Figure 3.13: Time dependent Mean Luminescence & Scatter from HeLa cells treated with pHLIP-Au100-
RubpySS Tyrodes buffers (0.08 mM, pH 6.5 or 7.4) for up to three hours at 4◦C measured by flow cytometry.
The uptake of pHLIP-Au100-RubpySS was analysed by flow cytometry using luminescence and side scat-
ter measurements, as one of the main benefits of 100 nm diameter particles is that they offer good light
scattering within cytometry measurements, and previous work in the group has demonstrated imaging of
individual 100 nm AuNPs using optical reflection microscopies [96]. A time resolved, pH treatment of HeLa
cells with pHLIP-Au100-RubpySS (8 pM) in Tyrodes buffer (0.08 mM, pH 6.5 or pH 7.4) at 4◦C produced an
increase in mean side scatter due to increased granularity of the cells, and mean luminescence due to higher
concentration of internalized ruthenium lumophore, for all samples indicating that nanoparticles are inter-
nalized at pH 6.5 and at pH 7.4. This increase of mean scatter and luminescence increased with treatment
length, and both indicated that particles internalized more quickly into cells treated in solution at pH 6.5
than at pH 7.4. After a three hour incubation the mean luminescence of cells treated at pH 6.5 and 7.4 was
230% and 150%, respectively. For the same experiment the mean side scatter of cells treated at pH 6.5 and
7.4 was 160% and 120%, respectively. Although only one biological repeat was performed of this experiment,
this result is corroborated by luminescence microscopy and ICP-MS data (sections: confocal microscopy &
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ICP-MS evaluation of pH-dependent cellular delivery, respectively). Analogous experiments performed at
37◦C did not produce a statistically significant difference between cells treated at pH 6.5 and 7.4, indicating
an inefficiency of pHLIP-mediated delivery of Au100NPs under physiological conditions within a three hour
treatment.
pH-resolved Treatment of HeLa Cells with pHLIPvar3-Au100-RubpySS
Figure 3.14: Mean Luminescence & Scatter from HeLa cells treated with pHLIPvar3-Au100-RubpySS (8
pM) for 2 hours in Tyrodes buffers (0.08 mM, pH 6.5 or 7.4) at 37◦C measured by flow cytometry. Data
composed of three biological repeats, presented with ± one standard deviation unit, and Tukey HSD test
data was also included, where statistically significant p-values of <0.05, <0.01, <0.001 are indicated by *,
**, and ***, respectively.
The pH dependency of pHLIPvar3-Au100-RubpySS internalization into HeLa cells was also studied by flow
cytometry. Again, side scatter and luminescence of treated cells contrasted with analogous measurements of
untreated cells were used as measures of nanoparticle internalization. Fig. 3.14 shows the mean luminescence
and side scatter intensities of HeLa cells. The mean luminescence intensity of cells treated with pHLIPvar3-
Au100-RubpySS was 370 ± 54% and 328 ± 30% for cells treated at pH 6.5 & 7.4, respectively. While the
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luminescence measured is greater for cells treated at pH 6.5 than at cells treated at pH 7.4, the difference is
not statistically significant. However, side scatter measurements did reveal a statistically significant differ-
ence with percentage side scatter values of 213 ± 13% and 178 ± 5.5% (p < 0.05) for cells treated at pH 6.5 &
7.4, respectively. While luminescence measurements have been shown to be more sensitive than side scatter
measurements for nanoparticles of all sizes studied in this work, side scatter measurements display smaller
standard deviation values, likely due to side scatter being a more direct measurement of nanoparticle uptake.
pH-resolved Treatment of HeLa Cells with Zonyl-Au100-RubpySS
Fig. 3.15 shows the mean luminescence and side scatter intensities of HeLa cells treated with Zonyl-
Au100-RubpySS (8 pM) for two hours at 37◦C. The mean side scatter intensities for treated cells for pH
6.5 and pH 7.4 were 234 ± 5% and 234 ± 8%, respectively. Mean luminescence intensities for cells treated
at pH 6.5 and 7.4 were 492 ± 33% and 565 ± 12%, respectively (p < 0.05, Tukey HSD). This statistically
significantly less intense ruthenium luminescence at pH 6.5 is possibly indicative of significant cleavage of
the ruthenium complex from the gold nanoparticle. As studied in Chapter 2, and published in [166] the
luminescence lifetime of the ruthenium complex increases when mixed with the Zonyl surfactant, and when
both substrates are bound to a gold nanoparticle. It is expected that cleaving the bonds holding together
the nanostructure would result in a return to the shorter lifetime of the free complex but this has not been
further investigated.
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Figure 3.15: Mean Luminescence & Scatter from HeLa cells treated with Zonyl-Au100-RubpySS in Tyrodes
buffers for two hours at 37◦C as measured by flow cytometry. Data presented with ± one standard deviation
unit, and Tukey HSD test data was also included, where statistically significant p-values of <0.05, <0.01,
<0.001 are indicated by *, **, and ***, respectively.
Confocal Microscopy evaluation of pH-Dependent Cellular Uptake
Relative uptake along with spatial analysis of the pH-dependent uptake of pHLIP, pHLIPvar3 and Zonyl-
labelled luminescent gold nanoparticles into HeLa cells was studied using confocal microscopy. In addition to
providing corroborative data to support the flow cytometry data, this technique was important for confirming
the internalization of labelled-AuNPs because of the technique’s ability to optically section biological samples,
permitting the imaging of specific sample depths. The fundamental principles of the technique are outlined in
Chapter 1, and outlined in this section, prior to the results, are the fundamentals of the acquisition procedure
along with the processing methods used to calculate mean luminescence intensity values normalised to cell
area.
For each sample, internalized particles were visualised by two confocal microscopy modes i) luminescence
mode (λex = 488nm, λem = 561 − 750nm), ii) reflection mode (λex/em = 637nm). The structure and
morphologies of treated and non-treated cells were visualised by two microscopy modes, i) transmission
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Figure 3.16: Analysis method applied to microscopy images of HeLa cells treated with labelled Au13NPs.
Foreground shows the image histograms of segmented confocal microscopy images, with inset raw images.
Data consists of confocal image slices of Non-treated HeLa cells, and HeLa cells treated with pHLIP-Au13-
RubpySS (1 nM) for two hours in pH 7.4 Tyrodes buffer (0.08 mM) at 37◦C. Binary masks are generated
from luminescence images using the Otsu method [235]. Background is then excluded by segmenting cell
regions. Mean intensity values were then calculated from cell regions and normalised to total cell area.
imaging (λex/em = 488nm) and ii) reflection imaging (λex/em637nm). Images of reflection at 637 nm
provided cellular distribution of individual 100 nm nanoparticles, and 13 nm nanoparticles were also visible
if particles agglomerated within cellular compartments. Luminescence imaging upon excitation at 488 nm
provides a distribution of ruthenium signal within cells, permitting visualisation of the 13 nm AuNPs which
are not visible in reflection imaging.
Herein is an example of the entire imaging & analysis procedure for cells treated with labelled-Au13NPs.
Fig. 3.16 shows an example of confocal image slices of i) untreated HeLa cells, and ii) HeLa cells treated
with pHLIP-Au13-RubpySS (1 nM) for two hours in pH 7.4 Tyrodes buffer (0.08 mM) at 37◦C. Images
were acquired using 488 nm laser excitation, with the emission collected from 561 − 741 nm o n a spectral
detector generating luminescence λ−stacks (18−image stack, 10 nm per image). Average intensities of each
pixel were Z−projected into a 2-dimensional image, and average intensities of each slice were plotted as
emission spectra to contrast against the steady−state emission of RubpySS.
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Image processing was performed in MatLab, and consisted of an Otsu-based thresholding function per-
mitting the segmentation of cell regions, followed by calculation of mean intensities of those cell regions. For
each image, a binary image mask was generated by applying an intensity threshold to each image using the
Otsu method [235] to remove as much of the image background as possible, and effectively discarding parts of
the field of view that did not belong to cell regions. Mean values for each thresholded image were calculated,
and then normalised to the area of the image mask (expressed as mean intensity pixel−1), and expressed as
a % of the control cells where the normalised mean value was set to 100%. The image histograms of the
segmented images of treated and untreated cells are shown in the figure, showing the treated cells occupying
a higher intensity range and a percentage mean of 142% of untreated cells.
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pH-resolved Treatment of HeLa Cells with pHLIP-Au13-RubpySS
Figure 3.17: Confocal microscopy images of HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) in Tyrodes
buffers (0.08 mM, pH 6.5 or 7.4) for two hours at 37◦C. For each row, from left to right i) luminescence
from 488 nm excitation, ii) luminescence from 488 nm excitation overlaid with transmission at 488 nm, and
iii) reflection at 637 nm. Images are accompanied by luminescence spectra of treated and untreated cells,
acquired on a multispectral detector. Scale bars set to 20 µm.
HeLa cells were treated with pHLIP-Au13-RubpySS (1 nM) particles in sterilised Tyrode’s buffers (0.08
mM, pH 6.5 or 7.4) and were stored in a cell culture incubator (37◦C, 4% CO2) for two hours, before
being washed with PBS, and subsequently fixed and mounted for confocal imaging (imaged on a Nikon
A1R confocal system). Fig. 3.17 shows i) luminescence, ii) luminescence & transmission and iii) reflection
confocal images of HeLa cells treated at pH 6.5, HeLa cells treated at pH 7.4 and HeLa cells that were
left untreated. The luminescence signal from cell interiors of treated samples is significantly greater than
signal emanating from untreated samples, indicating an increase in luminescent substrate within treated
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samples, where the luminescence signal increased as a function of treatment time (Fig. 8.28, appendix).
The intracellular luminescent signal from treated samples indicates nanoparticles appear to be gathering
into large clusters, possibly resultant from confinement of large groups of particles within endosomes. It has
been known for some time that nanoparticles often become trapped in endosomal compartments after being
uptaken by cells, and a significant amount of work has been applied into promoting their endosomal escape
[236, 237]. There is significant autofluorescence within the luminescence images along with ruthenium signal
resultant from the use of higher laser power in order to image significant signal from the low quantum yield
RubpySS complex. The transmission images indicated the cells were still attached to glass coverslips at the
time of fixation, and only few examples of non-viable cells visible, indicating that the cell population was
overall viable. The transmission images did not show evidence of nanoparticle scattering, indicating minimal
agglomeration of nanoparticles within cell compartments. This is corroborated by the 637 nm reflection
image which also does not show scattered signal from nanoparticle agglomerates. This information indicates
that internalized nanoparticles are internalized into cell compartments, but are remaining monodisperse and
not flocculating into larger particles.
In order to confirm that treated-cell luminescence was resultant from ruthenium emission, the steady
state emission of treated and non-treated cells were measured and contrasted. Fig. 3.18 shows an overlay
of i) steady state emission spectra of HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) for two hours
in Tyrodes buffer (pH 6.5, 0.08 mM), ii) the steady state emission spectra of untreated HeLa cells, iii) the
emission spectrum of ii) subtracted from i), and iv) the steady state emission of free pHLIP-Au13-RubpySS.
The strong overlay between the background-subtracted emission spectrum of cells treated with pHLIP-Au13-
RubpySS and the emission spectrum of free pHLIP-Au13-RubpySS acts as strong supporting evidence that
ruthenium emission is cause of greater luminescence intensity of treated cells.
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Figure 3.18: Steady state luminescence spectra from treated cells, non treated cells and particles prior to
treatment. In situ spectra acquired on a Nikon A1R spectral detector, λex = 488 nm, λem = 561 - 721
nm. perticle emission spectra acquired on an Edinburgh Instruments FLS920 time resolved luminescence
spectrometer, λex = 488 nm, λem = 561 - 721 nm.
Luminescence intensity analysis was performed for images of HeLa cells treated with pHLIP-Au13-
RubpySS. Fig. 3.19 shows a bar graph of the area weighted mean values across the treatment times.
Analysis of the area-weighted mean values showed an increase up to 224% and 179% mean luminescence
intensity for pH 6.5 and 7.4, respectively after a 90-minute treatment. This increasing trend of luminescence
signal from treated HeLa cells as a function of treatment time corroborates with previously measured flow
cytometry data, and the pH-independency of pHLIP-Au13-RubpySS internalization into HeLa cells at 37◦C
is also consistent with flow cytometry data.
109
Figure 3.19: Area-weighted mean values calculated from confocal microscopy images of HeLa cells treated
with pHLIP-Au13-RubpySS (1 nM) in Tyrodes buffers (0.08 mM) pH 6.5 and pH 7.4 at 37◦C. Included on
right hand y-axis is the number of cells within the images used in the quantification for each sample at pH
6.5 (orange circles) and pH 7.4 (green circles.
As indicated in the flow cytometry section of this thesis, it is expected that in addition to pHLIP-
mediated uptake, non-specific endocytotic uptake is also responsible for a significant amount of nanoparticle
internalization and the measures of how strongly each contribute to overall uptake is unclear. To determine
if low pH-triggered uptake process is present, a cold treatment at 4◦C was performed in order to inhibit
endocytotic processes and only observe pHLIP-Au13-RubpySS signal from particles internalized by pHLIP
and study their spatial distribution. Fig. 3.20 shows confocal microscopy images of HeLa cells treated with
pHLIP-Au13-RubpySS for two hours in Tyrodes buffer (0.08 mM, pH 6.5 or 7.4) at 4◦C. For cells treated
at each pH, images of the ruthenium luminescence channel, transmitted light, and reflection at 637 nm are
presented. Red luminescence signal from each sample is markedly stronger from cells treated at pH 6.5, with
apparent clusters of signal present from almost all cells within the field of view, contrasted with cells treated
at pH 7.4 where there is little evidence of stronger luminescence. Transmission images of cells treated at pH
6.5 and 7.4 do not show unusual cell morphologies, indicative that cell viability is not compromised by particle
treatment. Additionally, the reflection images of treated cells do not show evidence of agglomerates within
the cells, indicating that although there are clusters of particles that appear to be spatially near to each other
from the luminescence images, particles are not agglomerating due to the absence of cohesive reflection signal.
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Figure 3.20: Confocal microscopy images of HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) in Tyrodes
buffers (0.08 mM, pH 6.5 or 7.4) at 4◦C. For each row, from left to right i) luminescence from 488 nm
excitation, and detection from 560 − 740 nm ii) transmission at 488 nm, and iii) reflection at 637 nm
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pH-resolved Treatment of HeLa Cells with pHLIPvar3-Au13-RubpySS
HeLa cells were treated with pHLIPvar3-Au13-RubpySS (1 nM) In Tyrode’s buffer (0.08 mM, pH 6.5 &
pH 7.4) for two hours at 37◦C, (maintaining consistency with cytometry experiments) before being anal-
ysed by confocal microscopy. Images were acquired on a Zeiss LSM confocal microscope, and images of i)
transmitted light, ii) 637 nm reflectance, iii) luminescence from 488 nm excitation and iv) lambda stacks
from 488 nm excitation (stacks recorded from 490 − 730 nm, in 15 nm steps). Fig. 3.21 shows confocal
microscopy images of i) luminescence from 488 nm excitation, ii) transmitted light, iii) 488 nm reflection and
iv) overlay of 488 nm reflection & luminescence. Luminescence images of treated cells exhibit significantly
greater intensity over images of untreated cells, and subtraction of the steady state emission of untreated
cells from the spectrum of treated cells indicates the presence of a broad emission band with a λmax of ≈ 620
nm, overlaying well with the steady state emission of pHLIP-Au13-RubpySS. For the luminescence images,
area-weighted mean values were calculated for three sets of images of cells treated at pH 6.5 and 7.4 and
were expressed as a % of untreated cells. Mean luminescence intensity increased to 397 ± 75 % and 357 ± 59
% for pH 6.5 and 7.4, respectively. This represents a more marginal difference in uptake between treatments
at pH 6.5 and 7.4 than indicated by flow cytometry, but it is important to highlight that cytometry offers
significantly greater sensitivity than light microscopy.
112
Figure 3.21: Confocal Microscopy images of HeLa cells treated with pHLIPvar3-Au13-RubpySS (1 nM)
in Tyrodes buffers (0.08 mM, pH 6.5 or 7.4) for two hours at 37◦C, scale bars set to 25 µm. Images of
untreated cells also shown, with accompanying luminescence spectra of treated and untreated cells, acquired
by acquiring λ-stacks (λex = 488nm, λem = 550− 725nm).
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Additionally the 488 nm reflectance and transmission images show a relatively homogenous monolayer of
HeLa cells adhered to the glass coverslips with little evidence of non-viable (cells exhibiting spherical shape)
amongst the population.
pH-resolved Treatment of HeLa Cells with Zonyl-Au13-RubpySS
Confocal microscopy was also used to provide an indication of the extent of endocytotic gold nanoparticle
uptake into HeLa cells. For this experiment, HeLa cells were treated with Zonyl-Au13-RubpySS in Tyrode’s
buffer (0.08 mM, pH 6.5 or 7.4) for two hours at 37◦C (imaged on a Nikon A1R confocal system). Fig. 3.22
shows confocal luminescence microscopy images resultant from the treatment, where there luminescence
appears to originate from intense spots, likely indicating a large density of clustered nanoparticles within
cells. Inset to each image is the steady-state emission spectra from each sample (Fig. 3.22, inset) which
bears the characteristic broad emission band of RubpySS at ≈ 620 nm.
Figure 3.22: Confocal microscopy images of HeLa cells treated with Zonyl-Au13-RubpySS (1 nM) in Tyrodes
buffers (0.08 mM) pH 6.5 (left) and pH 7.4 (right) at 37◦C. Inset, steady state emission scans taken of treated
HeLa cells (λex = 488nm) with arrows indicating positions of cell nuclei.
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Figure 3.23: Confocal reflection microscopy images of HeLa cells treated with Zonyl-Au13-RubpySS (1 nM)
in Tyrodes buffers (0.08 mM pH 6.5 (left column) and pH 7.4 (right column)) at 37◦C. Images acquired using
illumination and detection at 637 nm. ROI indicated for each image, and 1D profiles drawn that intersect
internalized gold clusters.
Fig. 3.23 shows reflection-mode confocal microscopy images of HeLa cells treated with Zonyl-Au13-
RubpySS (1 nM) in Tyrodes solutions (0.08 mM) buffered to pH 6.5 and 7.4. The strong signal from
light-reflecting gold clusters is evident in both samples corroborating with the increase in side scatter as
a function of treatment time previously measured by flow cytometry. The clusters have a FWHM of ap-
proximately 1 µm in diameter, indicating clusters are several orders of magnitude bigger than individual
particles and likely representative of aggregating gold nanoparticles, which has been reported for some gold
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nanoparticles internalized into endosomal or lysosomal compartments [238]. This presents a useful analysis
of the stability of labelled-AuNPs post-internalization, as it appears that particles which maintain hold of
their stabilising labels more efficiently do not appear to aggregate.
pH-resolved Treatment, and Confocal Image analysis of HeLa Cells with Labelled-Au100NPs
Figure 3.24: Stages of image analysis leading to nanoparticle quantification. From left to right, columnn 1
shows reflectance images obtained using 488 nm excitation; middle column shows thresholded image showing
nanoparticle signal; and right column shows outlined particles with their assigned count number. Blue and
purple-tinted images represent sample treatments at pH 6.5 and 7.4, respectively.
In addition to studying labelled 13 nm gold nanoparticles, the pH-dependent uptake of analogous 100
nm labelled-nanoparticles was also studied. A useful benefit of using 100 nm AuNPs is that the particles are
more easily quantifiable because individual 100 nm gold nanoparticles can be identified [96], permitting more
meaningful uptake quantification. Fig. 3.24 shows the stages of the quantification method. Reflection images
were taken of treated cells using 488 nm excitation, containing elements of nanoparticles and cellular features.
Images were thresholded into binary images to remove unwanted cell features, leaving behind nanoparticle
reflection signal. The particles were then highlighted using the ImageJ outline tool, and subjected to the
’Analyse Particles’ function which counts the number of outlined features. Corresponding transmission
images of treated cells were then segmented for cell boundaries (Fig. 3.25) and cell area was calculated
in square microns. In this segmentation, transmission images were thresholded using the Otsu method to
produce a binary image, and the sobel edge operator was used to find edge features. The image was then
dilated using linear structuring elements, and interior holes were filled. The image was then smoothened
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Figure 3.25: Segmented transmission images of HeLa cells treated with pHLIPvar3-Au100-RubpySS (8 pM)
in Tyrodes buffer (0.08 mM, pH 6.5) for two hours at 37◦C. Segmented outline shown in red, and inset are
two expanded regions (blue & green) showing segmented cell boundaries.
by eroding the image twice with a diamond structuring element, and the outline of this mask was used
to segment cell regions. The full segmentation process is documented in Fig. 8.29 within the chapter’s
appendix. The resulting nanoparticle quantification was then expressed as the cell area a single nanoparticle
occupies, e.g. 1 nanoparticle per x µm2 of cell space.
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Figure 3.26: Live cell confocal microscopy images of HeLa cells treated with pHLIP-Au100-RubpySS (8
pM) in Tyrodes buffers (0.08 mM, pH 6.5 & 7.4) for three hours at 4◦C. Arrows indicate nuclear regions.
Images show transmitted light at 488 nm, luminescence from 488 nm excitation (detection from 550–725
nm), reflectance at 633 nm, and an overlay of transmission and luminescence images. Scale bars set to 20
µm.
pH-resolved Treatment of HeLa Cells with pHLIP-Au100-RubpySS
HeLa cells were grown to confluency in 35 mm MatTek glass bottom dishes before being treated with
pHLIP-Au100-RubpySS (8 pM) in Tyrodes buffers (0.08 mM, pH 6.5 & 7.4) for three hours at 4◦C before
being imaged live in phosphate buffered saline (Fig. 3.26). Transmission images indicate spread, viable
morphologies, although cell viability is properly examined later in this thesis. Luminescence imaging shows
that individual particles are luminescent when excited at 488 nm (detection from 561-720 nm), owing to
the ruthenium dye, and the particles show strong reflectance when irradiated with 637 nm light. Particles
appear to localise within cytosolic regions of the cells, and nuclear regions appear to be devoid of particles,
as determined by identifying nuclei from 488 nm reflection images. It has been previously reported that the
size boundary is 9 nm for nuclear diffusion, and 30 nm for internalization through nuclear pores [239, 240].
No significant evidence of nuclear internalization has been seen for the uptake of pHLIP-Au100-RubpySS,
demonstrating a potential drawback from the use of Au100NPs as a scaffold for imaging probes. Quantitative
analysis of nanoparticles internalized into HeLa cells revealed that HeLa cells treated at pH 6.5 had an average
of 1 nanoparticle per 15 ± 2 µm2 of cell space, whereas when cells were treated at pH 7.4 there was on average
1 particle per 21 ± 6 µm2 of cell space, supportive of pH-dependent uptake and consistent with the uptake
of pHLIP-Au13-RubpySS. The author would like to note that the image data used in this calculation was
acquired using three sets of technical repeats.
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pH-resolved Treatment of HeLa Cells with pHLIPvar3-Au100-RubpySS
Treatment of HeLa cells with pHLIPvar3-Au100-RubpySS (8 pM) in Tyrodes buffer (0.08 mM, pH 6.5 &
7.4) was also performed under live cell conditions. Cells were treated for two hours at 37◦C before being
washed with PBS twice, and subsequently imaged in PBS.
Figure 3.27: Confocal Microscopy images of HeLa cells treated with pHLIPvar3-Au100-RubpySS (8 pM) in
Tyrodes buffers (0.08 mM, pH 6.5 & 7.4) for two hours at 37◦C. Scale bars set to 20 µm, and arrows indicate
nuclear regions.
HeLa cells treated with pHLIPvar3-Au100-RubpySS also exhibited a pH-dependent internalization of
labelled-AuNPs at 37◦C, consistent with the pH-dependent uptake of pHLIPvar3-Au13-RubpySS. Cells
treated at pH 6.5 appear to have greater nanoparticle density than cells treated at pH 7.4, and this was
supported by quantitative analysis which showed that cells treated at pH 6.5 had an average of 1 particle
per 26 ± 7 µm2 of cell space, whereas when cells were treated at pH 7.4 there was on average 1 particle per
52 ± 8 µm2 of cell space. The image data used in this calculation was acquired using two sets of technical
repeats. It is also apparent from 488 nm reflection images that nanoparticles again appear to localise within
cytosolic regions, and are devoid from nuclear regions, this is not surprising it is known that the maximum
diameter of nuclear pores is ≈ 30 nm [239, 240].
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pH-resolved Treatment of HeLa Cells with Zonyl-Au100-RubpySS
Finally, to quantify the endocytotic uptake of gold nanoparticles as a function of microenvironmental pH,
HeLa cells were treated with Zonyl-Au100-RubpySS (8 pM) in Tyrodes buffers (0.08 mM, pH 6.5 & 7.4) for
three hours at 37◦C. Cells treated at pH 6.5 had an average internalized nanoparticle density of 1 particle
per 9 ± 1 µm2 of cell space, whereas when cells were treated at pH 7.4 there was on average 1 particle per
11 ± 6 µm2 of cell space. This data indicates that internalized Zonyl-Au100-RubpySS nanoparticle density is
not responsive to extracellular pH differences within the window of pH 6.5 - 7.4. This corroborates well with
the cytometry data, from which we also concluded a non-pH dependency of Zonyl-Au100-RubpySS uptake
into HeLa cells, and is also consistent with the uptake of Zonyl-Au13-RubpySS. Data comprised of three
technical repeats was used in this analysis.
Figure 3.28: Confocal microscopy images of HeLa cells treated with Zonyl-Au100-RubpySS in Tyrodes buffers
(0.08 mM) pH 6.5 (left) and pH 7.4 (right) at 37◦ for three hours.
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Transmission Electron Microscopy evaluation of pH-Dependent Cellular Uptake
The uptake of pHLIPvar3-Au13-RubpySS was evaluated by transmission electron microscopy in order to
assess the cellular distribution of individual particles using an imaging technique with nanometer scale
spatial resolution. Due to the electron-rich nature of gold nanoparticles, they are efficient electron scatterers
enabling their visualisation by electron microscopy techniques. This not only demonstrates their potential
for multimodal imaging but also creates a platform to image individual particles that are too small to be
visualised by conventional light microscopy techniques. Transmission electron microscopy has been widely
applied to the imaging of biological samples, although there is still much debate surrounding the effect of the
fixation and mounting processes on sample integrity and the distribution of internalized substances [125].
The technique of Energy Dispersive Analysis of X-rays was used in combination with TEM in order to
assess the elemental composition of treated HeLa cells. The technique is based on the principle that an
atom’s core electrons are excitable & ejectable by incident high energy electrons. Upon electron ejection,
the newly empty orbital is filled by one of the atom’s valence electrons, leaving behind an empty valence
orbital. This is a radiative process, with the energy released in the form of X-ray emission. The energy of the
emitted X-ray is characteristic of the atom, and electrons involved in the transition, enabling identification
of elements in a sample from their unique EDAX spectrum.
Figure 3.29: Energy Dispersive Analysis of X-rays spectra of i) HeLa cells treated with pHLIP-Au13-RubpySS
(1 nM) for two hours in Tyrodes buffer pH 6.5, at 37◦C for two hours, ii) pHLIP-Au13-RubpySS mounted
onto a Cu grid and iii) Untreated HeLa cells. Inset, transmission Electron micrographs of i) treated HeLa
cells (red outline), and ii) pHLIP-Au13-RubpySS particles on Cu grids (green outline).
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HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) for two hours in Tyrodes buffer (0.08 mM, pH 6.5),
at 37◦C for two hours, and were subsequently fixed, sectioned and mounted for imaging. Fig. 3.29 shows
EDAX spectra of i) nanoparticle containing region of treated cells (red line), ii) region of treated HeLa cells
devoid of nanoparticle presence (blue line) and iii) pHLIP-Au13-RubpySS nanoparticles on Cu grids (green
line). Cells treated with gold nanoparticles show characteristic gold Xrays at 9.7, 11.6 and 13.6 keV. It is
also noteworthy that no ruthenium bands were present within the EDAX spectrum. This was studied in
Chapter 2 where labelled-AuNPs were dried onto Cu grids for the acquisition of an EDAX spectrum, and
while Au in its high concentration was readily detectable, the low concentration of Ru resulted in low X-ray
flux resulting in no detectable ruthenium EDAX bands in the spectrum.
Thus far, pHLIPvar3 has been the most promising of the two pHLIP peptides, being an effective delivery
agent that offers efficient uptake of AuNPs within short time frames and under physiological conditions.
To assess the pH-dependent intracellular distribution of pHLIPvar3-Au13-RubpySS, HeLa cells were treated
with particles (1 nM) for two hours at 37◦C while immersed in Tyrode’s buffers (0.08 mM, pH 6.5 & 7.4).
Fig. 3.30 shows a selection of TEM images of HeLa cells treated with pHLIPvar3-Au13-RubpySS at pH
6.5. From qualitative analysis of internalized nanoparticles it appears that there was a large abundance of
particles confined to vesicular regions (images A - C), with a number of examples of individual particles that
were free of vesicular confinement (images D - F). Endosomes were shown by Tycko and Maxwell to have low
internal pH, using a pH sensitive fluorecein probe that revealed endosomic pH to be on the order of pH 5 -
6 [241]. It is possible that pHLIPvar3’s pH-dependent translocation could be mediating nanoparticle escape
from endosomes, but future work will need to be done to definitively conclude this.
Also observed were particles localised on the exterior of the cell’s membrane (images G & H), although
only a small number of examples were found compared with the quantity of particles that had been inter-
nalized. It is interesting that these vesicular regions of high nanoparticle density in Fig. 3.30- A, B & C are
likely responsible for the bright spots in the luminescence images of pHLIPvar3-Au13-RubpySS (Fig. 3.21).
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Figure 3.30: Transmission Electron micrographs of HeLa cells treated with pHLIPvar3-Au13-RubpySS (1
nM) for two hours in Tyrodes buffer (0.08 mM, pH 6.5), at 37◦C. A - C) Images of internalized particles
confined to vesicular regions, D - F) Images of internalized particles free within cell cytoplasm, G & H)
Images of non-internalized particles adhered to cell periphery.
HeLa cells were also treated with pHLIPvar3-Au13-RubpySS (1 nM) for two hours at 37◦C at pH 7.4 and
analysed by TEM (Fig. 3.31). In this instance, examples were found of internalized particles confined to
vesicular regions (images A - C), again corroborating with fluorescence microscopy images (Fig. 3.21), and
a large abundance of particles were non-internalized and instead remained adherent to the cell membrane.
Very few examples of these membrane bound nanoparticles are single entities, almost all are associating into
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Figure 3.31: Transmission Electron micrographs of HeLa cells treated with pHLIPvar3-Au13-RubpySS(1
nM) for two hours in Tyrodes buffer (0.08 mM, pH 7.4), at 37◦C. A - C) Images of internalized particles
confined to vesicular regions, D - F) Images of non-internalized particles adhered to cell periphery.
clusters. This is not too surprising as despite pHLIPvar3’s hydrophilic residues, most of the residues are
hydrophobic, likely spurring a favourable interaction between particles in aqueous solution.
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Sample [Au] at pH 6.5/ ppb [Au] at pH 7.4/ ppb τ/ hours δ
pHLIP-Au13RubpySS 65 27 3 4◦C
pHLIP-Au100-RubpySS 555 425 3 4◦C
pHLIPvar3-Au13-RubpySS 186 98 2 37◦C
pHLIPvar3-Au100-RubpySS 1308 864 2 37◦C
Table 3.2: ICPMS-measured gold concentration from HeLa cells treated with labelled gold nanoparticles for
two hours in Tyrodes buffers (0.08 nM, pH 6.5 or 7.4). Included in the table are each treatment length(τ)
and treatment temperature (δ). Labelled-Au13 nanoparticles had a final concentration of 1 nM, and labelled-
Au100 nanoparticles had a final concentration of 8 pM.
Inductively-Coupled Plasma Mass Spectrometry (ICP-MS) evaluation of pH-Dependent Cel-
lular Uptake
The concentration of gold internalized by HeLa cells treated with labelled gold nanoparticles was evaluated
by ICP Mass Spectrometry. In this procedure, once cell treatment had concluded, cells were washed and
digested using ultrapure aqua regia (3:1, HCl:HNO3) before being dispersed in 4% HNO3 for analysis. Prior
to sample acquisition, standard solutions of gold were prepared, and analysed to construct a calibration
curve. Concentrations of 0, 50, 100, 250, 500 & 1000 ppb were prepared and studied in absence of the helium
sheath gas, which is generally not required for high molecular weight elements such as gold. Sample solutions
were then analysed if the calibration line satisfied the r2 > 0.998 criteria, indicating an accurate calibration.
Table. 3.2.2 shows concentrations of gold detected from cells treated with peptide-laelled luminescent AuNPs.
For the analysis, all treated samples were normalised by subtracting measured gold signal from untreated
cells.
For pHLIP-Au13RubpySS, the concentrations of gold detected from cells treated for two hours at 4◦C
in Tyrodes buffers (0.08 mM) at pH 6.5 & 7.4 were 186 ppb & 98 ppb, respectively. pHLIP-Au100RubpySS
(8 pM, three hour treatment) treated HeLa cells, also showed the same trend with gold concentrations in
Tyrodes buffer (0.08 mM) pH 6.5 & 7.4 of 555 ppb & 425 ppb, respectively.
For pHLIPvar3-Au13RubpySS, the concentrations of gold detected from cells treated at pH 6.5 & 7.4
were 186 ppb & 98 ppb, respectively. For pHLIPvar3-Au100RubpySS, the concentrations of gold detected
within cells treated at pH 6.5 & 7.4 were 1308 ppb and 864 ppb, respectively. Both these results support
previously reported cytometry and confocal microscopy data indicating that internalization of pHLIPvar3-
labelled particles is more efficient at pH 6.5.
For all ICP-MS treatments, cells treated at pH 6.5 displayed higher concentrations of gold than cells
treated at pH 7.4. This is a strong corroboration with flow cytometry and light microscopy conclusions that
pHLIP & pHLIPvar3 are mediating a pH dependent transduction of luminescent AuNPs, and a good indi-
cation that the indirect luminescence measurements acquired through flow cytometry and light microscopy
are accurate representations of AuNP uptake. It interesting that for both labelled Au13NPs the ratio of gold
concentration is approximately 2:1 for pH 6.5:pH 7.4, whereas for the larger Au100NPs the ratio is signif-
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Sample Analysis Technique pH 6.5 pH 7.4
pHLIP-Au13-RubpySS
FC Scatter (%) 106 ± 1% 102 ± 3%
FC Luminescence (%) 210% 165%
Microscopy (%) – –
ICP-MS (/ppb) 65 27
pHLIP-Au100-RubpySS
FC Scatter (%) 160% 120%
FC Luminescence (%) 230% 150%
Microscopy (%) 1 AuNP per 15 ± 2 µm2 1 AuNP per 21 ± 6 µm2
ICP-MS (/ppb) 555 425
pHLIPvar3-Au13-RubpySS
FC Scatter (%) 108 ± 10% 112 ± 4%
FC Luminescence (%) 2064 ± 104% 1409 ± 204%
Microscopy (%) 397 ± 75% 357 ± 59%
ICP-MS (/ppb) 186 98
pHLIPvar3-Au100-RubpySS
FC Scatter (%) 213 ± 13% 178 ± 5%
FC Luminescence(%) 370 ± 54% 328 ± 30%
Microscopy(%) 1 AuNP per 26 ± 7 µm2 1 AuNP per 52 ± 8 µm2
ICP-MS (/ppb) 1308 864
Zonyl-Au13-RubpySS
FC Scatter (%) 109% 117%
FC Luminescence (%) 344% 348%
Zonyl-Au100-RubpySS
FC Scatter (%) 234 ± 4% 234 ± 6%
FC Luminescence (%) 492 ± 32% 562 ± 12%
Microscopy (%) 1 AuNP per 9 ± 1 µm2 1 AuNP per 11 ± 6 µm2
Table 3.3: Tabled summary of collected experimental data from this chapter consisting of pH-resolved uptake
of labelled gold nanoparticles from four imaging or spectrometric modalities.
icantly smaller for both peptides. For pHLIP-Au100-RubpySS the gold concentration ratio of cells treated
at pH 6.5:pH 7.4 is 1.3:1, and for pHLIPvar3-Au100-RubpySS the ratio was 1.5:1. This suggests that the
efficiency of pHLIP & pHLIPvar3 pH-mediated delivery of AuNPs into HeLa cells is less efficient with larger
particles.
Data Summary of pH-Resolved Uptake
Detailed in Table 3.2.2 are all reported relative and absolute labelled-AuNP uptake measurements deter-
mined through analysis of flow cytometry, Microscopy and ICP-MS as outlined in previous sections. Relative
measurements from analysis of flow cytometry and microscopy measurements are expressed as % lumines-
cence of untreated cells and absolute concentration values determined by ICP-MS are expressed in ppb of Au
having subtracted measured Au concentration of untreated cells. This higher uptake efficacy for pHLIPvar3-
mediated internalization of gold nanoparticles is supported by report by Weerakkody et al. that pHLIPvar3
internalises within 30 - 50 ms, much faster than Wt-pHLIP which internalises in approximately 40 seconds
[176]. Contrasting how the size of the particles affects pHLIP-mediated transduction has proven difficult.
For instance, the pH-resolved uptake of pHLIPvar3-Au13-RubpySS resulted in a flow cytometry lumines-
cence signal from cells treated at pH 7.4 was 70% of the luminescence intensity from cells treated at pH 6.5,
whereas for pHLIPvar3-Au100-RubpySS the mean luminescence intensity from cells treated at pH 7.4 was
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88% of the mean luminescence intensity from cells treated at pH 6.5. For Wt-pHLIP-labelled particles the
opposite was seen, where the percentage of flow cytometry luminescence intensity for pH 7.4 samples relative
to pH 6.5 samples for pHLIP-Au13-RubpySS and pHLIP-Au100-RubpySS were 78% and 65%, respectfully.
As pHLIP’s pH-dependent uptake has been shown to be inversely proportional to pH rather than an on/off
switch [204], the measured uptake will be sensitive to small pH differences between experiments and this
must be remembered when interpreting results.
3.2.3 Assessing the Effect of labelled-AuNP Treatments on Cell Viability using
the 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
Reduction Assay
To understand the effect of pH and nanoparticle internalization on HeLa cell viabilities, the 3-(4,5-Dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction assay was performed on a variety of
treated cells. This colormetric assay provides an assessment of enzymatic activity within cellular mitochon-
dria. The assay utilises a membrane-permeable dye which is reduced by mitochondrial succinate dehydroge-
nase into a blue formazan product precipitate. The formazan product is soluble in DMSO, permitting liquid
state UV/Vis absorption measurements where the stronger the absorbance, the greater cell viability.
In short, HeLa cells were cultured in 12-well plates, grown to 60% confluency and then treated with
particles or buffers. At the end of the treatment, cells were washed twice with phosphate buffered saline,
and treated with the MTT dye (final concentration of 0.5 mg ml−1). The MTT protocol was performed
on untreated cells to provide a negative control, and the absorption of all treated samples were expressed
as percentages relative to the absorbance of the negative control, which was arbitrarily set to 100%. Addi-
tionally, a positive control for each dataset was also prepared where cells were treated with Triton-X100 (an
ionic detergent utilised to induce cell death) prior to the assay.
Fig. 3.32 shows the relative cell viabilities of HeLa cells treated with Tyrodes buffers pH 5.0, 6.0, 6.5, 7.4
& 8.3. along with accompanying live cell phase contrast images showing cellular morphologies of all treated
and untreated samples. Cell samples treated within the higher pH range 6.5 - 8.3 exhibited no statistically
significant viability measurements to that of the negative control. Cells treated at lower pH values pH 5.0 -
6.0 displayed reduced mitochondrial activity, and therefore reduced viability. This is consistent with time-
resolved treatments of HeLa cells at pH 5.0 and 7.4 where cells treated at pH 5.0 saw a strong initial increase
in luminescence, but was significantly reduced at longer time points (Fig. 8.27, appendix). The phase
contrast image of cell samples treated at pH 5.0 indicate a slightly less dense cell monolayer, however the
cells were still adopting spread morphologies, and did not appear to have any visual signs of compromised
viabilities different to the negative control, or in any way similar to the positive control. Phase contrast
images of the positive control showed a significantly depleted monolayer of spherical cells detaching from
the coverslip. For all other cell samples, the cell density does not visually appear to differ from the negative
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Figure 3.32: MTT colorimetric assay showing the effect of pH on cell viability. HeLa cells were incubated in
Tyrodes buffers (0.08 mM, pH 6.5 or 7.4) for 2 hours at 37◦C. Mean data points calculated from 3 biological
repeats, and are presented with ± one standard deviation unit.
control, where all cells appear to be spread onto the bottom of the well, and integrated into a tightly-packed
cell monolayer.
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Figure 3.33: MTT colorimetric assay of HeLa cells treated with pHLIP-Au13-RubpySS (1 nM) and pHLIP-
Au100-RubpySS (8 pM) in Tyrodes buffers (0.08 mM, pH 6.5 or 7.4) for 2 hours at 37◦C, contrasted against
untreated cells (Negative Control), cells treated with Triton X-100 (Positive Control) and cells treated with
10% Water in DMEM. Mean data points calculated from 3 biological repeats, and are presented with ± one
standard deviation unit.
The effect of pH-dependent pHLIP-Au13&100-RubpySS internalization on HeLa cell viability was analysed
by MTT assay. HeLa cells were plated into a 24-well plate, permitted to adhere and proliferate for 24
hours before dosing with labelled-Au13 and labelled-Au100 nanoparticles at pH 6.5 or 7.4 for two hours at
37◦C. Fig. 3.33 shows the absorbance measurements of HeLa cells subjected to a pH-resolved treatment
of pHLIP-Au13&100-RubpySS followed by the MTT dye. All treated samples show strong mitochondrial
function comparable to that of untreated cells (100%). The only statistically significant difference found in
this experiment existed between all treated samples and the positive control (Tukey HSD, p < 0.01 in all
cases). This points to the conclusion that pH-resolved treatment with pHLIP-Au13&100-RubpySS particles
for two hours at 37◦C does not compromise cell viability, and therefore cell viability does not appear to be
a contributor to the pH-dependent uptake reported in earlier sections.
The effect of pH-dependent pHLIPvar3-Au13&100-RubpySS internalization on HeLa cell viability was
analysed by MTT assay. HeLa cells were plated into a 24-well plate, permitted to adhere and proliferate
for 24 hours before dosing with labelled-Au13 (1 nM) and labelled-Au100 (8 pM) nanoparticles in Tyrodes
solutions (0.08 mM, pH 6.5 or 7.4) for two hours at 37◦C. Fig. 3.34 shows the absorbance measurements of
HeLa cells subjected to a pH-resolved treatment of pHLIPvar3-Au13&100-RubpySS followed by the MTT dye.
All treated samples show strong mitochondrial function comparable to that of untreated cells (100%). The
only statistically significant difference found in this experiment existed between all treated samples and the
positive control (Tukey HSD, p < 0.01 in all cases). This points to the conclusion that pH-resolved treatment
129
Figure 3.34: MTT colorimetric assay of HeLa cells treated with pHLIPvar3-Au13-RubpySS (1 nM) and
pHLIPvar3-Au100-RubpySS (8 pM) for 2 hours in Tyrode’s buffers (0.08 mM, pH 6.5 or 7.4) at pH 6.5 or
7.4 at 37◦C. Mean data points calculated from 3 biological repeats, and are presented with ± one standard
deviation unit.
with pHLIPvar3-Au13&100-RubpySS particles for two hours at 37◦C does not compromise cell viability, and
therefore cell viability does not appear to be a contributor to the pH-dependent uptake previously reported.
This experiment in conjunction with MTT analysis of pHLIP-Au13&100-RubpySS-treated HeLa cells, and
previously reported MTT analysis of Zonyl-labelled gold nanoparticles [96] indicate that cellular internal-
ization of labelled gold nanoparticles does not affect cell mitochondrial activity, promoting the use of gold
nanoparticles as inert scaffolds for cargo delivery.
3.3 Conclusions
In this Chapter the pH-dependency of labelled-AuNP internalization into HeLa cells was reported. The
viabilities of all treated cells were analysed using a mitochondrial viability assay, and the colloidal stability
of labelled nanoparticles within the buffers was also investigated.
The multimodal potential of these labelled-AuNPs was demonstrated, where flow cytometry and light
microscopy provided direct and indirect measurements of nanoparticle internalization, indirectly through de-
tection of RubpySS luminescence and directly through detection of gold nanoparticle scattering. Nanoparticle
internalization was confirmed using confocal optical sectioning and quantified where possible. Transmission
electron microscopy then provided a spatial assessment of pHLIPvar3-Au13-RubpySS nanoparticles internal-
ized by HeLa cells, and ICP-MS analysis confirmed that the gold concentration of treated cells corroborated
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with flow cytometry luminescence data. This demonstrated that collecting the luminescence of surface
bound lumophore is an effective and accurate measure of nanoparticle internalization, and can be used at
high throughput in flow cytometry, or to study functional internalization using live cell imaging.
Labelled-Au100 nanoparticles provided advantages over labelled Au13 nanoparticles as they provided a
means to more easily quantify uptake within light microscopy where individual particles could be visualized,
and provided information on cell granularity within flow cytometry side scatter experiments. For example,
cells treated with pHLIP & pHLIPvar3-labelled Au13NPs did not show increased cell granularity during
the course of the nanoparticle treatment, however for pHLIP & pHLIPvar3-labelled Au100NPs there was a
very distinct increase in measured side scatter as a function of treatment length. The relationship between
the flux of light scattered by an spherical particle is proportional to r6, where r = particle radius [242].
When this scattering potential is applied to 13 & 100 nm gold nanoparticles, this proportional relationship
results in a scattering intensity ratio of 1: ≈200,000 for 13 nm:100 nm particles. For smaller particles,
luminescence detection is orders of magnitude more sensitive than scattered light detection, and therefore
provides a better indication of small nanoparticle internalization into HeLa cells. Conversely, cytometry
measurements of all HeLa cell treatments with labelled-Au100NPs resulted in an increase of scattered light
flux, indicating that side scatter measurements have far greater sensitivity when detecting light scattered
by labelled-Au100NPs. Cells treated with Zonyl-labelled Au13 and Au100 nanoparticles exhibited increased
cell granularities as a function of treatment time, and confocal reflection imaging of Zonyl-Au13-RubpySS
indicated the formation of large aggregates within the cells indicating the nanoparticles are no longer stable
once internalized. Although the use of Au100NPs often rendered easier measurement and quantification of
AuNP internalization it is important to highlight the importance of using smaller nanoparticles too. Firstly
it is useful that this work demonstrates that the pHLIP peptides mediate delivery of a range of different
size nanoparticles so that the photothermal efficiency of different sized nanoparticles can be investigated.
Secondly, as the long term aims of this work are to develop phohotothermal & photodynamic therapeutic
agents it is useful to study particles that are smaller than nuclear pores to permit particles to bypass the
nuclear membrane more easily easily target the nanoparticles towards cell nuclei in order to develop more
effective therapeutics.
The peptide that showed the most promising use as a pH-sensitive, delivery agent was pHLIPvar3, where
the pHLIPvar3-Au13-RubpySS and pHLIPvar3-Au100-RubpySS particles exhibited pH-dependent uptake
into HeLa cells under physiological conditions as demonstrated by flow cytometry, confocal microscopy &
ICP-MS. pHLIP-labelled particles did not show pH-dependent uptake under physiological conditions, how-
ever when cold treatments were performed, pH-dependent uptake was observed on account of sufficiently
slowing endocytotic mechanisms, again demonstrated by flow cytometry, microscopy & ICP-MS. Zonyl la-
belled AuNPs did not exhibit pH-dependent uptake, indicating that the efficiency of HeLa cell endocytotic
uptake is not pH-dependent within the region of pH 6.5 - 7.4.
Transmission electron microscopy of HeLa cells treated with pHLIPvar3-Au13-RubpySS revealed that
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internalized nanoparticles were still monodisperse, and treatment at pH 7.4 appeared to show a greater
concentration of particles adhered to cellular membranes, with a few examples of particles internalized into
cell vesicles. Treatment at pH 6.5 resulted in far fewer examples of particles adhered to plasma membranes,
and more examples of internalized particles were found where there were examples of particles confined to
vesicular compartments, and free within the cell cytosol.
Viability assessments indicated that neither the buffer nor any particle sample imposed any noticeable
cytotoxic effects on HeLa cervical adenocarcinoma cells during the two hour time course, however it was
noticed that treatment of the cells at 4◦C induced a decrease in cell viability as a function of treatment
duration. Crucially, treatment of the cells within the pH range 6.5 - 7.4 did not result in a pH dependent
viability, however treatment of cells as low as pH 5.0 rendered cells less viable, with reduced mitochondrial
function along with a less dense monolayer of cells.
3.4 Future Work
The environment that a gold nanoparticle encounters while within a cell’s microenvironment, and while
being uptaken is a complex one. The effects of colloidal stability on the uptake of gold nanoparticles are not
presently clear. Stability of the colloid is heavily dependent on the surfactant, and thus affects the proteins
that assemble a corona around the particles. Further study should involve a pH-resolved study of the
cellular uptake of labelled-AuNPs with varied polarity, hydrophobicity, charge & particle size. Flow imaging
of labelled-AuNPs during the addition of serum proteins or cell extracts is potentially a reasonable place to
start. Development of pHLIP variants that maintain AuNP monodisersity within cell microenvironments
and during transduction may also be an effective method in studying the effect of colloidal stability during
internalization.
Additionally, although the chosen incubation times and concentrations used within the treatment did
not result in a compromise of cell viability, a comprehensive analysis of a wide concentration range and
incubation times is important to develop deeper knowledge of the interactions between these particles and
cells. The retention time of these labelled-AuNPs within cells has also not been touched on in this work,
which would also be useful to build a fuller picture of their interactions.
The next step within particle labelling would be to target cell nuclei or mitochondria. Peptides such
as the nuclear localisation sequence (NLS) and RGD peptide have been used to target cargoes towards cell
nuclei [115]. That would be the next step to develop the application of these particles as delivery vessels.
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3.5 Experimental
3.5.1 Chemicals and Reagents
pHLIP (AAEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTC(thiopyridyl)G), kpHLIP (AAEQNPIY-
WARYAKWLFTTPLLLLKLALLVDADEGTC(thiopyridyl)G) and pHLIPvar3 (ACDDQNPWRAYLDLLF-
PTDTLLLDLLWC) were synthesised by Peptide Synthetics, Southampton, UK and were dissolved in 5%
DMF in phosphate buffered saline. Cell culture buffers, were prepared using tablets or powders purchased
from Sigma Aldrich, and sterilised for cell culture use by either autoclaving or injection through 0.22 µm
syringe filters.
3.5.2 Preparation of cells for Flow Cytometry/Fluorescence-Activated Cell Sort-
ing (FACS)
Prior to treatment, cells were plated into a 12-well culture plate and allowed to grow to approximately 60%
confluency. Cells were then washed with buffers before being treated with particles in a Tyrodes buffer(0.08
mM, pH 6.5 or 7.4), for a series of incubation times upto three hours. After treatment was complete, the
supernatant from each well was removed and each well was washed with PBS (0.1 M, 0.5 mL) twice before
being trypsinised at 37◦C for 10 minutes. Particles were then spun down at 1500 rpm for 10 minutes,
the supernatant removed, and redispersed in of PBS (0.1 M, 1 mL). Cell suspension was transferred to a
FACS tube before analysis. for all samples, the parameters of Forward Scatter, Side Scatter, and far red
luminescence were measured (488 nm excitation, emission >620 nm). 15,000 events were recorded for each
sample.
3.5.3 Preparation of cells for Confocal Microscopy
Preparation for Fixed Cell Imaging
For fixed cell imaging, glass coverslips were sterilised using absolute ethanol (rinsed and left to dry) and
placed into the wells of 6-well culture plates. 5x104 cells were then seeded into each well of the 6-well culture
plates on top of glass coverslips and allowed to grow to confluency for 24 hours. Before treatment, media
from each well was removed and cells were washed twice with the media used in the seeding experiment,
before being sequentially treated with the media and particles. After treatment, medium was removed and
cells were washed with PBS (2 mL x 2) and then paraformaldehyde (4% in 0.1M PBS, 2 mL) was added and
cells were left for 10 minutes at room temperature. Fixative was removed and cells were washed with PBS (2
mL x 2). Cells were then mounted onto glass microscope slides, using a drop of non-fluorescing Hydromount
to maintain sample hydration, before sealing the slide with nail varnish. Slides were left to dry in a cold
room and were imaged within a few days.
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Preparation for Live Cell Imaging
For live cell imaging, 5x104 cells were then seeded into the well of a MatTek(R) glass-bottom microscopy
dish and allowed to grow to confluency for 24 hours. Before treatment, media from each well was removed
and cells were washed twice with the media used in the seeding experiment, before being sequentially treated
with the media and particles. After treatment, medium was removed and cells were washed with PBS (2
mL x 2) and then PBS (2 mL) was added before transferring samples to the microscope for acquisition.
3.5.4 Preparation of cells for Inductively Coupled Plasma - Mass Spectrometry
HeLa cells were cultured as per above and treated as per the relevant experiment. After treatment was
complete, the supernatant from each well was removed and each well was washed with PBS (0.1 M, 0.5 mL)
twice before being trypsinised at 37◦C for 10 minutes. Particles were then spun down at 20,000 rpm for 10
minutes, the supernatant completely removed taking care not to disturb the cell pellet, before being allowed
to dissolve overnight in 200 µL of ultrapure aqua regia (3:1 volumetric ratio of hydrochloric and nitric acid).
Post dissolution, samples were diluted in ultrapure nitric acid (2700 µL of a 4% solution) prior to analysis.
3.5.5 Preparation of cells for Transmission Electron Microscopy
After treatment with nanoparticles, cell samples were fixed with a solution of Paraformaldehyde (4%) and
Glutaraldehyde (2.5%) in phosphate buffered saline for two hours, prior to sectioning and mounting onto
formvar-coated copper grids. Samples were then imaged on a JEOL JEM-1200EX and a JEOL JEM-2100
electron microscope each fitted with a Tungsten electron source and a Gatan camera.
3.5.6 Analysing Cell Viability of Nanoparticle-treated HeLa cells
After treatment of HeLa cells with labelled-AuNPs, the media from each well was withdrawn and cells
were washed with PBS (500 µl) and replaced with 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (0.5 mg/ml) in complete media (90% by volume), and were reincubated at 37◦C for 2 hours. After
the incubation, media was removed and DMSO (500 µl) was added to solubilise the formazan product. The




The effect of Cellular Glutathione on
the uptake of Labelled-Gold
Nanoparticles into HeLa Cervical
Cancer Cells
4.1 Introduction
The aim of this work was to study the dependency of labelled-AuNP (pHLIP-Au100-RubpySS, pHLIPvar3-
Au100-RubpySS & Zonyl-Au100-RubpySS) uptake efficiency and stability as a function of intracellular glu-
tathione concentration, the cell’s most prevalent reducing agent. As demonstrated in previous chapters, the
cellular uptake of labelled-Au100NPs has proved easier to quantify with microscopy techniques than with
labelled-Au13NPs, and the larger particles also provide sensitive measurements within techniques such as
side scatter analysis within flow cytometry. For these reasons, this study focuses exclusively on labelled-
Au100NPs and labelled-Au13NPs were excluded from study. The peptide-labelled AuNP constructs are
bound together by dative covalent bonds between thiol or dithiol groups and the gold nanoparticle surface,
the Zonyl-labelled AuNPs are held together by electrostatic interactions and therefore may be effected dif-
ferently by the cell’s reducing environment. These gold–sulfur bonds are sensitive to a reducing environment
so particular attention was paid to whether the ”strength” of the cells reducing environment affected the
efficiency of nanoparticle uptake, and also how the nanoparticle coating changed depending on the strength
of its reducing environment.
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4.1.1 Glutathione
Glutathione (GSH, Fig.4.1) is the most prevalent low-molecular-mass reducing agent within plants and
animals [243]. It acts as the eukaryotic cells thiol ”redox buffer” on the front line of the cells defensive
response to oxidative stress, which is defined as an imbalance between pro-oxidant species (for example,
reactive oxygen species, ROS) and anti-oxidant species (for example, GSH) [244]. GSH is an antioxidant
responsible for equilibrating the cells thiol/disulphide redox potential, and does so without exhibiting the
toxicity associated with cysteine [245].
Glutathione is a tripeptide, comprised of L-glutamate, L-cysteine and glycine and many of GSH’s impor-
tant reactions, that give GSH its biological function, involve its thiol group on its cysteine residue. GSH’s
biological function involves participation in bio-synthesis of iron-sulphur proteins in the mitochondria [246,
247, 248, 249], along with detoxification of metals, xenobiotic resistance, apoptosis, redox signalling and
sulphur storage and transport [243, 250, 251] of which many are catalyzed by various GSH peroxidases,
GSSG reductases and GSH transferases [252].
Figure 4.1: Structural formula of Glutathione (GSH)
GSH is able to donate an electron from the thiol group of its cystine residue to contribute a reducing
effect on its environment. The newly oxidised GSH will then combine with another oxidised GSH molecule to
form glutathione disulfide (GSSG, Fig. 4.2 ) which is rapidly recycled back into GSH by NADPH-dependent
glutathione reductases in key organelles as well as in the cytosol, rendering the species abundantly in its GSH
form apart from within the endoplasmic reticulum, where it predominantly exists in its GSSG form [253].
The reducing nature of GSH, and the oxidising nature of GSSG, mean that it is involved in practically all
major biological processes, including regulation of cell proliferation [254], signal transduction [255, 256], gene
expression [257] and apoptosis [258]. Literature in recent years has focussed on the biochemical, physiologic,
and toxicological effects of GSH [259, 260, 261, 262] along with medical and clinical aspects [263, 264, 265].
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4.1.2 Glutathione Production
GSH is synthesised from L-glutamate, L-cysteine and glycine, in a two step process facilitated by two ATP-
dependent enzymes. Step 1 is the production of γ-glutamylcysteine, catalysed by the enzyme glutamate
cysteine ligase (GCL), and is believed to be the rate determining step of the overall process of GSH formation
because very low γ-glutamylcysteine concentrations have been measured [266]. The second, and more rapid
step of GSH production is catalysed by glutathione synthase, and the factors that govern and regulate this
process are reported in work by Griffith [267]. Intracellular GSH concentration is generally considered to be
in the range of 1 - 11 mM, levels that greatly exceed free cysteine concentration [268, 269].
Figure 4.2: Structural formula of Glutathione Disulfide (GSSG)
4.1.3 Cellular Compartmentalisation of Glutathione
After synthesis within the cytosol of mammalian cells, GSH is transported to various intracellular compart-
ments such as the mitochondria, nucleus and endoplasmic reticulum where GSH adopts compartment-specific
functions essential to the needs of each organelle [270, 271]. 70% of the cells GSH pool is abundant in the




GSH is first synthesised in cellular cytosol, in a tightly regulated two step process, catalysed by γ-glutamylcysteine
and glutathione synthetase, respectively [273]. After synthesis, GSH is partitioned between the cells nucleus,
mitochondria and endoplasmic reticulum, while 70% of the cells GSH reservoir remains in the cytosol.
Bachawat et al. have compiled a comprehensive review of the different classes of intracellular GSH trans-
porters [274]. This review studied a wide class of trasporters that included GSH importers from the extra-
cellular environment, to GSH effluxers. Hgt1p was the first high affinity GSH transporter identified, and was
done so from the yeast S cerevisae [275]. The uptake of ’intact’ GSH into mammalian cells has been debated
[276]. There is evidence that intact GSH is uptaken using specific transporters [277, 278, 279, 280], and
that the uncoupled GSH constituent amino acids/peptides are also imported independently, as evidenced by
inhibition of the degrading enzyme γ-glutamyl transpeptidase [281, 282] Cell nuclei sequester GSH, and it is
believed that nuclear GSH accumulation plays an important role in the cell cycle and cell proliferation. It has
been proposed that GSH is also found in significant quantities in the endoplasmic reticulem and extracellular
compartments, adopting its oxidised form, GSSG [253, 283]
Nuclear Glutathione
The nucleus is the cell’s central kernel, a membrane-walled organelle that plays host to most of the cell’s
genetic material, which controls cell activities by regulating gene expression. In the nucleus, GSH plays an
important role in maintaining protein sulphyldryls that sustain DNA repair and expression [284], while also
playing a contributive role in DNA synthesis by donating a proton into the ribonucleotide reductase-catalysed
reduction of riboxynucleotides into deoxyribonucleotides [285]. Until recently, it was widely believed that
GSH could freely diffuse between the cell nucleus and cytoplasm through the nuclear pores. Nuclear con-
centration of GSH is strongly dependent on the cells current phase in the cell cycle. Recent work has shown
that in the cells growth phase (G1), where the biosynthetic activities of the cell which were previously slowed
down in its mitotic phase, begin to resume their high rate. Early in this phase, GSH accumulation begins
[272]. An increase in GSH concentration has been shown to be necessary for the cell to move from the G1
phase into the S phase of the cell cycle [286], but it has also been shown that addition of GSSG to plant
cells resulted in an arrest of the cell cycle in the G1 phase [287]. Additionally, the depletion of cytoplasmic
GSH upon nuclear recruitment of GSH is consistent with an oxidative process occurring in the early stages
of the G1 phase [288, 289]. A model (Fig. 4.3) for GSH partitioning between the nucleus and cytoplasm was
proposed by Vivancos et al. [290].
Mitochondrial Glutathione
The primary function of a cells mitochondria is the transduction of electrons through the electron transport
chain (ETC) to generate adenosine triphosphate (ATP), the cells molecular energy carrier, essential for
subsequent signalling cascades. A small portion of electrons generated from the ETC are however transferred
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Figure 4.3: GSH partitioning between the cell nucleus and cytopasm during the cell cycle. Adapted from
[290] and derived from [291, 292, 293]
directly to molecular oxygen, generating a variety of reactive oxygen species (ROS) and reactive nitrogen
species (RNS). To maintain an equilibrium of ROS & RNS production, the mitochondria uses its arsenal
of antioxidants each with is own target specificity [270]. In the mitochondria, GSH exists in its reduced
form and constitutes a minor fraction of the GSH pool at around 10 - 15%. However, taking into account
mitochondrial volume versus cytosolic volume, there are a number of reports that the concentration of GSH
within mitochondria is similar to that in the cytosol (10 - 14 mM) [270, 271, 294, 295].
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4.1.4 Measuring Glutathione Concentration
There are a variety of established methods of the measuring the concentration of GSH & GSSG. Meth-
ods have even become sophisticated enough to measure both together and even the measurement of GSH
concentration within intracellular organelles. The oldest and most common methods of measuring GSH
concentration are using fluorimetric assays [296] which have been further developed to measure both the
oxidised (GSSG), and reduced (GSH) forms as per the method of Hissin and Hilf [297]. Whole tissue GSH
concentrations can be measured by enzyme-catalysed procedures, one such method is diazo coupling before
recorded absorption [298] and another utilises a fluorometric method based upon the conjugation of GSH
with Monochlorobimane which has also been used to label free GSH in whole tissues [299]. A method for
determination of GSH:GSSG ratios has been reported by Asensi et al [300] using HPLC, where standard
solutions and N-ethylmaleimide were used to prevent reduced GSH oxidation. Additionally, a novel dual-
readout method based on gold nanoparticles surface plasmon resonance and förster resonance energy transfer,
where the readout could be measured using luminescent or calorimetric detection [301]. Methods have also
been reported for measuring the GSH concentration of intracellular compartments, for instance conjugation
of GSH with strongly electron-scattering gold nanoparticles has enabled the visualisation of GSH distribu-
tion via transmission electron microscopy [302]. Further, imaging fluorophores such as ThiolTracker Violet
(registered trademark of Invitrogen) conjugates to intracellular thiol-functionalised biomolecules, providing
an assessment of the cells overall redox environment which is detectable on a multitude of luminescence
detection platforms [303].
4.1.5 Glutathione and AuNPs
Glutathione has been identified as a useful release tool for nanoparticle-bound cargoes, due to the markedly
greater concentration of intracellular GSH (1 - 11 mM [268, 269]) over extracellular GSH (2 µM) [304].
Indeed, glutathione-mediated release of fluorescent cargoes from gold nanoparticles has been reported [305]
and this approach has even yielded clinical success [306]. Verma et al reported controlled release of the
enzyme β-galactosidase from positively charged trimethyl-ammonium-functionalized mixed monolayer pro-
tected clusters mediated by intracellular GSH, and that control of β-galactosidase release could be tuned by
the structure of the monolayer [307]. It was also shown that release of β-galactosidase was specific to the
presence of the thiol group of GSH by studying a non-thiol bearing analogous tripeptide. Han et al then
demonstrated that the same monolayer protected clusters encapsulate DNA through complementary electro-
static interactions, resulting in transcription inhibition of the T7 RNA polymerase. However, intracellular
GSH mediated controlled release of the DNA resulted in efficient transcription [308]. The GSH-mediated
release of anticancer drugs from AuNP surfaces has also been reported [309].
Additionally, the uptake of labelled gold nanoparticles has been reported to have a direct effect on GSH
concentration, as per Gao et al. who reported an early AuNP-induced depletion of cytosolic GSH in HL7702
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Human Liver cells that ultimately exacerbated cellular apoptosis [310]. Gold nanoparticles have also been
used as chemosensors for glutathione. Sudeep et al reported selective detection of cysteine and glutathione
at micromolar concentrations, by exploiting the interplasmon coupling of gold nanorods [311].
Gold nanoparticles functioned with glutathione have also been studied as possible alternatives to poly
ethylene glycol (PEG) coated AuNPs. Coating AuNPs with PEG helps reduce renal complications and
morbidity, caused by some other thiol-functionalised AuNPs such as the widely used AuNP-cap tiopronin,
however PEG-coating results in a compromised cellular uptake efficiency [312]. However, Simpson et al
demonstrated improved biocompatibility and retention of GSH-coated AuNPs compared with PEG-coated
analogues [313].
4.2 Results and Discussion
This section is divided into three subsections. Section i) describes the methodology of adjusting HeLa
cell intracellular GSH concentration to prepare [GSH]-modified HeLa cells and reports final concentrations
of intracellular GSH after application of the protocol. Section ii) reports the cell viability assay that was
performed on [GSH]-modified HeLa cells. And in section iii), the internalization of labelled, luminescent gold
nanoparticles into HeLa cells was reported as a function of intracellular [GSH] concentration. The cellular
uptake of labelled-AuNPs was studied using a variety of techniques including Flow cytometry (FACS),
Confocal Microscopy and Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Alongside which, the
colloidal stability of labelled gold nanoparticles is studied as a function of glutathione concentration, using
the spectroscopic techniques of UV/Vis spectroscopy and Electrophoretic Light Scattering.
4.2.1 Quantfication of GSH concentration in HeLa cells treated with Buthionine
Sulfoximine and N-Acetyl Cysteine by fluorimetric Assay
In order to establish the effect of glutathione on the uptake of AuNPs, protocols for modifying intracellular
GSH concentration of live HeLa cells needed to be established and tested. Vos et al. [314] demonstrated that
treatment of HeLa cells with buthionine sulfoximine resulted in a depletion of intracellular GSH. Green et
al [315] later reported that treatment of Mouse Embryonic Fibroblasts with buthionine sulfoximine (BSO)
resulted in differential depletion of GSH from the nuclei, mitochondria and cytoplasmic compartments, with
the cytoplasmic region suffering the biggest reduction in GSH concentration, and the nuclear pool being
the most resistant to GSH depletion. The cytotoxicity of treating cells with BSO was evaluated using
concentrations up to 1000 µM with negligible cytotoxic effects up to this concentration. Han et al [316]
established a method of increasing intracellular GSH by pretreating HeLa cells with 2.5 mM of N-Acetyl
Cysteine (NAC), a pro-oxidant species. They reported that NAC prevented Arsenic Trioxide (ATO)-induced
apoptosis of HeLa cells by replenishing depleted GSH, although they couldn’t rule out the possibility that
NAC was directly scavenging ATO.
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In this work, HeLa cells were treated with an aqueous solution of NAC (2.5 mM in 90% complete media)
to increase, and aqueous solutions of BSO (100 µM and 500 µM in 90% complete media) to decrease the
cells intracellular glutathione concentration. These were performed alongside a water control (10% H2O in
complete media) representing unmodified GSH concentration, and to account for the effects (if any) that
dilution of complete media would have on the experiment. To measure the concentration of [GSH]-modified
HeLa cells, the fluorimeteric assay protocol of Hissin and Hilf [297] was used. GSH has been shown to react
with o-phthalaldehyde (OPT) at pH 8.0 to form a fluorescent product, that excites at 350 nm and emits at
420 nm [296].
Cells were treated with the [GSH]-precursors in 90% complete media for 24 hours, and subsequently cells
were washed with PBS and the assay was performed. (Fig. 4.4) shows a plot of GSH concentration from
solutions of known GSH concentration (calibration data) together with GSH concentrations from [GSH]-
modified HeLa cells. A three-way ANOVA was performed (p = 0.004) indicating that each treatment bore
significantly different results, and a Tukey HSD test indicated a statistically significant (p < 0.01) difference
in fluorescence between cells treated with BSO and NAC, however not so for untreated and NAC-treated,
or untreated and BSO treated.
Figure 4.4: Results from fluorescence assay for determining GSH concentration. Fluorescence intensities of
all references were plotted against known concentrations of GSH (0 - 0.4 µg ml−1), an origin-intersecting
line of optimum fit was plotted through the reference data points, and mean sample fluorescence was plotted
along the line to calculate GSH concentration within the samples. Included in the plot are p values indicating
statistical significance between the datasets, as measured by the Tukey HSD test. Data composed of three
biological repeats, presented with ± one standard deviation unit, and Tukey HSD test data was also included,
where statistically significant p-values of <0.05, <0.01, <0.001 are indicated by *, **, and ***, respectively.
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The results indicated that treatment with N-acetyl cysteine provided approximately double the con-
centration of GSH to 0.1 µg ml−1 from 0.06 µg ml−1 for untreated cells, and treatment with buthionine
sulfoximine depleted the cells GSH concentration to (0.03 µg ml−1).
4.2.2 Measuring Cell viability of [GSH]-modified HeLa Cells by MTT Assay
In this section, the resulting cell viabilities of HeLa cells that had undergone modulation of intracellular GSH
concentration were assessed. It has been reported that cellular depletion in GSH has been shown to increase
oxidative stress [317, 318, 319], and therefore it was crucially important to study whether our modulation of
HeLa cell GSH concentration had resulted in similar oxidative stress. Cell viabilities were measured by the
2.4 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction assay.
Figure 4.5: MTT of [GSH]-modified HeLa cells treated with GSH precursors (NAC 2.5 mM, H2O, BSO 100
µM, & BSO 500 µM in 90% complete media) for 24 hours before being loaded with MTT precursor dye
for two hours at 37◦C. Absorbance was recorded at 590 nm, and samples were normalised to the negative
control of untreated HeLa cells in complete media. Cells treated with 0.5% Triton X-100 in DMEM were
used as a positive control. Phase contrast microscopy images included for each sample. Data composed of
three biological repeats, presented with ± one standard deviation unit, and Tukey HSD test data was also
included, where statistically significant p-values of <0.05, <0.01, <0.001 are indicated by *, **, and ***,
respectively.
As per the GSH assay, cells were treated with aqueous solutions of [GSH] precursors (NAC 2.5 mM,
H2O, BSO 100 µM, & BSO 500 µM) in 90% complete media for 24 hours at 37
◦C. Cells were subsequently
twice washed with PBS before the assay was performed. The percentage cell viability of HeLa cells treated
143
with [GSH] precursors for 24 hours is shown in Fig. 4.5, along with phase contrast images of the cells
that underwent each treatment. The data series consists of 3 independent duplicates with errors bars
that represent mean values plus/minus one standard deviation unit. For all treatments no statistically
significant difference was observed between cells treated with [GSH]-precursors and the untreated negative
control. Phase contrast images correlate this conclusion by showing very similar confluencies and cellular
morphologies. Contrasted to the positive control, where cells were treated with a mild detergent prior
to treatment with the MTT dye, all [GSH]-precursor treatments showed statistically significant greater
percentage viability (P < 0.01 in all cases), with the phase contrast images of the positive control showing
depleted confluency with remaining cells adopting spherical morphologies characteristic of dying HeLa cells,
indicating no cytotoxic response resulting from [GSH] modification of HeLa cells. It has been reported by
Connor et al.[320] that gold nanoparticles are uptaken by human cells without resulting in acute toxicity, and
work in previous chapters on the cellular uptake of labelled-AuNPs did not reveal a statistically significant
cytotoxic response by gold nanoparticle internalization, at the chosen concentrations and for the chosen
incubation lengths.
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4.2.3 Measuring the uptake of functionalised AuNPs into [GSH]-modified HeLa
Cells by Flow Cytometry
Flow cytometry was used to provide the main indications of labelled-Au100NP uptake into [GSH]-modified
HeLa cells having previously shown that luminescently labelled-Au100NPs provide sensitive measurements
within side scatter and luminescence detection.
Additionally, in order to assess colloidal stability when the labelled-Au100NPs encounter GSH, GSH
was titrated into a stirred solution of labelled-AuNPs whilst monitoring the colloid by UV/Vis absorption
spectroscopy. As outlined previously, gold surface plasmon resonance is an oscilation of gold nanoparticle
surface electrons in response to stimulation by light at their natural frequency. This behaviour manifests
as a large band with a gaussian profile in the colloid’s UV/Vis absorption spectrum. SPR band structure
characteristics such as absorbance, SPR λmax, and Full With at Half Maximum (FWHM) are sensitive to
interparticle distance [85] where upon aggregation, the band broadens, decreases in intensity and undergoes
a large bathrochromic shift, typically on the order of > 20 nm.
Treatment of [GSH]-modified HeLa Cells with pHLIP-Au100-RubpySS
Figure 4.6: Flow cytometry of HeLa cells treated with a precursor (NAC (2.5 mM), H2O control, BSO (100
µM) or BSO (500 µM)) before being treated with pHLIP-Au100-RubpySS (8 pM) for two hours in Tyrodes
buffer (0.08 mM, pH 6.5) at 37◦C. Side scatter and luminescence resultant from irradiation at 488 nm. Data
composed of three biological repeats, presented with ± one standard deviation unit, and Tukey HSD test
data was also included, where statistically significant p-values of <0.05, <0.01, <0.001 are indicated by *,
**, and ***, respectively.
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Fig. 4.6 shows mean % luminescence and side scatter of [GSH]-modified HeLas treated with pHLIP-Au100-
RubpySS (8 pM) in Tyrodes buffer (0.08 mM, pH 6.5) for 2 hours at 37◦C. Cells treated with these particles
did not show a statistically significant difference in luminescent or scattered light signal, as determined using
Tukey HSD and ANOVA (p = 0.79, calculated from luminescence data) tests. As shown in Fig. 8.45 when
GSH is titrated into pHLIP-Au100-RubpySS, the SPR band of the gold nanoparticles decreases its absorbance
in accordance with dilution but the SPR undergoes a small bathochromic shift of 3 nm, characteristic of
surface functionalisation. The SPR band of pHLIP-Au100-RubpySS undergoes a bathochromic shift of 4 nm,
decreases in intensity by 0.06 (31% decrease of SPR absorbance). Small changes in SPR position can be
attributed to surface functionalisation of the gold surface, and not with nanoparticle aggregation. The SPR
band ceases to shift after 2 mM of GSH has been added, which supports this decision and is also consistent
with the small increase in mean colloidal hydrodynamic diameter from 92 ± 30 nm to 134 ± 54 nm upon the
addition of GSH (24 µM) to pHLIP-Au100-RubpySS (Fig. 8.45). The pHLIP peptide is bound to the gold
nanoparticle via a disulphide thiopyridyl unit, a unit likely less susceptible to GSH-mediated reduction.
Treatment of [GSH]-modified HeLa Cells with pHLIPvar3-Au100-RubpySS
Fig. 4.7 shows mean % luminescence and mean % scatter from HeLa cells treated with pHLIPvar3-Au100-
RubpySS (8 pM) for 2 hours in Tyrodes buffer (0.08 mM, pH 6.5) at 37◦C. In this experiment, [GSH] was
shown to significantly affect both mean % cell scatter and mean % cell fluorescence, indicating that particles
were uptaken more quickly into cells with higher intracellular GSH concentration, in a consistent trend across
the four sample treatments. A Tukey HSD test on the luminesence data indicated a statistically significant
difference between samples treated with BSO (100 µM and 500 µM) and samples treated with NAC (p <
0.05). The same analysis on the side scatter data indicated a statistically significant difference between
samples treated with BSO (500 µM) and samples treated with H2O (p < 0.05) and a strong statistically
significant difference between samples treated with BSO (100 µM and 500 µM) and samples treated with NAC
(p < 0.01). An analysis of variance (ANOVA) test provided a p value of 0.013 (calculated from luminescence
data). It is also noteworthy that side scatter offered a more precise measurement, resultant from providing
smaller standard deviations and resultantly a greater degree of statistical significancy between samples (p
< 0.01) than luminescence measurements were able to. Additionally, UV/Vis absorbance measurements of
the pHLIPvar3-Au100-RubpySS indicated a reduction in surface plasmon resonance intensity, and a large
bathochromic shift of 17 nm as a function of increasing GSH concentration (Fig. 8.45). This was corroborated
by DLS measurements that showed significant particle aggregation as a function of GSH addition to the
colloid (Fig. 8.49) where the hydrodynamic diameter of untreated particles increased dramatically upon
the addition of 24 µM of GSH from 95 ± 26 nm to 759 ± 136 nm. Each pHLIPvar3 peptide is bound to
the gold surface by a dative covalent bond from a single thiol group on the peptide’s cysteine residue, this
single thiol that anchors pHLIPvar3 to the gold surface is potentially more susceptible to reduction than the
dithiol-attachment motif of pHLIP.
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Figure 4.7: Flow cytometry of HeLa cells treated with a precursor (NAC (2.5 mM), H2O control, BSO
(100 µM) or BSO (500 µM)) before being treated with pHLIPvar3-Au100-RubpySS (8 pM) for two hours
in Tyrodes buffer (0.08 mM, pH 6.5) at 37◦C. Side scatter and luminescence resultant from irradiation at
488 nm. Data composed of three biological repeats, presented with ± one standard deviation unit, and
Tukey HSD test data was also included, where statistically significant p-values of <0.05, <0.01, <0.001 are
indicated by *, **, and ***, respectively.
Treatment of [GSH]-modified HeLa Cells with Zonyl-Au100-RubpySS
Fig. 4.8 shows % Luminescence and side scatter of [GSH]-modified HeLas treated with Zonyl-Au100-
RubpySS. Cells treated with these particles do not show a statistically significant difference in accumulation
of Zonyl-Au100-RubpySS as a function of GSH concentration, as determined using Tukey HSD and ANOVA (p
= 0.47 calculated from luminescence data) tests. It is interesting to note that direct addition of GSH to Zonyl-
Au100-RubpySS in solution also yielded significant particle aggregation as shown by UV/Vis absorbance (Fig.
8.45) and by dynamic light scattering (Fig. 8.49). Upon a titration of GSH into Zonyl-Au100-RubpySS, the
SPR band of Zonyl-Au100-RubpySS underwent a bathochromic shift of 11 nm and decreased in intensity by
0.11 (52% decrease of SPR absorbance). This large decrease in absorbance, and large bathochromic shift are
strong indicators of nanoparticle aggregation. In addition, dynamic light scattering analysis of nanoparticle
hydrodynamic diameter showed the mean colloidal diameter increased from 92 ± 28 nm to 422 ± 95 nm upon
the addition of 24 µM of GSH. The Zonyl FSA fluorosurfactant contains a hydrophilic methylmethacrylate
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Figure 4.8: Flow cytometry of HeLa cells treated with a precursor (NAC (2.5 mM), H2O control, BSO (100
µM) or BSO (500 µM)) before being treated with Zonyl-Au100-RubpySS (8 pM) for two hours in Tyrodes
buffer (0.08 mM, pH 6.5) at 37◦C. Side scatter and luminescence resultant from irradiation at 488 nm. Data
composed of three biological repeats, presented with ± one standard deviation unit, and Tukey HSD test
data was also included, where statistically significant p-values of <0.05, <0.01, <0.001 are indicated by *,
**, and ***, respectively.
head-group, and a hydrophobic perfluorinated alkyl chain, and it has been shown that it is the methacrylate
head group that binds to the gold nanoparticle surface [96]. It is not yet known whether GSH’s destabilisation
of the Zonyl-Au100-RubpySS colloid is resultant from displacement or charge effects.
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Measuring the uptake of pHLIPvar3-labelled AuNPs into HeLa Cells by Confocal Microscopy
From the treatment of [GSH]-modified HeLa cells with pHLIPvar3-Au100-RubpySS, it was interesting that
higher [GSH] concentration equated to a stronger efficacy of nanoparticle internalization. It was therefore
important to confirm these observations with additional techniques and investigate any differences in intra-
cellular nanoparticle distribution. For this section, confocal microscopy was used to image optical sections
of HeLa cells treated with pHLIPvar3-Au100-RubpySS in order to find evidence of why [GSH] concentration
is affecting nanoparticle uptake efficacy.
Figure 4.9: Confocal microscopy images of HeLa cells treated with a precursor (NAC (2.5 mM), H2O control,
BSO (100 µM) or BSO (500 µM)) before being treated with pHLIPvar3-Au100-RubpySS (1 nM) for 2 hours
at 37◦C, pH 6.5. Cells were fixed in 4% paraformaldehyde in phosphate buffered saline for 10 minutes befre
being treated with ThiolTrackerTM (10 µM for 10 minutes)
Fig. 4.9 shows confocal microscopy images of [GSH]-modified HeLa cells treated with pHLIPvar3-Au100-
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RubpySS (8 pM) for two hours in Tyrodes buffer (0.08 mM, pH 6.5) at 37◦C. A high density of particles can be
seen to have been internalized into each cell sample. As with previously reported confocal images of HeLa cells
treated with pHLIPvar3-Au100-RubpySS, particles appear to be evenly distributed throughout the cell cytosol
while nuclear regions appear to be devoid of particles. Attempts were made to quantify ThiolTrackerTM
intensity, as well as internalized nanoparticle density. ThioltrackerTM intensity was quantified by segmenting
out the cells from the confocal images using the method outlined in Fig. 8.46. This provided a mask of
the cell area, which was used to normalise the total intensity of ThioltrackerTM luminescence from that
image to calculate area-weighted mean intensity values. Area-weighted intensities for each image of each
sample were then normalised to the intensity of cells treated with the water (10% H2O in complete media)
precursor which was set to 100%. Fig. 4.11 shows the area-weighted relative luminescence of [GSH]-modified
HeLa cells as a function of the [GSH]-modifying precursor. These area-weighted intensities indicate that
the ThioltrackerTM luminescence trend across the four samples corroborates with the previously reported
GSH assay, where NAC-treated cells are most luminescent, and BSO (500µM)-treated cells are the least
luminescent. It is also apparent from the confocal images of the ThiolTrackerTM in BSO-treated HeLa cells
that the most significant depletion of GSH occurs in the cytoplasmic regions of the cells, while the nuclear
pools appear to remain more rich in GSH. This is consistent with the observations of Green et al. [315] who
a reported a comparatively greater reduction in GSH from the cytoplasmic region than from the nuclear
region of mouse embryonic fibroblasts.
Figure 4.10: Image analysis procedure for quantifying internalized AuNPs. This example contains images of
HeLa cells treated with a precursor (NAC (2.5 mM), H2O control, BSO (100 µM) or BSO (500 µM)) before
being treated with pHLIPvar3-Au100-RubpySS (1 nM) for 2 hours at 37◦C, pH 6.5. Cells were fixed in 4%
paraformaldehyde in phosphate buffered saline for 10 minutes befre being treated with ThiolTrackerTM (10
µM for 10 minutes). Figure shows segmented GSH Image (A), Raw 488 nm reflection image (B), segmented
488 reflection image (C) and ’Analyse Particles’ function image showing outlined nanoparticles (D).
The method for the quantification of nanoparticle uptake into treated-HeLa cells is documented in Fig.
4.10. For the first stage of segmentation, images of the ThiolTrackerTM distribution were thresholded using
the Otsu method [235] and segmented in a process outlined within Fig. 8.46. providing an estimate of cell
area and boundaries (Image A). This cell area mask was then applied to an image of nanoparticle reflection
signal (Image B) and used to select only nanoparticle signal emanating from within cell regions (Image C).
An outline of this image was then used for quantification (Image D) where results were expressed as the cell
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area that a single nanoparticle occupies in µm2.
Figure 4.11: Mean % signal extracted from confocal microscopy images of HeLa cells treated with a precursor
(NAC (2.5 mM), H2O control, BSO (100 µM) or BSO (500 µM)) before being treated with pHLIPvar3-Au
100-
RubpySS (8 pM) for 2 hours in Tyrode’s buffer (0.08 mM, pH 6.5) at 37◦C. Signals normalised to either the
ThiolTrackerTM intensity, or nanoparticle reflection intensity of cells treated with 10% H2O in DMEM for
24 hours followed by particles. The author would like to note that the intensities for BSO (100 µM)-treated
cells consist of a single measurement, error bars represent ± one standard deviation unit.
Analysis of confocal microscopy images did not yield a statistically significant difference between nanopar-
ticles internalized into HeLa cells as a function of intracellular GSH concentration. The approximate cell
area per single Au100NP for NAC-treated, BSO-treated (100 µM) & BSO-treated (500 µM) was 6.1 ± 0.9
µm2, 6.6 ± 0.6 µm2 & 6.5 ± 1.1 µm2, respectively. Additionally, for each sample, the total intensities of
the reflectance images were normalised to the total cell area for each image, and these values were plotted
alongside ThiolTrackerTM luminescence in Fig. 4.11. Again, this method of relative quantification did not
show statistically significant differences. As within Chapter 3, it is confidently reported that little internal-
ization of labelled-AuNPs into cell nuclei has occurred. And therefore any nucleic areas within the images
effectively skew the quantification as they are devoid of particles. Therefore while these measurements were
performed to gain quantitative information from confocal images where possible, a separate step within the
quantification method where segmented removal of nuclear regions from the cell mask must be performed
to improve the accuracy of the calculation. Although this additional step would improve the calculation
accuracy, it was not pursued in this work as the flow cytometry data already provides a more balanced and
representative analysis of nanoparticle uptake.
Live cell confocal imaging was also performed after a 15 minute treatment of [GSH]-modified HeLa
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cells with pHLIPvar3-Au100-RubpySS. The experiment was designed to show whether a significant uptake
difference could be spatially observed by studying an earlier time point in the treatment, as well as confirming
that particles are internalized before chemical fixation. Fig. 8.48 (appendix) shows live cell microscopy images
of [GSH]-modified HeLa cells treated with pHLIPvar3-Au100-RubpySS (8 pM) in Tyrodes buffer (0.08 mM,
pH 6.5) for 15 minutes at 37◦C, where a significant density of nanoparticles can be seen within cytosolic
regions of all treated cells. A significant difference in AuNP uptake was not observed at these time points,
implying the differential accumulation of particles previously observed is likely resultant from accumulation
over a longer period.
Measuring the uptake of pHLIPvar3-labelled AuNPs by Inductively-Coupled Plasma Mass
Spectrometry
The uptake of pHLIPvar3-Au100-RubpySS was repeated using ICP-MS as the measurement method, a tech-
nique which offers parts per trillion (ppt) sesitivity. In this experiment, pH 6.5 and pH 7.4 were directly
compared, and standard solutions of 0, 50, 100, 250, 500 and 1000 ppb were used to calibrate the instrument
for detection. Fig. 4.12 shows the absolute concentrations of gold detected by ICP-MS resulting from the
uptake of pHLIPvar3-Au100-RubpySS at pH 7.4. The uptake of particles at pH 7.4 shows a dependency on
GSH concentration which appears to correlate with the cytometry-measured uptake of pHLIPvar3-Au100-
RubpySS at pH 6.5. The concentration of gold uptaken by cells treated at pH 6.5 was significantly above the
calibration range of the mass spectrometer, therefore limited conclusions can be drawn from this dataset.
The data is shown in supplementary Fig. 8.50 for reference.
Additionally, a flow cytometry study of the effect GSH imposes on the uptake pHLIPvar3-Au100-RubpySS
at pH 7.4 was also performed. In this experiment, cells were treated with particles (8 pM) in Tyrodes buffer
(0.08 mM, pH 7.4) for two hours at 37◦C, and prepared for flow cytometry using the normal protocol outlined
in the chapter’s experimental section. The % mean scatter & the % mean luminescence are shown in Fig.
8.44 in the appendix of this chapter. In this experiment, no statistically significant difference between the
uptake of pHLIPvar3-Au100-RubpySS was found across the GSH concentration range. However, due to the
higher sensitivity of ICP-MS, it is expected that this technique is able to detect smaller mass changes than
those visible using flow cytometry.
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Figure 4.12: ICP-MS of HeLa cells treated with a precursor (NAC (2.5 mM), H2O control, BSO (100 µM)
or BSO (500 µM)) before being treated with pHLIPvar3-Au100-RubpySS (8 pM) for two hours at 37◦C in
Tyrodes buffer (0.08 mM, pH 7.4).
4.3 Conclusions
A protocol was developed to prepare HeLa Cervical Adenocarcinoma cells with elevated or depleted concen-
trations of glutathione, and adjustment of intracellular GSH concentration was confirmed to be successful
by GSH assay. It was then established that the treatment of HeLa cells with [GSH]-precursors did not yield
a statistically significant effect on mitochondrial activity, and therefore cell viability, consistently with Green
et al. [315]
The uptake of pHLIP-Au100-RubpySS and Zonyl-Au100-RubpySS into [GSH]-modified HeLa cells was
not modulated by intracellular GSH concentration, as measured by Fluorescence-Activated Cell Sorting.
However, pHLIPvar3-Au100-RubpySS uptake into [GSH]-modified HeLa cells was more efficient when intra-
cellular GSH concentration was greater, and results suggest that the effects of modifying GSH concentration
and treatment pH may be additive, but this has yet to be proven. Zonyl-Au100-RubpySS particles provided
a control to measure the uptake of a non-thiol bound assembly, and GSH appeared to have no effect on
particle uptake as expected.
The addition of GSH to pHLIPvar3-Au100-RubpySS, pHLIP-Au100-RubpySS and Zonyl-Au100-RubpySS
during the addition of glutathione, induces aggregation within pHLIPvar3-Au100-RubpySS & Zonyl-Au100-
RubpySS particles, but has little effect on the stability of pHLIP-Au100-RubpySS particles.
Initial results suggest that both pHLIPvar3’s pH-dependent delivery mechanism and GSH’s ability to
destabilise the colloid is imposing an effect on the efficiency of nanoparticle internalization. This has raised
questions over whether GSH cleaves pHLIPvar3 from the surface of the gold, and how doing so improves the
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uptake efficiency of pHLIPvar3-Au100-RubpySS.
4.4 Future Work
An important addition of this work would be to re-measure the uptake of pHLIPvar3-Au100-RubpySS into
[GSH]-modified HeLas by ICP-MS. If the GSH concentration is imposing an effect on nanoparticle inter-
nalization that is co-dependent on pHLIP’s pH-dependent delivery mechanism, then this would likely be
reflected by a significant increase in GSH-concentration-dependent gold concentration of cells treated at pH
6.5. Furthermore, it is important to elucidate why GSH imposes such an effect and whether GSH is respon-
sible for cleaving pHLIPvar3 from the gold surfaces. One method to investigate this, would be to analyse
the supernatant of centrifuged labelled-AuNPs pretreated with GSH by mass spectrometry.
4.5 Experimental
The HeLa human cervical adenocarcinoma cell line were maintained at 37◦C in a humidified, 5% CO2
atmosphere in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% foetal bovine serum,
2 mM L-glutamine, 100 units/ml penicillin and 0.4 mg/ml streptomycin. Cells were routinely cultured in
755cm2 flasks and passaged using a standard Trypsin-EDTA protocol. For treatments, 5x104 and 1x105
cells were plated into 12-well and 6-well culture plates, respectively, and permitted to adhere and proliferate
for 24 hours prior to any treatment.
4.5.1 Modifying [GSH] of cultured HeLa cells
To prepare [GSH]-modified HeLas, aqueous stock solutions of N-Acetyl cysteine (25 mM) and Buthionine
Sulfoxide (5 mM) wee prepared and sterlised by injection through 0.22 µm sterilised filters. Plated HeLa
cells were then treated with [GSH]-modifying precursors N-Acetyl cysteine (2.5 mM in 90% complete me-
dia), Buthionine Sulfoxide (100µM in 90% complete media), Buthionine Sulfoxide (500µM in 90% complete
media), and H2O in 90% complete media (negative control) for 24 hours. After the treatment, media was
removed and cells were washed twice with PBS before being subjected to the relevant experiment. Addition-
ally, cells treated with these precursors are throughout this thesis, collectively referred to as [GSH]-modified
HeLas.
4.5.2 Measuring [GSH] of cultured HeLa cells by fluorimetric assay
For quantitative measurement of GSH concentration the method of [297] was used without modification.
Sample preparation
Briefly, the following solutions were prepared.
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• Cell lysis buffer: 0.1 % Triton X-100 in PO4-EDTA assay buffer
• Protein precipitation buffer: 50 % Trichloroacetic Acid in PO4-EDTA assay buffer
• PO4-EDTA assay buffer: 100 mM NaH2 PO4, 5 mM Na2EDTA. Adjusted to pH 8
• o-Phthalaldehyde (OPT): 1 mg/ml in 100 % Methanol
• GSH: 0.1 mg/ml in PO4-EDTA assay buffer
For sample preparation, cells were cultured, and treated with [GSH]-precursors in 12-well plates. Medium
was removed and cells were washed with PBS (1 mL). Ice cold cell lysis buffer was added (450 µL), cells were
scraped and lysate was transferred to an eppendorf. Ice cold protein precipitation buffer was then added and
cells were centrifuged (13,000 rpm, 5 minutes). The supernatant was then transferred to a fresh eppendorf.
OPT solution (1800 µL) was added to sample and reference cuvettes, standard concentrations of GSH [0,
0.05, 0.1, 0.2, 0.3, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 µg mL−1] were added to reference cuvettes, and
aliquots of sample supernatant (100 µL) were added to all sample cuvettes. TCA (100 µL) was added to all
reference cuvettes, and OPT (100 µL) was then added to all cuvettes. All samples and calibration cuvettes
were then covered and shaken for 15 minutes prior to acquisition.
Sample Analysis
For the [GSH] calibration curve, the 12 standard concentrations of GSH were used to calibrate the measure-
ment. Fluorescence was subsequently recorded via λexcitation at 350 nm, and λemission at 420 nm.
4.5.3 Analysing Cell Viability of [GSH]-modified HeLa cells
After treatment of HeLa cells with [GSH] precursors, the media from each well was withdrawn and cells
were washed with PBS (500 µl) and replaced with 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (0.5 mg/ml) in complete media (90% by volume), and were reincubated at 37◦C for 2 hours. After
the incubation, media was removed and DMSO (500 µl) was added to solubilise the formazan product. The
plate was rocked for 15 minutes in the dark before the absorption at 590 nm was recorded against a DMSO
blank.
4.5.4 Preparation of cells for Flow Cytometry
After treatment of [GSH]-modified HeLa cells with nanoparticles was complete, the supernatant from each
well was removed and each well was washed with PBS (0.1 M, 0.5 ml) twice before being trypsinised at 37◦C
for 10 minutes. Particles were then spun down at 20,000 rpm for 10 minutes, the supernatant removed, and
redispersed in of PBS (0.1 M, 1 mL). Cell suspension was transferred to a FACS tube before analysis.
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4.5.5 Preparation of cells for Confocal Microscopy
Preparation for Fixed Cell Imaging
Prior to cell seeding, 22 mm glass coverslips were sterilised using absolute ethanol (rinsed and left to dry)
and placed into the wells of 6-well culture plates. Cells were then seeded into 6-well culture plates on top of
glass coverslips and allowed to grow to confluency for 24 hours. After treatment, medium was removed and
cells were washed with PBS (2 ml x 2) and then paraformaldehyde (4% in 0.1M PBS, 2 ml) was added and
cells were left for 10 minutes at room temperature. Fixative was removed and cells were washed with PBS
(2 ml x 2). Cells were then mounted onto glass microscope slides, using a drop of Hydromount to maintain
sample hydration, before sealing the slide with nail varnish. Slides were left to dry at 4◦C and were imaged
within a few days.
Preparation for Live Cell Imaging
For live cell imaging, cells were initially seeded into 3 mL volume Mat Tek glass bottom dishes, and left to
grow to confluency for 24 hours. After treatment, medium was removed and cells were washed with PBS (2
ml x 2) and then PBS (2 ml) was added before transferring samples to the microscope for imaging.
4.5.6 Preparation of cells for Inductively Coupled Plasma - Mass Spectrometry
HeLa cells were cultured as per above and treated as per the relevant experiment. After treatment was
complete, the supernatant from each well was removed and each well was washed with PBS (0.5 ml x 2)
before being trypsinised at 37◦C for 10 minutes. Particles were then spun down at 20,000 rpm for 10
minutes, the supernatant completely removed taking care not to disturb the cell pellet, before being allowed
to dissolve overnight in 200 µl of ultrapure aqua regia (3:1 volumetric ratio of hydrochloric and nitric acid).
Post dissolution, samples were diluted in ultrapure nitric acid (2700 µL of a 4% solution) prior to analysis.
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Chapter 5
Lipid-coated AuNPs, co-labelled with
a Luminescent Europium Complex
5.1 Introduction
The aim of this work is to examine whether modifying the hydrophobicity of gold nanoparticles by coating the
particle surface with a simple lipid molecule results in a more favourable interaction with plasma membranes
and thereby improve the efficiency of their internalization into cancer cells. We wanted the design of the
probe to enable multimodal detection, so we synthesised gold nanoparticle scaffolds co-labelled with a lipid
and a luminescent substrate. Tetradecanoic acid (Myristic acid) was chosen to be the lipid surfactant, and a
luminescent europium complex was identified as a suitable compatible co-label owing to its neutral charge.
Herein, a review of lanthanide based luminescent probes and their partnership with gold nanoparticles, along
with synthesis of these multimodal probes, their characterisation and investigations into their uptake and
interactions with human cervical adenocarcinoma cells is reported.
5.1.1 Lumophores based on Lanthanide Complexes
Lanthanide elements are a chemically and spectroscopically unique series of the periodic table of elements, and
despite being referred to as ’rare earth elements’, many are enormously abundant such as the Y2O3 phosphor
which maintains heavy use within cathode ray tubes [321]. Lanthanide complexes offer luminescent properties
that scale the visible and near infrared spectrums, and their complexes are often facile to synthesise, often
with the stepwise addition of ligands.
Lanthanide ions possess the electronic configuration [Xe] 4f n were n is the number of electrons (0 – 14)
in the ion’s valence 4f orbitals. Across the lanthanide series there is little variation in chemical properties
as electrons within the (4f ) valence orbitals are shielded by electrons in the 5s2 5p6 sub-shells, however
the oxidation states available to lanthanide ions across the series varies from Ln2+ to Ln4+, depending on
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the element. All lanthanides have access to a trivalent Ln3+ state, the charge state that offers the most
favourable compromise between ionisation energy and lattice energy stabilisation of the lanthanide cation
[322]. Some lanthanides do have access to additional oxidation states, for instance Ln2+ oxidation states
(e.g. Sm2+ & Eu2+), or to Ln4+ oxidation states (e.g. Tb4+, Ce4+ & Dy4+). However, with the exception of
Ce4+, all other the Ln4+ oxidation state is only found in the solid state, and not accessible in solution [323].
It has been widely recognised that F electrons within lanthanides aren’t involved in bonding as their orbitals
endure far greater contraction than the valence S and D orbitals [324], additionally it has been demonstrated
through DFT calculations that f orbitals are non-participant in Ln-ligand bonding [325]. Additionally, F
electrons also exhibit poor shielding effects over other electrons, resulting in a contraction of lanthanide ionic
radii across the series through an increase in effective nuclear charge across the series. The coordination
numbers available to lanthanides ranges from 3 – 12, although 8 – 9 is most common. Lanthanides can also
be described as hard bases, due to the predominantly ionic nature of their bonding and that their preference
to bonding with hard donors such as oxygen and nitrogen.
Lanthanide luminescence is dependent on how efficiently the lanthanide’s excited state can be populated,
as well as how effectively quenching mechanisms are minimised [326]. Lanthanides are poor absorbers of light
(typical molar extinction coefficients of 1 - 10 M1 cm−1) resulting from restrictions of f −→ f transitions.
These transitions are governed by the Laporte selection rule which states that an allowed transition requires
a change in parity between transition orbitals, and the spin selection rule which states that in an emission
process, the transitioning electron must not change its spin state in order for the transition to be permitted.
To circumvent this problem of poor absorptivity, sensitizer groups are typically complexed to the lanthanide
ion, resulting in the lanthanide’s excited state being indirectly populated by transfer of energy absorbed by
the sensitizer groups to the lanthanide centre. These sensitizer groups can be bespokely designed for desired
molar excinction coefficients and chemical functionality. Once the lanthanide excited state is populated,
the excited electrons return to their ground state by spin-forbidden radiative transitions, which are weakly
allowed by vibronic coupling. This weak vibronic coupling results in a characteristic sharp band emission
spectrum across the lanthanide series. Additionally, due to the spin forbidden nature of the radiative
transitions, the process operates on a timescale far longer than organic fluorescence, where typical organic
luminescence lifetimes exist on the order of nanoseconds and lanthanide luminescence lifetimes (τ) exist on
the order of milliseconds [327, 328, 329].
5.1.2 Lanthanide Complexes as Biological Lumophores
Luminescent lumophores based on lanthanide complexes have been gaining increased use within biomedical
imaging [41]. Their millisecond luminescence lifetimes enable applications in time-resolved studies [330],
sharp band emission enables facile multiplexing and large Stokes shifts (typically < 100 nm) enable facile
separation between illumination light and emission signal. Lanthanide complexes have been used very suc-
cessfully in probing cellular pH, where typically the luminescence of the probe is modulated by protona-
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tion/deprotonation of a pH sensitive ligand [331, 332, 333, 334, 335] as well as other sensing applications
including anion detection [336, 337], metal ion detection [338, 339, 340], reactive oxygen species detection
[341, 342, 343] along with detection of amino acids & proteins [344, 345, 346].
Despite a rather attractive series of attributes, lanthanides typically suffer from relatively poor lumi-
nescence quantum yields, and there are four factors that affect a lanthanide’s quantum yield. Firstly, the
energy difference of the lanthanide’s lowest excited state and its ground multiplet state, of which Eu3+ has
one of the highest quantum yields of the lanthanide series due to the appropriate energies [326]. Secondly,
the relative energies of the sensitising unit’s excited state and the 5D excited state of the lanthanide ion.
Thirdly, the energy transfer efficiency between the sensitising unit and the lanthanide which occupies a
distance dependence the two constituents. And fourth, the quenching effect of coordinated water molecules
due to the overlap of the O — H vibration with lanthanide luminescence [347].
One of the largest drawbacks of lanthanide lumophores is the requirement of ultraviolet illumination to
excite the sensitizer groups, causing significant photo damage to biological structures. However, the appli-
cation of lanthanide-based materials within upconverting phosphors has been studied extensively [348, 349,
350, 351, 352]. There are a number of processes that result in upconversion such as Excited State Absorp-
tion (ESA), where multiple infrared photons are absorbed sequentially, or Energy Transfer Upconversion
(ETU) where an excited ion transfers energy to a neighbouring excited ion. This is a particularly attractive
modification of lanthanide-based imaging probes as physiologically damaging ultraviolet excitation would
no longer be required. Additionally, Wang et al. [353] recently developed upconverting lanthanide doped
nanoparticles, and demonstrated how tuning the host and dopant concentrations offered significant emission
changes despite single wavelength excitation.
5.1.3 Gold nanoparticles labelled with Lanthanide Lumophores as Cell Imaging
Probes
The labelling of gold nanoparticles with lanthanide complexes has been receiving increased attention over
the last decade as gold nanoparticles provide a useful platform to construct nanosized materials that bear
the unique luminescent signature of a lanthanide complex. The topic was recently reviewed by Lewis et al.
[42]. The surface labelling of gold nanoparticles with surface-bound organic fluorophores was first published
by Thomas & Kamat in 2000 [75, 74] and subsequent works demonstrating the coating of gold nanoparticles
with surface bound luminescent metal complexes were published some years later [94, 162, 95]. Lewis et
al. were the to first report the labelling gold nanoparticles with a luminescent lanthanide complex based
on a europium complex with a diethylene triamine pentaacetic acid (DTPA) ligand shell [94]. The DTPA
ligand was functionalised with phenylamide groups to sensitise lanthanide luminescence, and thiol units that
bind to soft metal surfaces. Davies et al. [139] later developed pH-sensitive nanoparticles synthesised by co-
labelling 13 nm gold nanoparticles with the pH Low Insertion peptide and a luminescent europium complex
with DTPA-bisamide ligands and quinoline sensitizers. Davies then demonstrated luminescence imaging
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of pH-mediated delivery of the nanoparticles into platelets using europium luminescence for visualisation.
Massue et al. [354] reported the labelling of gold nanoparticles with a heptadendate macrocyclic Eu(III)
cyclen conjugate that permitted the sensing of flavin monophosphate using a displacement mechanism that
switched-on Eu luminescence. Runowski et al. [355] reported the deposition of gold onto lanthanide clusters
(Eu3+ & Tb3+), forming core/shell type nanoparticles that exhibited strong luminescence in the red for
europium-doped, and green for terbium-doped. Aditionally, the gold surfaces were labelled with Surface
Enhanced Raman Spectroscopy (SERS) probes, and their raman signal was enhanced by the presence of
the gold surface by a factor of 105. Zhang et al. [356] demonstrated that the emission of upconverting
lanthanide doped nanoparticles was enhanced by plasmonic interactions from gold nanoparticles coupled to
the lanthanide nanoparticle surface.
5.1.4 Lipid-coated gold nanoparticles for cell delivery applications
Lipid-coating of gold nanoparticle surfaces in order to promote cell internalization, or to facilitate cell imaging
techniques has been reviewed quite extensively [73]. Li et al reported lipid-coated AuNP-mediated delivery
of plasmid DNA into Hek 293 cells, in a transfection method that offered 5 times better efficiency than by
lipid-only transfection [357]. The transfection of DNA-cationic lipid complexes was found to be relatively
inefficient, owing to the limited stability of the complexes [358, 359], however their stability was found to
increase markedly when both are co-labelled onto gold nanoparticles [360]. Additionally, for HEK 293 T cells
cells dosed with lipid-coated nanoparticles, a secondary treatment with nocodazole (NCZ) resulted in more
substantial dispersion of nanoparicles within cytoplasm rather than being confined to endosomes. Recently
reported was lipid-gold nanoparticle structure designed by Thaxton et al. [361] to be an analogue of the
high density lipoprotein (HDL) in order to measure the binding constant between HDL and cholesterol. In
addition, these HDL-AuNPs have been used to provide an indication of atherosclerosis by measuring the
build up of lipid-AuNPs within the aortas of mice held on high cholesterol diets [362]. Fig. 5.1 shows schemes
for a number of publications referenced in this work.
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Figure 5.1: Schemes illustrating a number of chosen publications referenced in this chapter.
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5.1.5 Myristic Acid
Myristic acid is a small lipid (Fig. 5.2) that has shown promise as a cellular targeting vector as its membrane
binding is not dependent on surface receptor recognition [363, 364]. The lipid is a saturated fatty acid
with a 14-carbon backbone, a methacrylate head group with a pka of 4.90 [365]. Cardo et al. recently
reported the delivery of the filamentous actin-binding peptide Lifeact to human platelets by conjugation to
myristic acid via a cleavable disulfide linker [366]. In this work, the efficiency of pH Low Insertion Peptide
(pHLIP), Trans-activating Transcriptional Activator (TAT) peptide and myristic acid as carriers for the
Lifeact peptide, filamentous actin-binding peptide, for which platelet membranes are impermeable. They
reported that myristoylation of the Lifeact peptide resulted in a higher loading efficiency, where the final
loaded concentration was more sensitive to the original treatment concentration than for pHLIP-conjugated
Lifeact. These results suggest that modification of cargo with a simple lipid can offer a substantial effect on
the efficiency of cell uptake.
Figure 5.2: Structural formula of myristic acid
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5.2 Results and Discussion
This section is divided into a series of subsections. i) the preparation of luminescent lipid-coated gold
nanoparticles, ii) the assessment of colloidal structure and photophysical properties of the labelled nanopar-
ticles, iii) the assessment of labelled-AuNP uptake into HeLa cervical adenocarcinoma cells by light mi-
croscopy and inductively coupled plasma mass spectrometry, and iv) cell viability studies analysing the
effect of cell treatment using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
reduction assay.
5.2.1 Preparation of EuL
EuL was prepared by Johnathan Lilley in accordance with the synthetic protocol of Davies et al. [139] and
was characterised by 1H & 13C NMR.
Figure 5.3: Steady state absorption and luminescence spectra of EuL. For excitation scans, the instrument’s
emission monochromator was set to 614 nm, and for emission scans, the excitation monochromator was set
to 360 nm. Long pass filters were used to prevent detection of scattered light.
Fig. 5.3 shows the structural formula of luminescent complex, EuL, along with the complexes’ steady state
absorption and luminescence spectra in 10% MeOH in H2O. The complex is equipped with quinoline units to
transfer energy to the europium luminescence state, and terminal thiol units for binding to soft metals. The
absorption band at 340 nm is attributed to the quinoline sensitizer unit. The emission spectrum shows the
characteristic europium sharp band emission with bands at 590, 614, 555 and 690 nm representing the 5D0
−→ 7FJ transitions, where J = 0, 1, 2, & 3, respectively. The sharp band emission of the europium emission
is resultant from weak vibronic coupling, resulting in electronic transitions that occur without significant
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geometric rearrangement of the molecule. Additionally, the band at 340 nm within both the excitation
and absorption spectrum confirms that the quinoline unit is responsible for populating the europium 5D0
excited state. Originally, efforts were made to co-label gold nanoparticles with myristate & ruthenium
complex, RubpySS. However, labelling Myr-AuNPs with RubpySS always resulted in particle flocculation as
myristate was unable to stabilise the particles whilst the RubpySS complex, with its 2+ charge, bound to
the surface. EuL has a neutral charge, enabling more facile nanoparticle labelling where negatively changed
nanoparticles do not flocculate from charge imbalances.
5.2.2 Preparation of Luminescent, Lipid-coated Gold Nanoparticles
Luminescent lipid-coated gold nanoparticles were prepared by subjecting Au13NPs & Au100NPs to a two-
step coating process illustrated in Fig. 5.4. Particles were initially coated with myristic acid, and then
subsequently coated with luminescent complex, EuL. The coating process was monitored using UV/Vis
absorption spectroscopy.
Figure 5.4: Schematic for the process of labelling AuNPs with Myristic acid & EuL.
164
Fig. 5.5 shows UV/Vis absorption spectra of Au13NPs being sequentially labelled with myristic acid
& EuL. Addition of both substrates was performed as sequential titrations, where particles were initially
labelled with myristic acid, and a UV/Vis absorbance spectrum was acquired inbetween additions. The SPR
band of the gold nanoparticles was monitored during the course of the titration, as the SPR band is sensitive
to morphology [82], core charge [83], solvent refractive index [84], inter-particle distance [85] and surface
functionalization [86]. SPR λmax is a useful indicator of gold nanoparticle surface functionalisation [94, 139,
96] and titration of both substrates into gold nanoparticles was iterated until SPR λmax changes began to
plateau, indicating that no further surface changes were occurring.
Figure 5.5: UV/Vis absorption documenting the labelling of Au13NPs (4.8 nM, 1.5 ml) with Myristic acid
(26 µM), and EuL (2.5 µM). Inset, change in SPR λmax; Absorbance, and FWHM for Myristic acid binding
to gold (A) and EuL binding to myristic acid-labelled AuNPs (B).
Citrate-stabilised, 13 nm diameter gold nanoparticles (Au13NPs, 4.8 nM, 1.5 mL) were stirred rapidly
in a cuvette using a microstirrer bead. Myristic acid (1 mM in 10% MeOH in H2O) was titrated into the
colloidal solution, and UV/Vis absorption spectra were taken in-between each addition (Fig. 5.5, inset A).
During the titration of Myristic acid, the SPR λmax underwent a bathochromic shift of 2.5 nm, and an
intensity increase consistent with previous reports of SPRλmax change upon the binding of methacrylate
groups to gold nanoparticle surfaces [96, 166]. The SPRλmax plateaued at 522 nm after 26 µM of myristic
acid had been titrated, indicating that no additional surface binding was taking place.
After the coating of Au13NPs with myristic acid, particles were left to stir for 10 minutes before a
solution of EuL (1 mg ml−1 in 10% methanol in H2O) was titrated into the solution, while still under
rapid stir. Addition of EuL (2.5 µM) to Myr-Au13 resulted in an increase in SPR absorbance and an
SPRλmax bathochromic shift of 2.5 nm (Fig. 5.5, inset B), consistent with reports of thiol binding to gold
nanoparticles [86, 180]. Additionally, previous work in the group has shown that MeOH imposes no effect on
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gold nanoparticle SPR bands [94]. Particles were then stirred for an additional 10 minutes before purification.
To purify the particles, unbound substrates were removed by passing the particles through sephadex G-15
size exclusion resin using water as the eluent. Particles were a deep red in colour, and were easily visible as
they eluted rapidly off the gel.
Figure 5.6: UV/Vis absorption monitoring the labelling of Au100NPs (40 pM, 1.5 ml) with Myristic acid (13
µM), and EuL(1.25 µM).
The co-labelling of Au100NPs was also performed by a sequential addition, monitored by UV/Vis absorp-
tion spectroscopy as shown in Fig. 5.6. Au100NPs (40 pM, 1.5ml) were stirred such that a rapid vortex was
present within the cuvette, and myristic acid (13 µM) was added to the colloid and left for 10 minutes. The
Gold SPRλmax underwent a small bathochromic shift of 1 nm and a reduction in insensity. EuL was then
added to the colloid under rapid stir, and addition of 1.25 µM induced a further small bathchromic shift of
1 nm and further reduction in SPR band intensity. Particles were again purified using sephadex G-15 size
exclusion resin using water as the eluent, where the brown colloid rapidly eluted off the gel.
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5.2.3 Photophysical Characterisation of Luminescent, Lipid-coated Gold Nanopar-
ticles
In order to investigate the suitability of Myr-Au13&100-EuL as luminescence agents, their steady state lu-
minescence was probed using luminescence spectroscopy. Excitation spectra were acquired by setting the
emission monochromator to 614 nm, scanning the excitation monochromator from 250 nm to 400 nm and
using a 590 nm long pass filter out scattered light. This scan indicated that the quinoline group is responsible
for the population of the Eu3+ luminescence state 5D0. Emission scans were taken by setting the excitation
monochromator to 340 nm, scanning the emission monochromator from 580 nm to 720 nm, using a 475 nm
long pass filter. This scan provided the sharp emission band structure characteristic of lanthanide f −→ f
radiative transitions, with the strongest emission band at 614 nm.
Fig. 5.7 shows the absorption, excitation and emission spectra of Myr-Au13-EuL. The characteristic
sharp emission band of europium can be seen within the emission spectrum (absorbance at 340 nm = 1.2
absorbance units), with emission bands at 590, 614, 655 and 690 nm representing the 5D0 −→ 7FJ transition
(where J = 0, 1, 2, 3). The excitation spectrum shows a band at 340 nm which overlaps with the quinoline
absorption band (Fig. 5.3) showing that Eu luminescence at 614 nm is resultant from quinoline excitation,
and a scatter peak at 300 nm. In addition, the absorption spectrum of Myr-Au13-EuL shows the surface
plasmon resonance band at 524 nm.
Figure 5.7: Steady state absorption and luminescence spectra of Myr-Au13-EuL. For excitation scans, the
instrument’s emission monochromator was set to 614 nm, and for emission scans, the excitation monochro-
mator was set to 360 nm. Long pass filters were used to prevent detection of scattered light.
Fig. 5.8 shows the absorption, excitation and emission spectra of Myr-Au100-EuL. Again, the easily
recognisable europium sharp band emission spectrum is present (absorbance at 340 nm = 1.1 absorbance
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units). The bands visible within the emission spectrum lie at 590, 614, 650 (very weak) and 690 nm, indicating
that any plasmon effects on EuL steady state luminescence are minimal. The UV/Vis absorption spectrum
shows the gold nanoparticle SPR band at 560 nm, and the excitation spectrum shows that quinoline is again
responsible for populating the europium 5D0 excited state.
Figure 5.8: Steady state absorption and luminescence spectra of Myr-Au100-EuL. For excitation scans, the
instrument’s emission monochromator was set to 614 nm, and for emission scans, the excitation monochro-
mator was set to 360 nm. Long pass filters were used to prevent detection of scattered light.
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5.2.4 Structural Characterisation of Luminescent, Lipid-coated Gold Nanopar-
ticles
Transmission electron microscopy was used to study labelled nanoparticle size as well as the effect of la-
belling on nanoparticle dispersity, as the labelling process involves the displacement of citrate ions that
initially provide stabilisation to the colloid, for myristic acid and EuL. For this experiment, freshly prepared
Myr-Au13-EuL nanoparticles were dried onto copper grids and imaged immediately. Fig. 5.9 shows TEM
micrographs of Myr-Au13-EuL, indicating monodisperse spherical particles of diameters between 10 - 20 nm,
indicating that labelling of Au13NPs with myristic acid & EuL did not induce nanoparticle flocculation.
Figure 5.9: Transmission electron micrographs of Myristic-Au13-EuL colloid, dried onto copper grids. Images
taken at 120,000x magnification (left) and 300,000x magnification (right).
To establish whether the secondary labelling of myristate-labelled gold nanoparticles with EuL displaced
the myristate from the gold surface, Myr-Au100-EuL and Au100-EuL were studied using dynamic light
scattering. Fig. 5.10 shows number-weighted hydrodynamic diameters of Myr-Au100-EuL and Au100-EuL
(both 8 pM in H2O) measured by DLS. The average diameters (from 3 technical repeats) for Myr-Au
100-EuL
and Au100-EuL were 82 ± 25 nm and 68 ± 26 nm, respectively. The significantly larger average diameter for
the Myr-Au100-EuL indicates that particles are moving slower in solution, strong evidence that the particles
myristate coating is still substantially intact, and that EuL is not significantly displacing the myristate from
the surface of the gold.
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Figure 5.10: Number-weighted distribution of Myristic-Au13-EuL (4 pM) hydrodynamic diameters as mea-
sured by dynamic light scattering.
5.2.5 internalization of Luminescent, Lipid-coated Gold Nanoparticles by HeLa
Cervical Adenocarcinoma Cells
To study the uptake of Myr-Au13-EuL into cancer cells, an in vitro cell treatment experiment was performed
and treated cells were imaged by epifluorescence microscopy. For this experiment, the HeLa cervical ade-
nocarcinoma cell line was cultured in 6-well plates on top of glass coverslips. Cells were permitted to grow
and proliferate for 24 hours post seeding, and then treated with Myr-Au13-EuL (1 nM in complete media)
for 6 hours at 37◦C. After the treatment time was concluded, cells were washed with PBS, fixed using 4%
paraformaldehyde and mounted onto glass coverslips for imaging.
To image Myr-Au13-EuL uptake, brightfield and luminescence modes were used. Brightfield images were
acquired using an arc lamp excitation while luminescence imaging was performed using λex = 340 nm, a 510
nm dichroic mirror to prevent acquisition of rayleigh scattered light. Additionally, a luminescence spectrum
of treated cells was acquired (λex = 340 nm, λem = 600 - 630 nm) to investigate whether treated cells bear
the luminescent signature of europium.
Fig. 5.11 shows epifluorescence images of HeLa cervical adenocarcinoma cells treated with Myr-Au13-
EuL. Brightfield images indicate cells are adopting a spread morphology, consistent with viable HeLa cells.
Luminescence images show strong red luminescence from treated cells, although it is not clear how much
of the signal arises from autofluorescence. An emission spectrum was taken of the treated cells (λex = 340
nm, λem = 600 - 630 nm) which showed the europium
5D0 −→ 7F2 emission band indicating the presence
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Figure 5.11: Epifluorescence images of HeLa cells treated with Myristic-Au13-EuL (1 nM) in complete media
for 4 hours at 37◦C. From left to right, i) transmission image; ii) Epifluorescence image using 360 nm
excitation; iii) overlay of transmission image and epifuorescence image; and iv) steady state emission of
treated HeLa cells showing 614 nm sharp europium emission band.
of europium signal within the luminescence images.
To study the effect of the myristic acid surface labelling on the internalization of gold nanoparticles, HeLa
cells were treated with Myr-Au13-EuL & an Au13-EuL control and the concentration of gold internalized
by treated cells was measured using Inductively Coupled Plasma Mass Spectrometry (ICP-MS). The gold
concentrations of cells treated with Myr-Au13-EuL & Au13-EuL were 17.6 ± 0.75 ppb and 8.2 ± 7.6 ppb, re-
spectively (3 biological repeats were performed, signal from untreated cells was subtracted and measurements
in absence of Helium sheath gas are reported).
HeLa cells were then cultured to investigate the uptake of Myr-Au100-EuL. In this experiment, an Au100-
EuL control sample was prepared, cells were treated for 6 hours (with 8 pM of nanoarticles in complete
media) and imaged live by confocal reflection microscopy, where gold nanoparticles offer strong contrast
owing to the efficiency that their electron-rich cores scatter incident light (Fig. 5.12).
Images of cells treated with Myr-Au100-EuL or Au100-EuL both show cells with internalized AuNPs,
with particles appear to be localised within cytoplasmic regions of the cells, and nuclear regions devoid of
particles. Additionally, cells treated with Myr-Au100-EuL show a higher density of internalized gold than
samples treated with Au100-EuL, consistent with ICP-MS measurements Myr-Au13-EuL & Au13-EuL that
showed a higher concentration of gold within cells treated with Myr-Au13-EuL.
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Figure 5.12: Live cell confocal microscopy images of HeLa cells treated with Myristic-Au100-EuL (8 pM) in
complete media for 6 hours at 37◦C. Transmission images taken at 488 nm, reflection images taken at 633
nm.
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5.2.6 Viability of HeLa Cells treated with Luminescent, Lipid-coated Gold
Nanoparticles by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT) reduction assay
In order to assess the effect of nanoparticle treatment on cell viability, the MTT reduction assay was employed
to assess cell mitochondrial function, an indicator of cell viability. For this experiment, HeLa cervical
adenocarcinoma cells were seeded into a 24-well plate, and allowed to adhere and proliferate for 24 hours.
Cells were then treated with particles (1 nM for Au13 samples & 8 pM for Au100 samples) in complete media
for 6 hours at 37◦C. After the treatment, media was removed and cells were washed with PBS. Cells were
then treated with the MTT dye in complete media and returned to incubation for an additional 2 hours at
37◦C.
After the MTT treatment was complete, the formazan product in each well was solubilised using DMSO
and the well plate was rocked for 20 minutes prior to acquisition. The absorbance of each well was recorded
at 590 nm, three biological repeats was performed for each sample, and a negative control (untreated cells),
a water control (cells treated with 10% water in complete media) and a positive control (cells treated with
triton X-100 detergent for 1 hour prior to MTT treatment). The absorbances of all samples were averaged
and expressed as a % of negative control absorption, and are shown in Fig. 5.13 along with phase contrast
images of all samples at the end of the particle treatment.
Absorption measurements were analysed by a one way analysis of variance (ANOVA) along with Tukey
HSD tests to study the statistical relationship between sample sets. All samples showed a strong statistically
significant difference with the positive control (p < 0.01) however none showed a statistically significant
difference with any other treated sample or negative control. The water control did not appear to exhibit an
effect on cell viability, despite initial expectations that a dilution of complete media would impose a positive
response. Additionally, analysis of absorption measurements from treated cells, the water control and the
negative control by a one-way anova resulted in a p value of 0.68, indicating no significant changes in sample
variance across the dataset.
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Figure 5.13: MTT of HeLa cells treated with Myristic-Au13-EuL (1 nM) and Myristic-Au100-EuL (8 pM)
in complete media for 6 hours at 37◦C. Also included are cells treated with water to examine the effect of
media dilution on cell viability. Absorbance was recorded at 590 nm, and samples were normalised to the
negative control of untreated HeLa cells in complete media. Cells treated with 0.5% Triton X-100 in DMEM
were used as a positive control. Data composed of three biological repeats, presented with ± one standard
deviation unit, and Tukey HSD test data was also included, where statistically significant p-values of <0.05,
<0.01, <0.001 are indicated by *, **, and ***, respectively.
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5.3 Conclusions
In summary, 13 nm and 100 nm diameter gold nanoparticles were synthesised and co-labelled with a lipid and
luminescent europium complex. Labelled particles were structurally characterised by dynamic light scattering
and transmission electron microscopy as monodisperse spherical particles. The steady state photophysical
properties of the labelled particles was then assessed by luminescence spectroscopy demonstrating successful
synthesis of luminescent nanoparticles bearing the Eu3+ luminescent signature. Both Myr-Au13-EuL & Myr-
Au100-EuL showed the characteristic EuL emission lines upon excitation at 340 nm, and band positions were
not affected by plasmon interactions with the gold surfaces. Cells treated with Myr-Au13-EuL & Myr-Au100-
EuL appeared to be uptaken more efficiently than cells treated with the non-myristoylated analogues Au13-
EuL & Au100-EuL as demonstrated by ICP-MS measurements and reflection microscopy, indicating that
these labelled AuNPs with a hydrophobic coating offer improved uptake efficiency over non-myristoylated
particles. Microscopy studies demonstrated Myr-Au13-EuL’s potential as a luminescence imaging probe,
as well as an indication that Myr-Au100-EuL & Au100-EuL particles are internalized into cell cytoplasmic
regions. Cells treated with Myr-Au13-EuL or Myr-Au100-EuL did not show any cytotoxic response after
a 6 hour treatment time, as measured by the MTT reduction assay, which provided an assessment of cell
viability through measuring mitochondrial activity. This further adds to the overall project conclusion that
gold nanoparticles provide a non-cytotoxic scaffold to build cellular delivery agents.
5.4 Future Work
In this work I have presented evidence that labelling AuNPs with a simple lipid offers a higher efficiency of
uptake into cancer cells than nanoparticles devoid of a lipid coating. This evidence would be much stronger
if backed up with additional repeats of the ICP-MS analysis of Myr-Au13-EuL versus Au13-EuL uptake into
HeLa cells. This would be supplemented with FACS analysis of Myr-Au100-EuL versus Au100-EuL uptake
into HeLa cells. Additionally, time resolved studies would be important to study the effect that myristic
acid and the gold nanoarticles impose on EuL luminescence. A comprehensive analysis of the cytotoxicity
of all labelled-AuNPs used in this chapter would also be an important step, paying particular focus on
concentration and incubation time.
5.5 Experimental
5.5.1 Chemicals and Reagents
All materials and reagents were purchased from Sigma Aldrich, VWR or Fisher Scientific and used without
any modification unless specified.
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5.5.2 Synthesis of luminescent Europium complex, EuL
EuL was prepared by Johnathon Lilley according to the protocol of Davies et al. [139]. The ligand H3L
was characterised by 1H & 13C nuclear magnetic resonance and mass spectrometry. 1H NMR (300 MHz,
d6-DMSO) δH ppm: 10.19 (2H, br, NH), 8.82 (2H, d, J = 3.8, Hh), 8.34 (2H, d, J = 8.4, Hj), 7.57 (2H, d,
J = 8.2, Hl) 7.49 (2H, dd, J = 8.4, 3.8, Hi), 7.06 (2H, d, J = 8.2, Hk), 4.08 (4H, t, J = 6.6, Hg), 3.48 (8H,
s, Hm, Hp), 3.41 (2H, s, Hq), 3.03 (4H, br, Ho), 2.92 (4H, br, Hn), 2.85 (4H, t, J = 7.1, Hb), 2.32 (6H, s,
Ha), 1.81 (4H, t, J = 6.6, Hf), 1.60 1.35 (12H, m, Hc, Hd, He). 13C NMR (400 MHz, d6-DMSO) δC ppm:
195.3, 173.6, 170.2, 152.3, 148.6, 139.6, 131.7, 125.9, 124.4, 122.3, 121.2, 108.6, 68.3, 58.9, 57.3, 55.3, 52.3,
51.4, 30.6, 29.1, 28.6, 28.3, 27.9, 25.1. MS (ES-TOF)+ m/z: 994.9 [M + H]+.
H3L (0.21 g, 0.21 mmol, 1.00 eq) was dissolved in THF : H2O (20 ml, 1:1 by volume) and the pH was
adjusted to 6 with addition of TBAOH (40% in water). A solution of EuCl3.6H2O (0.08 g, 0.21 mmol, 1.00
eq.) in water (4 ml) was prepared and added to the H3QuinSAc solution. The vessel holding the EuCl3.6H2O
solution was washed out with water (2 x 1 ml) and this was also added to the H3L solution. The solution
was left to stir for 15 minutes at RT, whereupon the THF was removed in vacuo and the pH was adjusted to
6 with addition of TBAOH (40% in water), which yielded a tarry precipitate. The water was decanted out
and the precipitate triturated in acetone for 1 hour, filtered and further triturated with MeCN for 1 hour
and filtered to give EuL as a brown powder (0.17 g, 0.15 mmol, 71%). MS (ES-TOF)+ m/z: 1144.4 [M +
H]+.
5.5.3 Synthesis of colloidal gold
13 nm citrate-stabilized AuNPs were synthesized by the method according to Schulz et al.[159] and subse-
quently a seeded growth protocol by Ziegler et al. [69] was used with 13 nm AuNP seeds to synthesise 100
nm diameter AuNPs. Particles were characterized by dynamic light scattering, capilliary electrophoresis,
transmission electron microscopy and UV/Vis absorption spectroscopy. The approximate concentrations
have also been estimated as 1.6 nM for Au13NPs and 40 pM for Au100NPs.
Synthesis of Au13NPs
For Au13NPs, the method of Schulz et al.[159] was followed with a few modifications. Refer to chapter 2
for complete characterisation. Briefly, a solution of trisodium citrate (60.6 mg), citric acid (13.3 mg) and
ethylenediaminetetraacetic acid (1.0 mg) in H2O (100 mL) was brought to reflux with rapid stirring. Rapid
addition of HAuCl4 (8.0 mg) in H2O (25 mL) to the vortex of the solution resulted in a colour change
from pale colourless to a deep wine red, approximately 30 seconds post-addition. Boiling was continued for
an additional 10 minutes, the heating mantle was then removed and stirring was continued until particles
had cooled to room temperature. The colloid was characterized by a UV/Vis absorption at 516 nm, a zeta
potential (ζ) of -37 ± 7 mV (pH 6.2), and DLS number distribution indicated a particle size of 11 ± 3 nm.
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Transmission electron microscopy also confirmed the synthesis of approximately 13 nm seeds.
Synthesis of Au25NPs
Au13NPs (34 mL) were diluted to 40 mL with H2O, and stirred rapidly in a roundbottom flask equipped
with a reflux condenser. Solutions of i) trisodium citrate and ascorbic acid in H2O (20 mL) and ii) HAuCl4
in H2O were both simultaneously added to the colloidal solution in a dropwise fashion. After addition
was complete, the mixture was heated at 150◦C for 30 minutes, and then allowed to cool slowly to room
temperature.
Synthesis of Au50NPs
Au25NPs (9 mL) were diluted to 40 mL with H2O, and stirred rapidly in a roundbottom flask equipped with
a reflux condenser. Solutions of i) trisodium citrate and ascorbic acid in H2O (20 mL) and ii) HAuCl4 in H2O
were both simultaneously added to the colloidal solution in a dropwise fashion. After addition was complete,
the mixture was heated at 150◦C for 30 minutes, and then allowed to cool slowly to room temperature.
Synthesis of Au100NPs
Au50NPs (40 mL) were stirred rapidly in a roundbottom flask equipped with a reflux condenser. Solutions
of i) trisodium citrate and ascorbic acid in H2O (20 mL) and ii) HAuCl4 in H2O were both simultaneously
added to the colloidal solution in a dropwise fashion. After addition was complete, the mixture was heated
at 150◦C for 30 minutes, and then allowed to cool slowly to room temperature.
5.5.4 Preparation of cells for Fluorescence-Activated Cell Sorting (FACS)
Prior to treatment, cells were plated into a 12-well culture plate and allowed to grow to approximately 60%
confluency. Cells were then washed with buffers before being treated with particles in a Tyrodes buffer(0.08
mM, pH 6.5 or 7.4), for a series of incubation times upto three hours. After treatment was complete, the
supernatant from each well was removed and each well was washed with PBS (0.1 M, 0.5 mL) twice before
being trypsinised at 37◦C for 10 minutes. Particles were then spun down at 1500 rpm for 10 minutes,
the supernatant removed, and redispersed in of PBS (0.1 M, 1 mL). Cell suspension was transferred to a
FACS tube before analysis. for all samples, the parameters of Forward Scatter, Side Scatter, and far red
luminescence were measured (488 nm excitation, emission >620 nm). 15,000 events were recorded for each
sample.
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5.5.5 Preparation of cells for Confocal Microscopy
Preparation for Fixed Cell Imaging
For fixed cell imaging, glass coverslips were sterilised using absolute ethanol (rinsed and left to dry) and
placed into the wells of 6-well culture plates. 5x104 cells were then seeded into each well of the 6-well culture
plates on top of glass coverslips and allowed to grow to confluency for 24 hours. Before treatment, media
from each well was removed and cells were washed twice with the media used in the seeding experiment,
before being sequentially treated with the media and particles. After treatment, medium was removed and
cells were washed with PBS (2 mL x 2) and then paraformaldehyde (4% in 0.1M PBS, 2 mL) was added and
cells were left for 10 minutes at room temperature. Fixative was removed and cells were washed with PBS (2
mL x 2). Cells were then mounted onto glass microscope slides, using a drop of non-fluorescing Hydromount
to maintain sample hydration, before sealing the slide with nail varnish. Slides were left to dry in a cold
room and were imaged within a few days.
Preparation for Live Cell Imaging
For live cell imaging, 5x104 cells were then seeded into the well of a MatTek(R) glass-bottom microscopy
dish and allowed to grow to confluency for 24 hours. Before treatment, media from each well was removed
and cells were washed twice with the media used in the seeding experiment, before being sequentially treated
with the media and particles. After treatment, medium was removed and cells were washed with PBS (2
mL x 2) and then PBS (2 mL) was added before transferring samples to the microscope for acquisition.
5.5.6 Preparation of cells for Inductively Coupled Plasma - Mass Spectrometry
HeLa cells were cultured as per above and treated as per the relevant experiment. After treatment was
complete, the supernatant from each well was removed and each well was washed with PBS (0.1 M, 0.5 mL)
twice before being trypsinised at 37◦C for 10 minutes. Particles were then spun down at 20,000 rpm for 10
minutes, the supernatant completely removed taking care not to disturb the cell pellet, before being allowed
to dissolve overnight in 200 µL of ultrapure aqua regia (3:1 volumetric ratio of hydrochloric and nitric acid).
Post dissolution, samples were diluted in ultrapure nitric acid (2700 µL of a 4% solution) prior to analysis.
5.5.7 Preparation of cells for Transmission Electron Microscopy
Samples were then imaged on a JEOL JEM-1200EX and a JEOL JEM-2100 electron microscope each fitted
with a Tungsten electron source and a Gatan camera. Cell samples were fixed with a solution of Paraformalde-
hyde (4%) and Glutaraldehyde (2.5%) in phosphate buffered saline for two hours, prior to sectioning and
mounting onto formvar-coated copper grids.
178
5.5.8 Analysing Cell Viability of Nanoparticle-treated HeLa cells
After treatment of HeLa cells with labelled-AuNPs, the media from each well was withdrawn and cells
were washed with PBS (500 µl) and replaced with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (0.5 mg/ml) in complete media (90% by volume), and were reincubated at 37◦C for 2 hours. After
the incubation, media was removed and DMSO (500 µl) was added to solubilise the formazan product. The




Project Evaluation & Future Study
6.1 Project Conclusions
In this work, functional imaging probes were constructed from 13 nm (Au13) & 100 nm (Au100) diameter gold
nanoparticles. Aqueous gold nanoparticles were labelled using targeting vectors based on a myrisityl lipid or
the pHLIP cell penetrating peptide series, along with a metal complex lumophore where suitable combinations
were chosen to suit application and experiment. The lumophores chosen were built from ruthenium and
europium complexes (RubpySS and EuL, respectively), and covalently labelled to gold nanoparticles via
long alkyl chains to maximise their emission by reducing the potential of Au surface quenching.
Effective surface labelling protocols were established such that the nanopartices were labelled with a high
density of lumophores in order to ensure nanoparticles were sufficiently luminescent, whilst still retaining
good nanoparticle monodispersity. The maximum possible density of surface bound RubpySS lumophores
was limited by colloidal stability, resultant from the labelling of negatively-charged nanoparticles with a
positively-charged lumophore. Despite this, it was found that pHLIP variants were able to stabilise the
nanoarticles during RubpySS loading and nanoparticles were successfully labelled with 140 - 270 RubpySS
labels and 35,000 - 66,000 RubpySS labels for Au13 & Au100 respectively. Additionally, the labelling protocols
were refined by varying the loading concentrations, volumes and stirring speed in order to yield homogenously
labelled nanopartices which were stable at physiological pH, which was important to ensure that interaction &
uptake of labelled particles was consistent for all particles within the colloid. The labelling of nanoparticles
with the europium complex, EuL was more facile as the neutral complex did not promote nanoparticle
flocculation during surface labelling.
The RubpySS complex showed emission enhancement when bound to an Au nanoparticle surface and
when dispersed into peptide solutions through lengthened luminescence lifetimes, suggesting a reduction
of quenching mechanisms. Additionally, the labelled-Au100 nanoparticles were highly luminescent during
in-flow imaging where individual particles were visualized in scatter and luminescence modes. Au13 &
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Au100 nanoparticles labelled with RubpySS were sufficiently luminescent for confocal imaging of treated
cells, permitting the visualisation of Au13NPs during live conditions that are not observable by reflectance
imaging.
pHLIP-Au13&100-RubpySS and pHLIPvar3-Au13&100-RubpySS nanoparticles were readily uptaken into
cultured human cervical adenocarcinoma cell monolayers within 15 minutes, and were easily visible by
luminescence, reflection & TEM imaging, and gold concentrations were measured from treated cell samples
using using ICP-Mass spectrometry. The measured pH-dependent uptake of gold nanoparticles mediated
by pHLIP & pHLIPvar3 was consistent across each of these techniques, demonstrating that these peptides
mediate the delivery of gold nanoparticles into cancer cells using pH as a biomarker for the disease. These
techniques also demonstrate the multimodal potential of these probes, and the strong correlation between
flow cytometry scatter and luminescence data proved useful in characterising nanoparticle internalization &
dispersity as well as reinforcing the reliability of measuring luminescence from surface bound lumophores.
The pHLIPvar3 peptide proved to be an efficient mediator of pH-driven cellular transduction of labelled
gold nanoparticle cargoes. Within two hour treatments the peptide facilitated significantly greater nanoparti-
cle internalization (p < 0.01, by flow cytometry luminescence) of cells maintained under cancerous conditions
than cells maintained under normal physiological conditions. This was consistent for both labelled-Au13 and
labelled-Au100 nanoparticles, and the peptide was demonstrably more effective as a pH-triggered cellular
delivery vector than the Wt-pHLIP. TEM imaging indicated that internalized pHLIP-labelled nanoparticles
were located in a variety of intracellular spaces including within free cytosol, vesicular regions, and mem-
brane regions, suggesting that subsequent nuclear or mitochondrial targeting may be possible. Cells treated
with the non-pH targetting Zonyl-Au13&100-RubpySS nanoparticles did not display pH-dependent internali-
sation, indicating that the efficiency of endocytotic mechanisms were not affected within the pH range used
in experiments.
Modulation of intracellular glutathione of human cervical adenocarcinoma cells also revealed that Au100
nanoparticles labelled with pHLIPvar3 were sensitive to glutathione (GSH) concentration, and it was ob-
served that these particles were uptaken more efficiently into cells that exhibited higher concentrations of
GSH (p < 0.01, by flow cytometry luminescence) in a manner that appeared independent of endocytotic
mechanisms, and was not demonstrated by Wt-pHLIP labelled AuNPs. The reducing nature of GSH ap-
peared to have a destabilising effect on pHLIPvar3-labelled nanoparticles, as demonstrated by observing the
addition of GSH to nanoarticles in solution, but it is not clear at present how greater GSH concentration
facilitates a more efficient nanoparticle uptake efficiency. The treatment of [GSH]-modified HeLa cells with
Zonyl-Au100-RubpySS did not result in differential internalization efficiencies, indicating that endocytotic
mechanisms were not affected by intracellular GSH concentration.
It was also demonstrated in this work that gold nanoparticles that had been rendered more hydropho-
bic by labelling their surfaces with a myrisityl lipid were more efficiently internalized by human cervical
adenocarcinoma cells than non-labelled analogues, as demonstrated by ICP-MS and confocal microscopy.
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Labelling AuNPs with lipids improves their uptake efficiency, and the inclusion of the lipid into the particle’s
surface label did not impose a cytotoxic effect on the treated cells. The EuL luminescent signal from the
5D0 −→7 F2 band was also detected from cells treated with Myr-Au13-EuL demonstrating the suitability of
these particles for cellular imaging applications.
The labelled-AuNPs studied in this work all possessed zeta potentials < −30 mV, this indicates that
these particles are stable species that do not appear to significantly leach surface labels. The inert nature of
these labelled nanoparticles offers benefits for future use within photothermal applications as it is important
to have a therapeutic that only becomes cytotoxic upon irradiation, and not when only internalized. To
the author’s knowledge, 100 nm AuNPs are the largest nanoparticle cargo that has been delivered into cells
via a pHLIP-mediated, pH-dependent mechanism. This demonstrates pHLIP’s vesatility for delivering large
cargoes in a pH dependent manner, opening the avenue for future research into exploitation of AuNP size
dependency on the effectiveness of photothermal therapeutics constructed from AuNPs, in which individual
particles can easily be imaged. Additionally, this work includes images of internalized pHLIP-labelled AuNPs
taken under live conditions and without any enhancement solutions. Also highlighted in this work was the
effect of colloidal stability on the internalisation efficiency of labelled-AuNPs. As any pH-resolved treatment
of cells involves dispersion of sample within different buffers, the effect of each buffer on colloidal stability
must be known in order to produce a reliable experiment, and such information has been missing from many
peer-reviewed publications of pH-dependent nanoparticle delivery into cells.
6.2 Future Work
The next objective to pursue would be for the development of theranostic multimodal nanoprobes. The
use of targeted delivery of gold nanoparticles within photothermal therapy is becoming more common due
to the good efficiency that gold nanoparticles release heat when excited with NIR radiation. This work
is strongly paving the way towards a new form of photothermal probe, particularly as high loadings of
internalized particles are shown to be free from vesicular compartments, raising the possibility for subsequent
targeting. Subsequent targeting to nuclei or mitochondria would enable the application of these particles
within photothermal therapy to be more effective, and more likely that treatment results in cell mortality.
Additionally, the incorporation of a surface label that releases reactive oxygen species upon photoirradiation
would enable application of these nanoparticles within photodynamic therapies. One such method where this
might be achieved would be incorporation of porphyrin rings into the ruthenium complex [367]. Additionally,
the manipulation of intracellular GSH concentration may be useful to improve nanoparticle internalization






All materials were purchased from Sigma Aldrich, VWR International or Fisher Scientific, and were used
without modification unless stated.
pHLIP (AAEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTC(thiopyridyl)G), kpHLIP (AAEQN-
PIYWARYAKWLFTTPLLLLKLALLVDADEGTC(thiopyridyl)G) and pHLIPvar3 (ACDDQNPWRAYLDLLF-
PTDTLLLDLLWC) were synthesised by Peptide Synthetics, Southampton, UK and were dissolved in 5%
DMF in phosphate buffered saline.
7.2 Molecular Structure Analysis
7.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy
1H and 13C1H PENDANT NMR spectra were recorded using a Bruker AC 300, AV 300, AMX 400 or AV
400 spectrometer, and Si(CH3)4 was used as the external reference.
7.2.2 Electrospray Ionisation (ESI) Mass Spectrometry
Electrospray mass spectrometry was performed using a Waters Micromass instrument with a time of flight
mass analyser and a nitrogen laser.
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7.3 Nanoparticle Structure Analysis
7.3.1 UV/Vis Absorption Spectroscopy
UV-Vis absorption spectra were recorded using a Varian Cary 50 or Varian Cary 5000 dual beam spectrom-
eter. Samples were prepared in 1cm path length quartz cuvettes for acquisition, scanned at a rate of 300 nm
min−1 and corrected for solvent absorption.
7.3.2 Laser Doppler Velocimetry/Dynamic Light Scattering
DLS measurements were carried out on a Malvern Zetasizer Nano ZS, using a 633 incident laser mounted at
178◦ off detection. For each experiment, averages of 5 technical repeat measurements were reported in this
thesis.
7.3.3 Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
ICP-MS was performed using at the University of Warwick, on an Agilent 7500cx ICP-MS with an inte-
grated auto-sampler. Samples were digested using ultrapure aqua regia, before being diluted in 4% HNO3
for analysis. Concentrations of ruthenium and gold in nanoparticle samples were determined using linear
calibration curves constructed from purchased standards, with R2 > 0.998 in all cases.
7.3.4 Laser Doppler Micro-Electrophoresis
Zeta Potential (ζ) measurements were recorded on a Malvern Zetasizer Nano ZS. Calibration was performed
using a standard solution (carboxylated polystyrene latex dispersed in a pH 9.2) buffer prior to sample
acquisition. For each experiment, averages of 3 technical repeat measurements were reported in this thesis.
7.4 Luminescence Characterisation Techniques
7.4.1 Luminescence Spectroscopy
Steady state luminescence spectra were acquired on an Edinburgh FLS920 Time Resolved Spectrometer
fitted with a 450 W Xenon Arc lamp and a Hamamatsu R928 photomultiplier tube, or a Photon Technology
International (PTI) L-210M fitted with a 75 W Xenon Arc lamp & a Shimadzu R298 photomultiplier tube
in a model 814 analogue/photon counting multiplier. For emission scans, long-pass filters of 500 nm and
590 nm were used for ruthenium and europium complexes, respectively. For excitation scans of ruthenium
complexes, a long pass filter of 590 nm was used.
184
7.4.2 Time-resolved luminescence measurements
Time-resolved luminescence measurements were acquired using the time correlated single photon counting
(TCSPC) module of the Edinburgh FLS920 Time Resolved Spectrometer. Samples were excited using a
444 nm picosecond pulse-length diode laser, and a Hamamatsu R928 photomultiplier tube was used for
detection. Upon acquisition of the lifetime data, the data was fitted by a Levernberg-Marquandt non-linear
fitting algorithm using an arrhenius model function, and fitting was iterated until residual measurements
appeared completely random and χ2 values were as close to 1.000 as possible, with the smallest number of
exponents as possible.
7.5 Cell Culture
The human alveolar adenocarcinoma A549 cell line (line 86012804) were purchased from the European cell
Authority, and were cultured using Dulbeccos Modified Eagles Medium (DMEM) supplemented by 10%
Foetal Bovine Serum (FBS) with Penicillin (100l) Streptomycin (100l) and L-Glutamine (100l), hereafter
referred to as ’complete media’. Cells were cultured in 13 ml of complete media in vented T75 flasks at 37C
with 5% CO2. Cells were routinely passaged by a 1 10 dilution using a Trypsin-EDTA protocol. Briefly,
cell media was routinely replaced 48 - 72 hours after incubation. Old media was removed from the flask, and
cells were washed with PBS (2ml) before brief incubation with Trypsin (2ml, and returned to incubation for
5 minutes) until cells had detached from the surface of the flask. Complete media (8 ml) was added to cells
to quench the Trypsin, before cells were pelleted by centrifugation (1500rpm, 15 minutes). The supernatant
was decanted, and cells were resuspended in fresh media (13 ml), seeded into a new flask and returned to
incubation.
7.6 Flow Techniques
7.6.1 Fluorescence-Activated Cell Sorting (FACS)
Fluorescence-Activated Cell Sorting was performed on a FACS Calibur. The FACS Calibur was set up to
record forward scatter, side scatter and luminescence (λex = 488 nm, λem = >620 nm) with collection of
at least 15,000 events per sample. Acquired data was then analysed using Flowing Software 2 to calculate
mean values.
7.7 Nanosight
Nanoparticle tracking was performed using a Nanosight NS300 particle analyser equipped with a 55 mW
488 nm laser, operating in scatter mode with no dichroic mirrors in place, and luminescence mode with a




Confocal imaging was performed on three systems. i) Leica TCS SP2 Confocal system on a DMRE Inverted
Microscope (Leica Microsystems). ii) The Nikon A1R Inverted Confocal/TIRF System on a Ti inverted
microscope with an EMCCD and Spectral Detector. iii) The Zeiss LSM710 Confocal System on an Observer
inverted Z1 microscope.
7.8.2 Epifluorescence Microscopy
Epi-imaging was performed using the Olympus IX71 Inverted Microscope attachment to the FLS920 Time
Resolved Spectrometer, equipped with a LUCPLFLN 400.60 NA objective and a Hamamatsu electron-
multiplying (EMCCD) C9100-13 camera.
7.8.3 Transmission Electron Microscopy
Biological samples were imaged using Jeol 1200EX TEM operating at a voltage 80 keV, fitted with a LaB6
filament, and Gatan multiscan camera. Images were acquired using Digital Micrograph 1.8 (Gatan, CA,
USA). EDAX measurements were performed using a Jeol 2100 LaB6 TEM fitted with an Oxford Instruments
INCA EDS system with a tungsten filament electron source and a Gatan camera.
7.9 Colorimetric Assays
MTT absorption measurements were performed using a Tecan Infinite F200 Pro plate reader measuring
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